TW200911884A - Liquid crystal aligning agent, liquid crystal alignment film, method for producing the same, and liquid crystal display device - Google Patents
Liquid crystal aligning agent, liquid crystal alignment film, method for producing the same, and liquid crystal display device Download PDFInfo
- Publication number
- TW200911884A TW200911884A TW97129403A TW97129403A TW200911884A TW 200911884 A TW200911884 A TW 200911884A TW 97129403 A TW97129403 A TW 97129403A TW 97129403 A TW97129403 A TW 97129403A TW 200911884 A TW200911884 A TW 200911884A
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- liquid crystal
- compound
- formula
- crystal alignment
- Prior art date
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 255
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 87
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 240
- 238000000034 method Methods 0.000 claims abstract description 68
- 229920000642 polymer Polymers 0.000 claims abstract description 25
- 230000005855 radiation Effects 0.000 claims abstract description 16
- 125000003700 epoxy group Chemical group 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims description 98
- 239000000758 substrate Substances 0.000 claims description 58
- 125000000217 alkyl group Chemical group 0.000 claims description 33
- 238000000576 coating method Methods 0.000 claims description 33
- 239000011248 coating agent Substances 0.000 claims description 32
- 125000004432 carbon atom Chemical group C* 0.000 claims description 29
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 25
- 229910052799 carbon Inorganic materials 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 18
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
- 108010039918 Polylysine Proteins 0.000 claims description 12
- 125000003709 fluoroalkyl group Chemical group 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 12
- 229920000656 polylysine Polymers 0.000 claims description 12
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 6
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 125000004434 sulfur atom Chemical group 0.000 claims description 6
- 125000005037 alkyl phenyl group Chemical group 0.000 claims description 4
- 238000004132 cross linking Methods 0.000 claims description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims description 4
- 230000001678 irradiating effect Effects 0.000 claims description 4
- 238000006317 isomerization reaction Methods 0.000 claims description 4
- 125000002933 cyclohexyloxy group Chemical group C1(CCCCC1)O* 0.000 claims description 3
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims description 2
- 125000002345 steroid group Chemical group 0.000 claims 3
- 150000002222 fluorine compounds Chemical class 0.000 claims 1
- 229920005575 poly(amic acid) Polymers 0.000 abstract description 15
- 239000004642 Polyimide Substances 0.000 abstract description 3
- 229920001721 polyimide Polymers 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 description 102
- 230000015572 biosynthetic process Effects 0.000 description 101
- 239000010408 film Substances 0.000 description 98
- 239000000243 solution Substances 0.000 description 63
- -1 polyethylene laurate Polymers 0.000 description 51
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 49
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 34
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 34
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 34
- 239000002904 solvent Substances 0.000 description 31
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 29
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 28
- 229910001868 water Inorganic materials 0.000 description 27
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 26
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 26
- 239000002585 base Substances 0.000 description 25
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 24
- 239000003960 organic solvent Substances 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 23
- 239000002253 acid Substances 0.000 description 23
- 229910000027 potassium carbonate Inorganic materials 0.000 description 23
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 21
- 125000006158 tetracarboxylic acid group Chemical group 0.000 description 21
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- 210000002858 crystal cell Anatomy 0.000 description 19
- 230000018044 dehydration Effects 0.000 description 19
- 238000006297 dehydration reaction Methods 0.000 description 19
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- 150000004985 diamines Chemical class 0.000 description 17
- 229910052757 nitrogen Inorganic materials 0.000 description 17
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 16
- 235000011181 potassium carbonates Nutrition 0.000 description 16
- 239000002244 precipitate Substances 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- 239000003054 catalyst Substances 0.000 description 15
- 238000010992 reflux Methods 0.000 description 15
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 15
- 235000019439 ethyl acetate Nutrition 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 13
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 239000012044 organic layer Substances 0.000 description 12
- 239000007787 solid Substances 0.000 description 12
- 229910014033 C-OH Inorganic materials 0.000 description 11
- 229910014570 C—OH Inorganic materials 0.000 description 11
- 239000013078 crystal Substances 0.000 description 11
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 10
- 235000019341 magnesium sulphate Nutrition 0.000 description 10
- 238000012423 maintenance Methods 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 150000003431 steroids Chemical class 0.000 description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 239000012024 dehydrating agents Substances 0.000 description 8
- DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 8
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 125000000962 organic group Chemical group 0.000 description 7
- 108010026466 polyproline Proteins 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- YZWKKMVJZFACSU-UHFFFAOYSA-N 1-bromopentane Chemical compound CCCCCBr YZWKKMVJZFACSU-UHFFFAOYSA-N 0.000 description 6
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 6
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000004988 Nematic liquid crystal Substances 0.000 description 6
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 150000008065 acid anhydrides Chemical class 0.000 description 6
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000007363 ring formation reaction Methods 0.000 description 6
- 229910052707 ruthenium Inorganic materials 0.000 description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 6
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 239000000428 dust Substances 0.000 description 5
- 230000005611 electricity Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 description 5
- 238000006798 ring closing metathesis reaction Methods 0.000 description 5
- 230000003068 static effect Effects 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000008096 xylene Substances 0.000 description 5
- JOLPMPPNHIACPD-ZZXKWVIFSA-N (e)-3-(4-aminophenyl)prop-2-enoic acid Chemical compound NC1=CC=C(\C=C\C(O)=O)C=C1 JOLPMPPNHIACPD-ZZXKWVIFSA-N 0.000 description 4
- CPDDDTNAMBSPRN-ZZXKWVIFSA-N (e)-3-(4-bromophenyl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=C(Br)C=C1 CPDDDTNAMBSPRN-ZZXKWVIFSA-N 0.000 description 4
- BHUPIKYIGMWGAD-UHFFFAOYSA-N 2-amino-9-(hydroxymethyl)-3-oxophenoxazine-1-carboxylic acid Chemical compound C1=CC=C2OC3=CC(=O)C(N)=C(C(O)=O)C3=NC2=C1CO BHUPIKYIGMWGAD-UHFFFAOYSA-N 0.000 description 4
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 4
- 239000004593 Epoxy Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 125000001570 methylene group Chemical class [H]C([H])([*:1])[*:2] 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 3
- DIIIISSCIXVANO-UHFFFAOYSA-N 1,2-Dimethylhydrazine Chemical compound CNNC DIIIISSCIXVANO-UHFFFAOYSA-N 0.000 description 3
- FWHUTKPMCKSUCV-UHFFFAOYSA-N 1,3-dioxo-3a,4,5,6,7,7a-hexahydro-2-benzofuran-5-carboxylic acid Chemical compound C1C(C(=O)O)CCC2C(=O)OC(=O)C12 FWHUTKPMCKSUCV-UHFFFAOYSA-N 0.000 description 3
- VLDPXPPHXDGHEW-UHFFFAOYSA-N 1-chloro-2-dichlorophosphoryloxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(Cl)=O VLDPXPPHXDGHEW-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 3
- RHRNYXVSZLSRRP-UHFFFAOYSA-N 3-(carboxymethyl)cyclopentane-1,2,4-tricarboxylic acid Chemical compound OC(=O)CC1C(C(O)=O)CC(C(O)=O)C1C(O)=O RHRNYXVSZLSRRP-UHFFFAOYSA-N 0.000 description 3
- YGYCECQIOXZODZ-UHFFFAOYSA-N 4415-87-6 Chemical compound O=C1OC(=O)C2C1C1C(=O)OC(=O)C12 YGYCECQIOXZODZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- 229920000954 Polyglycolide Polymers 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229910021603 Ruthenium iodide Inorganic materials 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 150000001350 alkyl halides Chemical class 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical group C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 3
- 239000004305 biphenyl Substances 0.000 description 3
- 235000013985 cinnamic acid Nutrition 0.000 description 3
- 229930016911 cinnamic acid Natural products 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 229930005346 hydroxycinnamic acid Natural products 0.000 description 3
- 235000010359 hydroxycinnamic acids Nutrition 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 239000003607 modifier Substances 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 230000010287 polarization Effects 0.000 description 3
- 239000004633 polyglycolic acid Substances 0.000 description 3
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
- 150000004060 quinone imines Chemical group 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- LJZVDOUZSMHXJH-UHFFFAOYSA-K ruthenium(3+);triiodide Chemical compound [Ru+3].[I-].[I-].[I-] LJZVDOUZSMHXJH-UHFFFAOYSA-K 0.000 description 3
- YBCAZPLXEGKKFM-UHFFFAOYSA-K ruthenium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Ru+3] YBCAZPLXEGKKFM-UHFFFAOYSA-K 0.000 description 3
- 239000000565 sealant Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- NGSWKAQJJWESNS-ZZXKWVIFSA-N trans-4-coumaric acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-N 0.000 description 3
- AGGJWJFEEKIYOF-UHFFFAOYSA-N 1,1,1-triethoxydecane Chemical compound CCCCCCCCCC(OCC)(OCC)OCC AGGJWJFEEKIYOF-UHFFFAOYSA-N 0.000 description 2
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 2
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 2
- KVNYFPKFSJIPBJ-UHFFFAOYSA-N 1,2-diethylbenzene Chemical compound CCC1=CC=CC=C1CC KVNYFPKFSJIPBJ-UHFFFAOYSA-N 0.000 description 2
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 2
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- HDPLHDGYGLENEI-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC1CO1 HDPLHDGYGLENEI-UHFFFAOYSA-N 0.000 description 2
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 2
- KUAUJXBLDYVELT-UHFFFAOYSA-N 2-[[2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C1OC1COCC(C)(C)COCC1CO1 KUAUJXBLDYVELT-UHFFFAOYSA-N 0.000 description 2
- IQHSSYROJYPFDV-UHFFFAOYSA-N 2-bromo-1,3-dichloro-5-(trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC(Cl)=C(Br)C(Cl)=C1 IQHSSYROJYPFDV-UHFFFAOYSA-N 0.000 description 2
- ILWROKQKEDTIKB-UHFFFAOYSA-N 2-pentan-2-yloxy-1-phenylethanone Chemical compound CCCC(C)OCC(=O)C1=CC=CC=C1 ILWROKQKEDTIKB-UHFFFAOYSA-N 0.000 description 2
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 2
- HLBLWEWZXPIGSM-UHFFFAOYSA-N 4-Aminophenyl ether Chemical compound C1=CC(N)=CC=C1OC1=CC=C(N)C=C1 HLBLWEWZXPIGSM-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- BEKFRNOZJSYWKZ-UHFFFAOYSA-N 4-[2-(4-aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]aniline Chemical compound C1=CC(N)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(N)C=C1 BEKFRNOZJSYWKZ-UHFFFAOYSA-N 0.000 description 2
- HYDATEKARGDBKU-UHFFFAOYSA-N 4-[4-[4-(4-aminophenoxy)phenyl]phenoxy]aniline Chemical group C1=CC(N)=CC=C1OC1=CC=C(C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)C=C1 HYDATEKARGDBKU-UHFFFAOYSA-N 0.000 description 2
- NVKGJHAQGWCWDI-UHFFFAOYSA-N 4-[4-amino-2-(trifluoromethyl)phenyl]-3-(trifluoromethyl)aniline Chemical group FC(F)(F)C1=CC(N)=CC=C1C1=CC=C(N)C=C1C(F)(F)F NVKGJHAQGWCWDI-UHFFFAOYSA-N 0.000 description 2
- WJMQNPAEXWNWMD-UHFFFAOYSA-N 4-[9-(4-aminophenyl)-10h-anthracen-9-yl]aniline Chemical compound C1=CC(N)=CC=C1C1(C=2C=CC(N)=CC=2)C2=CC=CC=C2CC2=CC=CC=C21 WJMQNPAEXWNWMD-UHFFFAOYSA-N 0.000 description 2
- IMLXLGZJLAOKJN-UHFFFAOYSA-N 4-aminocyclohexan-1-ol Chemical compound NC1CCC(O)CC1 IMLXLGZJLAOKJN-UHFFFAOYSA-N 0.000 description 2
- CCTOEAMRIIXGDJ-UHFFFAOYSA-N 4-hydroxy-2-benzofuran-1,3-dione Chemical compound OC1=CC=CC2=C1C(=O)OC2=O CCTOEAMRIIXGDJ-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- VQVIHDPBMFABCQ-UHFFFAOYSA-N 5-(1,3-dioxo-2-benzofuran-5-carbonyl)-2-benzofuran-1,3-dione Chemical compound C1=C2C(=O)OC(=O)C2=CC(C(C=2C=C3C(=O)OC(=O)C3=CC=2)=O)=C1 VQVIHDPBMFABCQ-UHFFFAOYSA-N 0.000 description 2
- KPIAHQAOODFLBZ-UHFFFAOYSA-N 9-methylcarbazole-3,6-diamine Chemical compound NC1=CC=C2N(C)C3=CC=C(N)C=C3C2=C1 KPIAHQAOODFLBZ-UHFFFAOYSA-N 0.000 description 2
- NKSQIEJTEVJKKB-UHFFFAOYSA-N 9-phenylcarbazole-3,6-diamine Chemical compound C12=CC=C(N)C=C2C2=CC(N)=CC=C2N1C1=CC=CC=C1 NKSQIEJTEVJKKB-UHFFFAOYSA-N 0.000 description 2
- YCZUWQOJQGCZKG-UHFFFAOYSA-N 9h-carbazole-3,6-diamine Chemical compound C1=C(N)C=C2C3=CC(N)=CC=C3NC2=C1 YCZUWQOJQGCZKG-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 2
- MPONAPFARZGDTH-UHFFFAOYSA-N Cl.OS(O)=O Chemical compound Cl.OS(O)=O MPONAPFARZGDTH-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- YVHAIVPPUIZFBA-UHFFFAOYSA-N Cyclopentylacetic acid Chemical compound OC(=O)CC1CCCC1 YVHAIVPPUIZFBA-UHFFFAOYSA-N 0.000 description 2
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- 235000014443 Pyrus communis Nutrition 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- OYTKINVCDFNREN-UHFFFAOYSA-N amifampridine Chemical compound NC1=CC=NC=C1N OYTKINVCDFNREN-UHFFFAOYSA-N 0.000 description 2
- 229960004012 amifampridine Drugs 0.000 description 2
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- DMLAVOWQYNRWNQ-UHFFFAOYSA-N azobenzene Chemical class C1=CC=CC=C1N=NC1=CC=CC=C1 DMLAVOWQYNRWNQ-UHFFFAOYSA-N 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- WKDNYTOXBCRNPV-UHFFFAOYSA-N bpda Chemical compound C1=C2C(=O)OC(=O)C2=CC(C=2C=C3C(=O)OC(C3=CC=2)=O)=C1 WKDNYTOXBCRNPV-UHFFFAOYSA-N 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- CURBACXRQKTCKZ-UHFFFAOYSA-N cyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1C(C(O)=O)C(C(O)=O)C1C(O)=O CURBACXRQKTCKZ-UHFFFAOYSA-N 0.000 description 2
- VKIRRGRTJUUZHS-UHFFFAOYSA-N cyclohexane-1,4-diamine Chemical compound NC1CCC(N)CC1 VKIRRGRTJUUZHS-UHFFFAOYSA-N 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000007641 inkjet printing Methods 0.000 description 2
- XAOGXQMKWQFZEM-UHFFFAOYSA-N isoamyl propanoate Chemical compound CCC(=O)OCCC(C)C XAOGXQMKWQFZEM-UHFFFAOYSA-N 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000001459 lithography Methods 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- YTVNOVQHSGMMOV-UHFFFAOYSA-N naphthalenetetracarboxylic dianhydride Chemical compound C1=CC(C(=O)OC2=O)=C3C2=CC=C2C(=O)OC(=O)C1=C32 YTVNOVQHSGMMOV-UHFFFAOYSA-N 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 150000002923 oximes Chemical class 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- 238000000059 patterning Methods 0.000 description 2
- DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- ZSLKNYNUPNHOLY-UHFFFAOYSA-N purine-2,7-diamine Chemical compound NC1=NC=C2N(C=NC2=N1)N ZSLKNYNUPNHOLY-UHFFFAOYSA-N 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- VHNQIURBCCNWDN-UHFFFAOYSA-N pyridine-2,6-diamine Chemical compound NC1=CC=CC(N)=N1 VHNQIURBCCNWDN-UHFFFAOYSA-N 0.000 description 2
- YAAWASYJIRZXSZ-UHFFFAOYSA-N pyrimidine-2,4-diamine Chemical compound NC1=CC=NC(N)=N1 YAAWASYJIRZXSZ-UHFFFAOYSA-N 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000004528 spin coating Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- OAXARSVKYJPDPA-UHFFFAOYSA-N tert-butyl 4-prop-2-ynylpiperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(CC#C)CC1 OAXARSVKYJPDPA-UHFFFAOYSA-N 0.000 description 2
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- YKNMIGJJXKBHJE-UHFFFAOYSA-N (3-aminophenyl)-(4-aminophenyl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=CC(N)=C1 YKNMIGJJXKBHJE-UHFFFAOYSA-N 0.000 description 1
- LTUMRKDLVGQMJU-VHSABMJYSA-N (5z,9z)-6,10,14-trimethylpentadeca-5,9,13-trien-2-one Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CCC(C)=O LTUMRKDLVGQMJU-VHSABMJYSA-N 0.000 description 1
- OTVRYZXVVMZHHW-FNOPAARDSA-N (8s,9s,10r,13r,14s,17r)-3-chloro-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1C=C2CC(Cl)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 OTVRYZXVVMZHHW-FNOPAARDSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- YFORDJRKPMKUDA-UHFFFAOYSA-N 1,1'-biphenyl;cyclohexane Chemical compound C1CCCCC1.C1=CC=CC=C1C1=CC=CC=C1 YFORDJRKPMKUDA-UHFFFAOYSA-N 0.000 description 1
- WJMXTYZCTXTFJM-UHFFFAOYSA-N 1,1,1,2-tetraethoxydecane Chemical compound C(C)OC(C(OCC)(OCC)OCC)CCCCCCCC WJMXTYZCTXTFJM-UHFFFAOYSA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- LNDGACQEAYKNOI-UHFFFAOYSA-N 1,1,1-trifluoro-4-iodobutane Chemical compound FC(F)(F)CCCI LNDGACQEAYKNOI-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- ACTKAGSPIFDCMF-UHFFFAOYSA-N 1,3-oxazol-2-amine Chemical compound NC1=NC=CO1 ACTKAGSPIFDCMF-UHFFFAOYSA-N 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- KJDRSWPQXHESDQ-UHFFFAOYSA-N 1,4-dichlorobutane Chemical compound ClCCCCCl KJDRSWPQXHESDQ-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- JPZYXGPCHFZBHO-UHFFFAOYSA-N 1-aminopentadecane Chemical compound CCCCCCCCCCCCCCCN JPZYXGPCHFZBHO-UHFFFAOYSA-N 0.000 description 1
- YEUIMZOJSJEGFM-UHFFFAOYSA-N 1-cyclohexyl-n,n-bis(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC1CCCCC1)CC1CO1 YEUIMZOJSJEGFM-UHFFFAOYSA-N 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 1
- BDQNKCYCTYYMAA-UHFFFAOYSA-N 1-isocyanatonaphthalene Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1 BDQNKCYCTYYMAA-UHFFFAOYSA-N 0.000 description 1
- JPEWDCTZJFUITH-UHFFFAOYSA-N 1-methoxydecane Chemical compound CCCCCCCCCCOC JPEWDCTZJFUITH-UHFFFAOYSA-N 0.000 description 1
- BUZMJVBOGDBMGI-UHFFFAOYSA-N 1-phenylpropylbenzene Chemical compound C=1C=CC=CC=1C(CC)C1=CC=CC=C1 BUZMJVBOGDBMGI-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- STTIQGVRGFWCSX-UHFFFAOYSA-N 2-(2,3,5-trimethylcyclopentyl)acetic acid Chemical compound CC1C(C(CC1C)C)CC(=O)O STTIQGVRGFWCSX-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- FPZWZCWUIYYYBU-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl acetate Chemical compound CCOCCOCCOC(C)=O FPZWZCWUIYYYBU-UHFFFAOYSA-N 0.000 description 1
- BJINVQNEBGOMCR-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethyl acetate Chemical compound COCCOCCOC(C)=O BJINVQNEBGOMCR-UHFFFAOYSA-N 0.000 description 1
- IOHPVZBSOKLVMN-UHFFFAOYSA-N 2-(2-phenylethyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1CCC1=CC=CC=C1 IOHPVZBSOKLVMN-UHFFFAOYSA-N 0.000 description 1
- PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical compound NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 description 1
- MFAWEYJGIGIYFH-UHFFFAOYSA-N 2-[4-(trimethoxymethyl)dodecoxymethyl]oxirane Chemical compound C(C1CO1)OCCCC(C(OC)(OC)OC)CCCCCCCC MFAWEYJGIGIYFH-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- WTYYGFLRBWMFRY-UHFFFAOYSA-N 2-[6-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COCCCCCCOCC1CO1 WTYYGFLRBWMFRY-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- SVONRAPFKPVNKG-UHFFFAOYSA-N 2-ethoxyethyl acetate Chemical compound CCOCCOC(C)=O SVONRAPFKPVNKG-UHFFFAOYSA-N 0.000 description 1
- IEFWDQQGFDLKFK-UHFFFAOYSA-N 2-n,2-n-dimethyl-1,3,5-triazine-2,4,6-triamine Chemical compound CN(C)C1=NC(N)=NC(N)=N1 IEFWDQQGFDLKFK-UHFFFAOYSA-N 0.000 description 1
- SVNYYRBVMLHBTG-UHFFFAOYSA-N 2-octadecoxybenzene-1,4-diamine Chemical compound CCCCCCCCCCCCCCCCCCOC1=CC(N)=CC=C1N SVNYYRBVMLHBTG-UHFFFAOYSA-N 0.000 description 1
- HCGFUIQPSOCUHI-UHFFFAOYSA-N 2-propan-2-yloxyethanol Chemical compound CC(C)OCCO HCGFUIQPSOCUHI-UHFFFAOYSA-N 0.000 description 1
- YEYKMVJDLWJFOA-UHFFFAOYSA-N 2-propoxyethanol Chemical compound CCCOCCO YEYKMVJDLWJFOA-UHFFFAOYSA-N 0.000 description 1
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical group C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 1
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical group C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- QHAXASKQEOLOPT-UHFFFAOYSA-N 3,4,5,6-tetrabutylphthalic acid Chemical compound C(CCC)C=1C(=C(C(=C(C1C(=O)O)C(=O)O)CCCC)CCCC)CCCC QHAXASKQEOLOPT-UHFFFAOYSA-N 0.000 description 1
- SCJHPUGWYHCYAZ-UHFFFAOYSA-N 3,5-diethyl-2-propylpyridine Chemical compound CCCC1=NC=C(CC)C=C1CC SCJHPUGWYHCYAZ-UHFFFAOYSA-N 0.000 description 1
- GWHLJVMSZRKEAQ-UHFFFAOYSA-N 3-(2,3-dicarboxyphenyl)phthalic acid Chemical compound OC(=O)C1=CC=CC(C=2C(=C(C(O)=O)C=CC=2)C(O)=O)=C1C(O)=O GWHLJVMSZRKEAQ-UHFFFAOYSA-N 0.000 description 1
- ZBMISJGHVWNWTE-UHFFFAOYSA-N 3-(4-aminophenoxy)aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(N)=C1 ZBMISJGHVWNWTE-UHFFFAOYSA-N 0.000 description 1
- CPDDDTNAMBSPRN-UHFFFAOYSA-N 3-(4-bromophenyl)prop-2-enoic acid Chemical compound OC(=O)C=CC1=CC=C(Br)C=C1 CPDDDTNAMBSPRN-UHFFFAOYSA-N 0.000 description 1
- RNLHGQLZWXBQNY-UHFFFAOYSA-N 3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine Chemical compound CC1(C)CC(N)CC(C)(CN)C1 RNLHGQLZWXBQNY-UHFFFAOYSA-N 0.000 description 1
- SAUDGWSSPBMGCL-UHFFFAOYSA-N 3-[1-(3-aminopropyl)piperidin-4-yl]propan-1-amine Chemical compound NCCCC1CCN(CCCN)CC1 SAUDGWSSPBMGCL-UHFFFAOYSA-N 0.000 description 1
- DKKYOQYISDAQER-UHFFFAOYSA-N 3-[3-(3-aminophenoxy)phenoxy]aniline Chemical compound NC1=CC=CC(OC=2C=C(OC=3C=C(N)C=CC=3)C=CC=2)=C1 DKKYOQYISDAQER-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- TVOXGJNJYPSMNM-UHFFFAOYSA-N 3-[4-(2,3-dicarboxy-4,5,6-triphenylphenyl)phenyl]-4,5,6-triphenylphthalic acid Chemical compound C=1C=CC=CC=1C=1C(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)C(C(=O)O)=C(C(O)=O)C=1C(C=C1)=CC=C1C(C(=C1C=2C=CC=CC=2)C=2C=CC=CC=2)=C(C(O)=O)C(C(O)=O)=C1C1=CC=CC=C1 TVOXGJNJYPSMNM-UHFFFAOYSA-N 0.000 description 1
- YOWKKGPNCDIFFB-UHFFFAOYSA-N 3-decyloxolane-2,5-dione Chemical compound CCCCCCCCCCC1CC(=O)OC1=O YOWKKGPNCDIFFB-UHFFFAOYSA-N 0.000 description 1
- YAXXOCZAXKLLCV-UHFFFAOYSA-N 3-dodecyloxolane-2,5-dione Chemical compound CCCCCCCCCCCCC1CC(=O)OC1=O YAXXOCZAXKLLCV-UHFFFAOYSA-N 0.000 description 1
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 description 1
- MECNWXGGNCJFQJ-UHFFFAOYSA-N 3-piperidin-1-ylpropane-1,2-diol Chemical compound OCC(O)CN1CCCCC1 MECNWXGGNCJFQJ-UHFFFAOYSA-N 0.000 description 1
- BZECBEKZECEQRI-UHFFFAOYSA-N 3-tetradecyloxolane-2,5-dione Chemical compound CCCCCCCCCCCCCCC1CC(=O)OC1=O BZECBEKZECEQRI-UHFFFAOYSA-N 0.000 description 1
- ICNFHJVPAJKPHW-UHFFFAOYSA-N 4,4'-Thiodianiline Chemical compound C1=CC(N)=CC=C1SC1=CC=C(N)C=C1 ICNFHJVPAJKPHW-UHFFFAOYSA-N 0.000 description 1
- IBOFVQJTBBUKMU-UHFFFAOYSA-N 4,4'-methylene-bis-(2-chloroaniline) Chemical compound C1=C(Cl)C(N)=CC=C1CC1=CC=C(N)C(Cl)=C1 IBOFVQJTBBUKMU-UHFFFAOYSA-N 0.000 description 1
- HNBQUQRHRREMJN-UHFFFAOYSA-N 4,4,4-trifluoro-1-iodobutan-1-ol Chemical compound FC(CCC(O)I)(F)F HNBQUQRHRREMJN-UHFFFAOYSA-N 0.000 description 1
- FBRZXUWXLQSJKY-UHFFFAOYSA-N 4,9-dioxatricyclo[5.3.1.02,6]undecane-3,5,8,10-tetrone Chemical compound C1C2C3C(=O)OC(=O)C3C1C(=O)OC2=O FBRZXUWXLQSJKY-UHFFFAOYSA-N 0.000 description 1
- CMSGUKVDXXTJDQ-UHFFFAOYSA-N 4-(2-naphthalen-1-ylethylamino)-4-oxobutanoic acid Chemical compound C1=CC=C2C(CCNC(=O)CCC(=O)O)=CC=CC2=C1 CMSGUKVDXXTJDQ-UHFFFAOYSA-N 0.000 description 1
- NRLUQVLHGAVXQB-UHFFFAOYSA-N 4-(4-amino-2-chloro-5-methoxyphenyl)-5-chloro-2-methoxyaniline Chemical group C1=C(N)C(OC)=CC(C=2C(=CC(N)=C(OC)C=2)Cl)=C1Cl NRLUQVLHGAVXQB-UHFFFAOYSA-N 0.000 description 1
- QYIMZXITLDTULQ-UHFFFAOYSA-N 4-(4-amino-2-methylphenyl)-3-methylaniline Chemical group CC1=CC(N)=CC=C1C1=CC=C(N)C=C1C QYIMZXITLDTULQ-UHFFFAOYSA-N 0.000 description 1
- HYBVISCYJVVEDX-UHFFFAOYSA-N 4-(4-aminophenyl)-3-chloroaniline Chemical group C1=CC(N)=CC=C1C1=CC=C(N)C=C1Cl HYBVISCYJVVEDX-UHFFFAOYSA-N 0.000 description 1
- KHYXYOGWAIYVBD-UHFFFAOYSA-N 4-(4-propylphenoxy)aniline Chemical compound C1=CC(CCC)=CC=C1OC1=CC=C(N)C=C1 KHYXYOGWAIYVBD-UHFFFAOYSA-N 0.000 description 1
- DZIHTWJGPDVSGE-UHFFFAOYSA-N 4-[(4-aminocyclohexyl)methyl]cyclohexan-1-amine Chemical compound C1CC(N)CCC1CC1CCC(N)CC1 DZIHTWJGPDVSGE-UHFFFAOYSA-N 0.000 description 1
- WUPRYUDHUFLKFL-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(OC=2C=CC(N)=CC=2)=C1 WUPRYUDHUFLKFL-UHFFFAOYSA-N 0.000 description 1
- SSDBTLHMCVFQMS-UHFFFAOYSA-N 4-[4-(1,1,1,3,3,3-hexafluoropropan-2-yl)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=C(C(C(F)(F)F)C(F)(F)F)C=C1 SSDBTLHMCVFQMS-UHFFFAOYSA-N 0.000 description 1
- JCRRFJIVUPSNTA-UHFFFAOYSA-N 4-[4-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC(C=C1)=CC=C1OC1=CC=C(N)C=C1 JCRRFJIVUPSNTA-UHFFFAOYSA-N 0.000 description 1
- KMKWGXGSGPYISJ-UHFFFAOYSA-N 4-[4-[2-[4-(4-aminophenoxy)phenyl]propan-2-yl]phenoxy]aniline Chemical compound C=1C=C(OC=2C=CC(N)=CC=2)C=CC=1C(C)(C)C(C=C1)=CC=C1OC1=CC=C(N)C=C1 KMKWGXGSGPYISJ-UHFFFAOYSA-N 0.000 description 1
- GBHZJPJEMDSLFX-UHFFFAOYSA-N 4-[4-[2-[4-(4-aminophenyl)phenyl]-1,1,1,3,3,3-hexafluoropropan-2-yl]phenyl]aniline Chemical compound Nc1ccc(cc1)-c1ccc(cc1)C(c1ccc(cc1)-c1ccc(N)cc1)(C(F)(F)F)C(F)(F)F GBHZJPJEMDSLFX-UHFFFAOYSA-N 0.000 description 1
- PJWQLRKRVISYPL-UHFFFAOYSA-N 4-[4-amino-3-(trifluoromethyl)phenyl]-2-(trifluoromethyl)aniline Chemical group C1=C(C(F)(F)F)C(N)=CC=C1C1=CC=C(N)C(C(F)(F)F)=C1 PJWQLRKRVISYPL-UHFFFAOYSA-N 0.000 description 1
- SJILKDPNOANEEJ-UHFFFAOYSA-N 4-decoxy-4-oxobutanoic acid Chemical compound CCCCCCCCCCOC(=O)CCC(O)=O SJILKDPNOANEEJ-UHFFFAOYSA-N 0.000 description 1
- YBNWBQXABYLBMR-UHFFFAOYSA-N 4-dodecoxybenzene-1,3-diamine Chemical compound CCCCCCCCCCCCOC1=CC=C(N)C=C1N YBNWBQXABYLBMR-UHFFFAOYSA-N 0.000 description 1
- ZMWWYPZBEJOZDX-UHFFFAOYSA-N 4-hexadecoxybenzene-1,3-diamine Chemical compound CCCCCCCCCCCCCCCCOC1=CC=C(N)C=C1N ZMWWYPZBEJOZDX-UHFFFAOYSA-N 0.000 description 1
- 229940073735 4-hydroxy acetophenone Drugs 0.000 description 1
- MWRVRCAFWBBXTL-UHFFFAOYSA-N 4-hydroxyphthalic acid Chemical compound OC(=O)C1=CC=C(O)C=C1C(O)=O MWRVRCAFWBBXTL-UHFFFAOYSA-N 0.000 description 1
- CNPURSDMOWDNOQ-UHFFFAOYSA-N 4-methoxy-7h-pyrrolo[2,3-d]pyrimidin-2-amine Chemical compound COC1=NC(N)=NC2=C1C=CN2 CNPURSDMOWDNOQ-UHFFFAOYSA-N 0.000 description 1
- KWHCPERWLHBLOT-UHFFFAOYSA-N 4-methylsulfanylbenzoic acid Chemical compound CSC1=CC=C(C(O)=O)C=C1 KWHCPERWLHBLOT-UHFFFAOYSA-N 0.000 description 1
- QPDNZLWPWXPPIO-UHFFFAOYSA-N 4-n-[4-[4-(4-aminoanilino)phenyl]phenyl]benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NC1=CC=C(C=2C=CC(NC=3C=CC(N)=CC=3)=CC=2)C=C1 QPDNZLWPWXPPIO-UHFFFAOYSA-N 0.000 description 1
- RHJVCIJERZCGKT-UHFFFAOYSA-N 4-octadecoxybenzene-1,3-diamine Chemical compound CCCCCCCCCCCCCCCCCCOC1=CC=C(N)C=C1N RHJVCIJERZCGKT-UHFFFAOYSA-N 0.000 description 1
- SZLOMZIVKBNFKQ-UHFFFAOYSA-N 4-pentadecoxybenzene-1,3-diamine Chemical compound CCCCCCCCCCCCCCCOC1=CC=C(N)C=C1N SZLOMZIVKBNFKQ-UHFFFAOYSA-N 0.000 description 1
- YAPVGSXODFOBBR-UHFFFAOYSA-N 4-pentoxybenzaldehyde Chemical compound CCCCCOC1=CC=C(C=O)C=C1 YAPVGSXODFOBBR-UHFFFAOYSA-N 0.000 description 1
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 1
- BGQNOPFTJROKJE-UHFFFAOYSA-N 5,6-diamino-1,3-dimethylpyrimidine-2,4-dione Chemical compound CN1C(N)=C(N)C(=O)N(C)C1=O BGQNOPFTJROKJE-UHFFFAOYSA-N 0.000 description 1
- BBTNLADSUVOPPN-UHFFFAOYSA-N 5,6-diaminouracil Chemical compound NC=1NC(=O)NC(=O)C=1N BBTNLADSUVOPPN-UHFFFAOYSA-N 0.000 description 1
- HOOIIRHGHALACD-UHFFFAOYSA-N 5-(2,5-dioxooxolan-3-yl)-3-methylcyclohex-3-ene-1,2-dicarboxylic acid Chemical compound C1C(C(O)=O)C(C(O)=O)C(C)=CC1C1C(=O)OC(=O)C1 HOOIIRHGHALACD-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- ZXLYUNPVVODNRE-UHFFFAOYSA-N 6-ethenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=C)=N1 ZXLYUNPVVODNRE-UHFFFAOYSA-N 0.000 description 1
- XVMFICQRQHBOOT-UHFFFAOYSA-N 6-methoxy-1,3,5-triazine-2,4-diamine Chemical compound COC1=NC(N)=NC(N)=N1 XVMFICQRQHBOOT-UHFFFAOYSA-N 0.000 description 1
- CPNAVTYCORRLMH-UHFFFAOYSA-N 6-phenylphenanthridine-3,8-diamine Chemical compound C=1C(N)=CC=C(C2=CC=C(N)C=C22)C=1N=C2C1=CC=CC=C1 CPNAVTYCORRLMH-UHFFFAOYSA-N 0.000 description 1
- ATCQNYLEZRQALQ-UHFFFAOYSA-N 6-propan-2-yloxy-1,3,5-triazine-2,4-diamine Chemical compound CC(C)OC1=NC(N)=NC(N)=N1 ATCQNYLEZRQALQ-UHFFFAOYSA-N 0.000 description 1
- VYQYKCAZJQOVJO-UHFFFAOYSA-N 9-ethylcarbazole-3,6-diamine Chemical compound NC1=CC=C2N(CC)C3=CC=C(N)C=C3C2=C1 VYQYKCAZJQOVJO-UHFFFAOYSA-N 0.000 description 1
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 1
- LURIWVTTYAYTRK-UHFFFAOYSA-N C(C(O)CO)OCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(C(O)CO)OCCCC(C(OCC)(OCC)OCC)CCCCCCCC LURIWVTTYAYTRK-UHFFFAOYSA-N 0.000 description 1
- ICWNIKLKVHTFOW-UHFFFAOYSA-N C(C)OC(CCCCCCCCCCCCNCCNCCN)(OCC)OCC Chemical compound C(C)OC(CCCCCCCCCCCCNCCNCCN)(OCC)OCC ICWNIKLKVHTFOW-UHFFFAOYSA-N 0.000 description 1
- RKYOSRQGOOVSPT-UHFFFAOYSA-N C(C1CO1)NCC1CO1.NN Chemical compound C(C1CO1)NCC1CO1.NN RKYOSRQGOOVSPT-UHFFFAOYSA-N 0.000 description 1
- UGGZPAYEYLXUKI-UHFFFAOYSA-N C(C1CO1)OCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(C1CO1)OCC(C(OCC)(OCC)OCC)CCCCCCCC UGGZPAYEYLXUKI-UHFFFAOYSA-N 0.000 description 1
- QMUVQASGACIPFI-UHFFFAOYSA-N C(C1CO1)OCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(C1CO1)OCCC(C(OCC)(OCC)OCC)CCCCCCCC QMUVQASGACIPFI-UHFFFAOYSA-N 0.000 description 1
- BBZVHMRVAMPMSQ-UHFFFAOYSA-N CCCCCCCCC(CC)(CCC)C(C)(OC)OC Chemical compound CCCCCCCCC(CC)(CCC)C(C)(OC)OC BBZVHMRVAMPMSQ-UHFFFAOYSA-N 0.000 description 1
- ILQGVXGCESQZGE-UHFFFAOYSA-N CN1C(CCC1)=O.[Ru] Chemical compound CN1C(CCC1)=O.[Ru] ILQGVXGCESQZGE-UHFFFAOYSA-N 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- AQZGPSLYZOOYQP-UHFFFAOYSA-N Diisoamyl ether Chemical compound CC(C)CCOCCC(C)C AQZGPSLYZOOYQP-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 101000919504 Gallus gallus Beta-crystallin B1 Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 238000007341 Heck reaction Methods 0.000 description 1
- WJYIASZWHGOTOU-UHFFFAOYSA-N Heptylamine Chemical compound CCCCCCCN WJYIASZWHGOTOU-UHFFFAOYSA-N 0.000 description 1
- 101000713575 Homo sapiens Tubulin beta-3 chain Proteins 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- AJOYCSBPBSZRHI-UHFFFAOYSA-N NC(CC(C(OCC)(OCC)OCC)CCCCCCCC)C Chemical compound NC(CC(C(OCC)(OCC)OCC)CCCCCCCC)C AJOYCSBPBSZRHI-UHFFFAOYSA-N 0.000 description 1
- XKWIZSBPRYNVCL-UHFFFAOYSA-N NC1=CC=C(OC2=CC=C(C=C2)C2=C(NC3=CC=CC=C23)C2=CC=C(C=C2)OC2=CC=C(C=C2)N)C=C1 Chemical compound NC1=CC=C(OC2=CC=C(C=C2)C2=C(NC3=CC=CC=C23)C2=CC=C(C=C2)OC2=CC=C(C=C2)N)C=C1 XKWIZSBPRYNVCL-UHFFFAOYSA-N 0.000 description 1
- IWUILFKKGDFNTH-UHFFFAOYSA-N NC1CC(C(NC1N)C#N)C#N Chemical compound NC1CC(C(NC1N)C#N)C#N IWUILFKKGDFNTH-UHFFFAOYSA-N 0.000 description 1
- KMCMODAVNVQVIE-UHFFFAOYSA-N O=[PH2]C1=CC=CC=C1.OC(=O)C1=CC=CC=C1C(O)=O.OC(=O)C1=CC=CC=C1C(O)=O Chemical compound O=[PH2]C1=CC=CC=C1.OC(=O)C1=CC=CC=C1C(O)=O.OC(=O)C1=CC=CC=C1C(O)=O KMCMODAVNVQVIE-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-O Piperidinium(1+) Chemical compound C1CC[NH2+]CC1 NQRYJNQNLNOLGT-UHFFFAOYSA-O 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000265 Polyparaphenylene Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- WDVSHHCDHLJJJR-UHFFFAOYSA-N Proflavine Chemical compound C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21 WDVSHHCDHLJJJR-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- 239000004990 Smectic liquid crystal Substances 0.000 description 1
- 229910006404 SnO 2 Inorganic materials 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- PLZVEHJLHYMBBY-UHFFFAOYSA-N Tetradecylamine Chemical compound CCCCCCCCCCCCCCN PLZVEHJLHYMBBY-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102100036790 Tubulin beta-3 chain Human genes 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- QLBRROYTTDFLDX-UHFFFAOYSA-N [3-(aminomethyl)cyclohexyl]methanamine Chemical compound NCC1CCCC(CN)C1 QLBRROYTTDFLDX-UHFFFAOYSA-N 0.000 description 1
- AZWHFTKIBIQKCA-UHFFFAOYSA-N [Sn+2]=O.[O-2].[In+3] Chemical compound [Sn+2]=O.[O-2].[In+3] AZWHFTKIBIQKCA-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- NJYZCEFQAIUHSD-UHFFFAOYSA-N acetoguanamine Chemical compound CC1=NC(N)=NC(N)=N1 NJYZCEFQAIUHSD-UHFFFAOYSA-N 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- UPOYFZYFGWBUKL-UHFFFAOYSA-N amiphenazole Chemical compound S1C(N)=NC(N)=C1C1=CC=CC=C1 UPOYFZYFGWBUKL-UHFFFAOYSA-N 0.000 description 1
- 150000004984 aromatic diamines Chemical class 0.000 description 1
- 125000005337 azoxy group Chemical group [N+]([O-])(=N*)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- ZLSMCQSGRWNEGX-UHFFFAOYSA-N bis(4-aminophenyl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=C(N)C=C1 ZLSMCQSGRWNEGX-UHFFFAOYSA-N 0.000 description 1
- JWXLCQHWBFHMOI-NIQMUPOESA-N bis[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] carbonate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C(C1)[C@]2(C)CC[C@@H]1OC(=O)O[C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1 JWXLCQHWBFHMOI-NIQMUPOESA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- 239000001191 butyl (2R)-2-hydroxypropanoate Substances 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- KMGBZBJJOKUPIA-UHFFFAOYSA-N butyl iodide Chemical compound CCCCI KMGBZBJJOKUPIA-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000003098 cholesteric effect Effects 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- TXWRERCHRDBNLG-UHFFFAOYSA-N cubane Chemical compound C12C3C4C1C1C4C3C12 TXWRERCHRDBNLG-UHFFFAOYSA-N 0.000 description 1
- RZIPTXDCNDIINL-UHFFFAOYSA-N cyclohexane-1,1,2,2-tetracarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CCCCC1(C(O)=O)C(O)=O RZIPTXDCNDIINL-UHFFFAOYSA-N 0.000 description 1
- MNUSMUGFHGAOIW-UHFFFAOYSA-N cyclohexane-1,1,2-tricarboxylic acid Chemical compound OC(=O)C1CCCCC1(C(O)=O)C(O)=O MNUSMUGFHGAOIW-UHFFFAOYSA-N 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- IGARGHRYKHJQSM-UHFFFAOYSA-N cyclohexylbenzene Chemical compound C1CCCCC1C1=CC=CC=C1 IGARGHRYKHJQSM-UHFFFAOYSA-N 0.000 description 1
- NLUNLVTVUDIHFE-UHFFFAOYSA-N cyclooctylcyclooctane Chemical compound C1CCCCCCC1C1CCCCCCC1 NLUNLVTVUDIHFE-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical group CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 125000004427 diamine group Chemical group 0.000 description 1
- WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 description 1
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 229940113088 dimethylacetamide Drugs 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Natural products C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- LTYMSROWYAPPGB-UHFFFAOYSA-N diphenyl sulfide Chemical compound C=1C=CC=CC=1SC1=CC=CC=C1 LTYMSROWYAPPGB-UHFFFAOYSA-N 0.000 description 1
- GPAYUJZHTULNBE-UHFFFAOYSA-O diphenylphosphanium Chemical compound C=1C=CC=CC=1[PH2+]C1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-O 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- UHKJHMOIRYZSTH-UHFFFAOYSA-N ethyl 2-ethoxypropanoate Chemical compound CCOC(C)C(=O)OCC UHKJHMOIRYZSTH-UHFFFAOYSA-N 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 239000005329 float glass Substances 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- PKWIYNIDEDLDCJ-UHFFFAOYSA-N guanazole Chemical compound NC1=NNC(N)=N1 PKWIYNIDEDLDCJ-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- KAJZYANLDWUIES-UHFFFAOYSA-N heptadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCCN KAJZYANLDWUIES-UHFFFAOYSA-N 0.000 description 1
- PWSKHLMYTZNYKO-UHFFFAOYSA-N heptane-1,7-diamine Chemical compound NCCCCCCCN PWSKHLMYTZNYKO-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- AWKZQVYCCQCKBH-UHFFFAOYSA-N hydrazine 1-methylpyrrolidin-2-one Chemical compound CN1C(CCC1)=O.NN AWKZQVYCCQCKBH-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- BUHXFUSLEBPCEB-UHFFFAOYSA-N icosan-1-amine Chemical compound CCCCCCCCCCCCCCCCCCCCN BUHXFUSLEBPCEB-UHFFFAOYSA-N 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229940018564 m-phenylenediamine Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- BDJSOPWXYLFTNW-UHFFFAOYSA-N methyl 3-methoxypropanoate Chemical compound COCCC(=O)OC BDJSOPWXYLFTNW-UHFFFAOYSA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- DDCYYCUMAFYDDU-UHFFFAOYSA-N methyl thiohypochlorite Chemical compound CSCl DDCYYCUMAFYDDU-UHFFFAOYSA-N 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N mono-methylamine Natural products NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- OXKUGIFNIUUKAW-UHFFFAOYSA-N n,n-dimethylformamide;hydrazine Chemical compound NN.CN(C)C=O OXKUGIFNIUUKAW-UHFFFAOYSA-N 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N n-butyl carbinol Natural products CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N n-hexyl alcohol Natural products CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KQSABULTKYLFEV-UHFFFAOYSA-N naphthalene-1,5-diamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1N KQSABULTKYLFEV-UHFFFAOYSA-N 0.000 description 1
- DOBFTMLCEYUAQC-UHFFFAOYSA-N naphthalene-2,3,6,7-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=C2C=C(C(O)=O)C(C(=O)O)=CC2=C1 DOBFTMLCEYUAQC-UHFFFAOYSA-N 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- MIVZUXGHPJSKRI-UHFFFAOYSA-N pentane-1,1,1,2-tetracarboxylic acid Chemical compound CCCC(C(O)=O)C(C(O)=O)(C(O)=O)C(O)=O MIVZUXGHPJSKRI-UHFFFAOYSA-N 0.000 description 1
- 125000005004 perfluoroethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- RPVOKBZITVQZPD-UHFFFAOYSA-N phenol;hydroiodide Chemical compound I.OC1=CC=CC=C1 RPVOKBZITVQZPD-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- XQZYPMVTSDWCCE-UHFFFAOYSA-N phthalonitrile Chemical compound N#CC1=CC=CC=C1C#N XQZYPMVTSDWCCE-UHFFFAOYSA-N 0.000 description 1
- ZRXDBIJHYWJRMT-UHFFFAOYSA-N piperidine-1,4-diamine Chemical compound NC1CCN(N)CC1 ZRXDBIJHYWJRMT-UHFFFAOYSA-N 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 108010094020 polyglycine Proteins 0.000 description 1
- 229920000232 polyglycine polymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 150000003141 primary amines Chemical group 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- ZZYXNRREDYWPLN-UHFFFAOYSA-N pyridine-2,3-diamine Chemical compound NC1=CC=CN=C1N ZZYXNRREDYWPLN-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 125000004151 quinonyl group Chemical group 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- 150000003609 titanium compounds Chemical class 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- ABVVEAHYODGCLZ-UHFFFAOYSA-N tridecan-1-amine Chemical compound CCCCCCCCCCCCCN ABVVEAHYODGCLZ-UHFFFAOYSA-N 0.000 description 1
- SRPWOOOHEPICQU-UHFFFAOYSA-N trimellitic anhydride Chemical compound OC(=O)C1=CC=C2C(=O)OC(=O)C2=C1 SRPWOOOHEPICQU-UHFFFAOYSA-N 0.000 description 1
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
- G02F1/133723—Polyimide, polyamide-imide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L63/00—Compositions of epoxy resins; Compositions of derivatives of epoxy resins
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/13378—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by treatment of the surface, e.g. embossing, rubbing or light irradiation
- G02F1/133788—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by treatment of the surface, e.g. embossing, rubbing or light irradiation by light irradiation, e.g. linearly polarised light photo-polymerisation
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nonlinear Science (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Mathematical Physics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Liquid Crystal (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Abstract
Description
200911884 九、發明說明 【發明所屬之技術領域】 本發明係關於液晶配向劑、液晶配向膜及其形成方、法 以及液晶顯示元件。更詳言之,係關於可用以形成不需進 行摩擦處理而藉由照射偏光或非偏光之輻射線賦予 '液^酉己 向能之液晶配向膜之液晶配向劑,自該液晶配向劑形成不 會伴隨著產生塵埃或靜電之液晶配向膜之方法,以及顯示 品質優異之液晶顯不兀件。 【先前技術】 過去,具有正介電各向異性向列型液晶係在附加具有 液晶配向膜之透明電極之基板夾層構造中,因應必要而使 液晶分子之長軸在基板間以〇〜3 6 0度連續扭轉而形成,已 知有具有TN (扭轉型向列)型、STN (超扭轉型向列) 型、IP (平面內切換)型等液晶單元之液晶顯示元件(參 照特開昭56-9 1 277號公報及特開平1 - 1 20528號公報)。 該等液晶單元中,爲了使液晶以相對於基板面於一定 方向配向,因此有必要在基板表面上設置液晶配向膜。該 液晶配向膜通常係藉由以縲縈等布材以一定方向對基板表 面上形成之有機膜表面往復摩擦之方法(摩擦法)形成。 但,若以摩擦處理進行液晶配向膜之形成,由於容易在製 程內產生塵埃,產生靜電,故有於配向膜表面附著塵埃而 成爲顯示不良發生原因之問題。尤其是具有TFT (薄膜電 晶體)元件之基板之情況,因產生之靜電造成TFT元件 200911884 之電路受損,亦爲成品率下降之原因。而且,對於爾後逐 漸高精密化之液晶顯示元件,爲了伴隨著像素之高密度化 而在基板表面上產生凹凸,故進行均勻摩擦處理變有困難 〇 作爲於液晶單元中使液晶配向之其他方法,已知有藉 由使在基板表面上形成之由聚乙烯月桂酸酯、聚醯亞胺、 偶氮苯衍生物等之感光性薄膜照射偏光或非偏光輻射線, 藉此賦予液晶配向能之光配向法。依據此方法,不會發生 靜電或塵埃,而可實現均一液晶配向(參照特開平6-2 8 7453號公報、特開平1 0-25 1 646號公報、特開平11-2815號公報、特開平1 1 - 1 5 2475號公報、特開 2000-144136號公報、特開2000-319510號公報、特開2000-28 1 724號公報、特開平9-2973 1 3號公報、特開 2003 -307736號公報、特開2004-163646號公報以及特開2002-25 0924號公報)。 不過,TN (扭轉型向列)型、STN (超扭轉向列)型 等之液晶單元中,液晶配向膜有必要具有使液晶分子相對 於基板面以既定角度成傾斜配向之預傾角特性。藉由光配 向法形成液晶配向膜時,預傾角通常係藉由使照射之輻射 線朝基板面之入射方向自基板法線傾斜而賦予。 又’作爲與上述不同之液晶顯不兀件之動作模式亦已 知有使具有負的介電各向異性之液晶分子與基板成垂直配 向之垂直(垂直排列(homeotropical))配向模式之 VA (垂直對準)型液晶單元。該動作模式在基板間施加電壓 200911884 使液晶分子向著與基板平行之方向傾斜時,有必要使液晶 分子自基板法線方向向基板面內之一方向傾斜。至於爲此 之方法’提案有例如在基板表面上設置突起之方法、於透 明電極上設置條紋之方法、藉由使用摩擦配向膜使液晶分 子自基板法線方向向著基板面內之一方向傾斜(使預傾斜 )之方法等。 已知上述光配向法作爲垂直配向模式之液晶單元中控 制液晶分子傾斜方向之方法亦有用。亦即已知藉由使用以 光配向法賦予配向控制力及預傾角之垂直配向膜,可均一 地控制施加電壓時之液晶分子傾斜方向(參照特開2003-3 0773 6號公報、特開2004-1 63 646號公報、特開2004-8 3 8 1 0號公報、特開平 9-2 1 1 468號公報及特開 2003 -1 1 443 7號公報)。 如此,以上述光配向法製造之液晶配向膜爲可有效適 用於各種液晶顯示元件者。然而,過去之光配向膜若要獲 得大的預傾角而有必需照射大量幅射線之問題,例如已報 導有於含有偶氮苯衍生物之光配向膜中,爲了獲得足夠之 預傾角不得不照射1 〇,〇 00 J/m2以上之其光軸自基板法線傾 斜之輻射線(參照特開2002-25 0924號公報、特開2004-83810 號公報及 J_ of the SID 11/3, 2003,p.579)。 【發明內容】 本發明係鑑於上述問題而完成者’其目的係提供一種 可用於形成不需進行摩擦處理而藉由照射偏光或非偏光之 -6- 200911884 輻射線賦予液晶配向能之液晶配向膜之液晶配向劑。 本發明另一目的係提供一種自該液晶配向劑形成不會 伴隨著產生塵埃或靜電之液晶配向膜之方法。 本發明又其他目的係提供一種液晶配向性優異之液晶 配向膜及顯示品質優異之液晶顯示元件。 本發明又其他目的及優點由下列說明可更爲清楚。 依據本發明,本發明之上述目的及優點,第一爲藉由 含有下列之液晶配向劑而達成: (A )選自由聚酿胺酸及聚醯亞胺組成之群組之至少 一種之聚合物,以及 (B )具有藉波長200〜400nm之光進行交聯反應或異 構化反應之感光基與環氧基之化合物。 本發明之上述目的及優點第二係藉由自上述液晶配向 劑形成之液晶配向膜而達成,第三係藉由具有在基板上塗 佈上述液晶配向劑形成塗膜’使該塗膜照射偏光或非偏光 之輻射線之步驟之液晶配向膜形成方法而達成。 進而’本發明之上述目的及優點第四爲藉由具備上述 液晶配向膜之液晶顯示元件而達成。 【實施方式】 以下,詳細的說明本發明。 本發明之液晶配向劑係含有(A )選自聚醯胺酸及聚 醯亞胺所組成群組之至少一種聚合物。 200911884 < (A )聚合物> 上述之聚醯胺酸可藉由使四羧酸二酐與二胺反應而合 成。上述聚醯亞胺可藉由使聚醯胺酸脫水閉環而合成。 [四羧酸二酐] 上述聚醯胺酸之合成中所用之四羧酸二酐可舉例爲例 如丁院四羧酸二酐、;1,2,3,4_環丁烷四羧酸二酐、12-二甲 基-1,2,3,4 -環丁烷四羧酸二酐、丨,3_二甲基環丁 院四竣酸二酐、1,3 -二氯- :ι,2,3,4 -環丁烷四羧酸二酐、 1.2.3.4- 四甲基-1,2,3,4_環丁烷四羧酸二酐、1,2,3,4-環戊 烷四羧酸二酐、1,2,4,5·環己烷四羧酸二酐、3,3,,4,4,-二 環己基四羧酸二酐、2,3,5 -三羧基環戊基乙酸二酐' 2.3.4.5- 四氫呋喃四羧酸二酐、1,3,3^4,5,91)_六氫_5-(四 氫^^-二氧代一-呋喃基彡-萘并^一-^-呋喃-^-二酮、 l,3,3a,4,5,9b-六氫-5-甲基-5-(四氫-2,5-二氧代-3-呋喃基 )_ 奈并[l,2-c] -咲喃-1,3-二嗣、l,3,3a,4,5,9b -六氨-5 -乙 基-5-(四氫-2,5-二氧代-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,913-六氫-7-甲基-5-(四氫-2,5-二氧 代-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-六氫·7-乙基-5-(四氫-2,5-二氧代·3-咲喃基)-萘并[l,2-c]-呋喃-l,3-二酮、l,3,3a,4,5,9b-六氫-8-甲基·5-(四氫- 2.5- 二氧代-3-呋喃基)-萘并[1,2-(:]-呋喃-1,3-二酮、 1,3,3a,4,5,9b -六氫-8-乙基-5-(四氫-2,5-二氧代-3-呋喃基 )-萘并[1,2-〇]-肤喃-1,3-二酮'1,3,3&,4,5,913-六氫-5,8 - 一 -8- 200911884 甲基-5-(四氫-2,5-二氧代-3-呋喃基)-萘并[1,24]-呋喃-1,3-二酮、雙環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酐、3-氧 雜雙環[3.2.1]辛烷-2,4-二酮-6-螺-3’-(四氫呋喃-2,,5,-二 酮)、5- (2,5 -二氧代四氫-3-呋喃機)-3 -甲基-3-環己烯-1,2-二羧酸酐、3,5,6-三羧基-2-羧基甲基原冰片烷-2 : 3,5 :6-二酐、4,9-二氧雜三環[5.3.1.02,6]十一烷-3,5,8,10-四 酮、以下式(T-I )及(T-II )分別表示之化合物等脂肪族 或脂環族四羧酸二酐,200911884 IX. Description of the Invention [Technical Field] The present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film, a method for forming the same, and a liquid crystal display element. More specifically, it relates to a liquid crystal alignment agent which can be used to form a liquid crystal alignment film which imparts a liquid to a liquid which is not subjected to rubbing treatment by irradiation of polarized light or non-polarized light, and forms a liquid crystal alignment agent from the liquid crystal alignment agent. It is accompanied by a method of producing a liquid crystal alignment film which generates dust or static electricity, and a liquid crystal display which exhibits excellent quality. [Prior Art] In the past, a positive dielectric anisotropic nematic liquid crystal system has a substrate sandwich structure in which a transparent electrode having a liquid crystal alignment film is added, and if necessary, the long axis of the liquid crystal molecules is between the substrates. A liquid crystal display element having a liquid crystal cell such as a TN (torsional nematic) type, an STN (super twisted nematic) type, or an IP (in-plane switching) type is known to be formed by continuously twisting at 0 degrees (refer to Japanese Patent Laid-Open No. 56). -9 1 277 and JP-A-10-1 20528). In these liquid crystal cells, in order to align the liquid crystal in a certain direction with respect to the substrate surface, it is necessary to provide a liquid crystal alignment film on the surface of the substrate. The liquid crystal alignment film is usually formed by a method (rubbing method) of reciprocating rubbing of the surface of the organic film formed on the surface of the substrate in a certain direction with a cloth such as a crucible. However, when the liquid crystal alignment film is formed by the rubbing treatment, dust is generated in the process and static electricity is generated. Therefore, dust adheres to the surface of the alignment film, which causes a display failure. In particular, in the case of a substrate having a TFT (Thin Film Transistor) device, the circuit of the TFT element 200911884 is damaged due to the generated static electricity, which is also a cause of a decrease in yield. Further, in the liquid crystal display device which is gradually higher in precision, unevenness is generated on the surface of the substrate in order to increase the density of the pixel, so that it is difficult to perform uniform rubbing treatment, and other methods for aligning the liquid crystal in the liquid crystal cell are used. It is known that a polarizing film or a non-polarizing radiation which is formed of a polyethylene laurate, a polyimide, an azobenzene derivative or the like formed on a surface of a substrate is irradiated with a polarized or non-polarized radiation. Orientation method. According to this method, static electricity or dust does not occur, and a uniform liquid crystal alignment can be achieved (refer to Japanese Laid-Open Patent Publication No. Hei 6-2-8 7453, Japanese Patent Application Laid-Open No. Hei No. Hei. No. Hei. Japanese Unexamined Patent Publication No. Publication No. JP-A No. 2000- 144 136, JP-A-2000-319510, JP-A-2000-28 1 724, JP-A-9-2973, No. 3, No. 2003-307736 Japanese Laid-Open Patent Publication No. 2004-163646 and JP-A-2002-25 0924. However, in a liquid crystal cell such as a TN (torsional nematic) type or an STN (super twisted nematic) type, it is necessary for the liquid crystal alignment film to have a pretilt characteristic in which liquid crystal molecules are obliquely aligned at a predetermined angle with respect to the substrate surface. When the liquid crystal alignment film is formed by the photo-alignment method, the pretilt angle is usually imparted by inclining the incident radiation from the substrate normal to the incident direction of the substrate surface. Further, as an operation mode different from the above-described liquid crystal display, a vertical (homeotropic) alignment mode VA (which is a vertical alignment of liquid crystal molecules having a negative dielectric anisotropy with a substrate) is also known. Vertical alignment type liquid crystal cell. This operation mode applies a voltage between the substrates. When the liquid crystal molecules are tilted in a direction parallel to the substrate, it is necessary to tilt the liquid crystal molecules from the normal direction of the substrate toward one of the substrate faces. As for the method for this, there are proposed, for example, a method of providing a protrusion on a surface of a substrate, a method of providing a stripe on a transparent electrode, and tilting a liquid crystal molecule from a normal direction of the substrate toward a direction in the plane of the substrate by using a rubbing alignment film ( The method of making the pretilt). It is also known that the above-described photoalignment method is also useful as a method of controlling the tilt direction of liquid crystal molecules in a liquid crystal cell of a vertical alignment mode. In other words, it is known that the tilting direction of liquid crystal molecules when a voltage is applied can be uniformly controlled by using a vertical alignment film which imparts an alignment control force and a pretilt angle by a photo-alignment method (refer to Japanese Patent Laid-Open Publication No. 2003-3 0773 No. Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. Thus, the liquid crystal alignment film produced by the above-described photoalignment method is effective for various liquid crystal display elements. However, in the past, the light alignment film had to be irradiated with a large amount of radiation if it had to obtain a large pretilt angle, for example, it has been reported in a light alignment film containing an azobenzene derivative, in order to obtain a sufficient pretilt angle. Irradiation of 1 〇, 〇00 J/m2 or more of its optical axis tilted from the substrate normal (see JP-A-2002-25 0924, JP-A-2004-83810, and J_ of the SID 11/3, 2003) , p.579). SUMMARY OF THE INVENTION The present invention has been made in view of the above problems, and its object is to provide a liquid crystal alignment film which can be used to form a liquid crystal alignment energy by irradiating a polarized or non-polarized -6-200911884 radiation without performing a rubbing treatment. Liquid crystal alignment agent. Another object of the present invention is to provide a method of forming a liquid crystal alignment film which is not accompanied by generation of dust or static electricity from the liquid crystal alignment agent. Still another object of the present invention is to provide a liquid crystal alignment film excellent in liquid crystal alignment and a liquid crystal display element excellent in display quality. Still other objects and advantages of the present invention will become apparent from the following description. According to the present invention, the above objects and advantages of the present invention are first achieved by the following liquid crystal alignment agent: (A) a polymer selected from at least one group consisting of polyacrylic acid and polyamidiamine And (B) a compound having a photosensitive group and an epoxy group which are subjected to a crosslinking reaction or an isomerization reaction by light having a wavelength of from 200 to 400 nm. The above objects and advantages of the present invention are achieved by a liquid crystal alignment film formed from the above liquid crystal alignment agent, and the third system is formed by applying a coating film on the substrate to form a coating film to polarize the coating film. Or a method of forming a liquid crystal alignment film in the step of non-polarizing radiation. Further, the above objects and advantages of the present invention are attained by the liquid crystal display element including the above liquid crystal alignment film. [Embodiment] Hereinafter, the present invention will be described in detail. The liquid crystal alignment agent of the present invention contains (A) at least one polymer selected from the group consisting of polylysine and polyimine. 200911884 <(A) Polymer> The above polylysine can be synthesized by reacting a tetracarboxylic dianhydride with a diamine. The above polyimine can be synthesized by dehydrating a poly-proline. [Tetracarboxylic dianhydride] The tetracarboxylic dianhydride used in the synthesis of the above polyamic acid can be exemplified by, for example, butyl tetracarboxylic dianhydride; 1,2,3,4-cyclobutanetetracarboxylic acid Anhydride, 12-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, hydrazine, 3 dimethylcyclobutylene tetraphthalic acid dianhydride, 1,3 -dichloro-: , 2,3,4-cyclobutane tetracarboxylic dianhydride, 1.2.3.4-tetramethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,2,3,4-ring Pentane tetracarboxylic dianhydride, 1,2,4,5·cyclohexane tetracarboxylic dianhydride, 3,3,4,4,-dicyclohexyltetracarboxylic dianhydride, 2,3,5- Tricarboxycyclopentyl acetic acid dianhydride '2.3.4.5- Tetrahydrofuran tetracarboxylic dianhydride, 1,3,3^4,5,91)_hexahydro-5-(tetrahydro^^-dioxo-furan Rhodium-naphtho-(i-)-furan-^-dione, l,3,3a,4,5,9b-hexahydro-5-methyl-5-(tetrahydro-2,5-dioxo -3-furanyl)-naphtho[l,2-c]-purine-1,3-dioxin, l,3,3a,4,5,9b-hexaamine-5-ethyl-5-( Tetrahydro-2,5-dioxo-3-furanyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3&,4,5,913-hexahydro- 7-Methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphtho[1,2-c]-furan-1,3-dione, l,3,3a, 4,5,9b- Hexahydro-7-ethyl-5-(tetrahydro-2,5-dioxo-3-yanoyl)-naphtho[l,2-c]-furan-l,3-dione, l, 3,3a,4,5,9b-hexahydro-8-methyl·5-(tetrahydro-2.5-dioxo-3-furanyl)-naphtho[1,2-(:]-furan-1 ,3-dione, 1,3,3a,4,5,9b-hexahydro-8-ethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphtho[1] ,2-〇]-furan-1,3-dione '1,3,3&,4,5,913-hexahydro-5,8-a-8- 200911884 methyl-5-(tetrahydro-2, 5-dioxo-3-furanyl)-naphtho[1,24]-furan-1,3-dione, bicyclo[2.2.2]-oct-7-ene-2,3,5,6- Tetracarboxylic dianhydride, 3-oxabicyclo[3.2.1]octane-2,4-dione-6-spiro-3'-(tetrahydrofuran-2,5,-dione), 5- (2) ,5-dioxotetrahydro-3-furan)-3 -methyl-3-cyclohexene-1,2-dicarboxylic anhydride, 3,5,6-tricarboxy-2-carboxymethyl borneol Alkane-2: 3,5:6-dianhydride, 4,9-dioxatricyclo[5.3.1.02,6]undecane-3,5,8,10-tetraone, the following formula (TI) and (T-II) an aliphatic or alicyclic tetracarboxylic dianhydride such as a compound,
〇 R4 R4 〇〇 R4 R4 〇
A^r3—VA (式(T-I)及(T-II)中,R1及R3各爲具有芳香環 之2價有機基,R2及R4各爲氫原子或烷基,且複數存在 之R2及R4可分別相同或不同); 均苯四酸二酐、3,3’,4,4’-二苯甲酮四羧酸二酐、 3,3’,4,4’-聯苯四羧酸二酐、1,4,5,8-萘四羧酸二酐、 2,3,6,7-萘四羧酸二酐、3,3’,4,4’-聯苯醚四羧酸二酐、 3,3’,4,4’-二甲基二苯基矽烷四羧酸二酐、3,3’,4,4’-四苯 基矽烷四羧酸二酐、1,2,3,4-呋喃四羧酸二酐、4,4’-雙( 3,4-二羧酸苯氧基)二苯基硫醚二酐、4,4’-雙(3,4-二羧 200911884 基苯氧基)二苯基颯二酐、4,4’-雙(3,4_二羧基苯氧基) 二苯基丙烷二酐、3,3’,4,4’-全氟異亞丙基二苯二甲酸二 酐、3,3’,4,4’-聯苯四羧酸二酐、2,2’,3,3’-聯苯四羧酸二 酐、雙(苯二甲酸)苯基氧化磷二酐、對-伸苯基雙(三 苯基苯二甲酸)二酐、間一伸苯基雙(三苯基苯二甲酸) 二酐、雙(三苯基苯二甲酸)-4,4’-二苯基醚二酐、雙( 三苯基苯二甲酸)-4,4’-二苯基甲烷二酐、乙二醇-雙(無 水苯偏三甲酸酯)、丙二醇-雙(無水苯偏三甲酸酯)、 1,4-丁二醇-雙(無水苯偏三甲酸酯)、:1,6-己二醇-雙( 無水苯偏三甲酸酯)、1 ,8辛二醇-雙(無水苯偏三甲酸酯 )、2,2-雙(4-羥基苯基)丙烷-雙(無水苯偏三甲酸酯) 、以下式(T-1 )〜(T-4 )分別表示之化合物等之芳香族 四羧酸二酐: 0A^r3—VA (In the formulae (TI) and (T-II), R1 and R3 are each a divalent organic group having an aromatic ring, and R2 and R4 are each a hydrogen atom or an alkyl group, and plural R2 and R4 are present. Can be the same or different); pyromellitic dianhydride, 3,3',4,4'-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-biphenyltetracarboxylic acid Anhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 3,3',4,4'-diphenyl ether tetracarboxylic dianhydride , 3,3',4,4'-dimethyldiphenylnonanetetracarboxylic dianhydride, 3,3',4,4'-tetraphenylnonanetetracarboxylic dianhydride, 1,2,3, 4-furantetracarboxylic dianhydride, 4,4'-bis(3,4-dicarboxylic acid phenoxy)diphenyl sulfide dianhydride, 4,4'-bis(3,4-dicarboxyl 200911884 Phenoxy)diphenylphosphonium dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylpropane dianhydride, 3,3',4,4'-perfluoroisopropene Diphthalic acid dianhydride, 3,3',4,4'-biphenyltetracarboxylic dianhydride, 2,2',3,3'-biphenyltetracarboxylic dianhydride, bis(phthalic acid) Phenylphosphine oxide dianhydride, p-phenylene bis(triphenylphthalic acid) dianhydride, meta-phenylene bis(triphenylbenzene) Formic acid) dianhydride, bis(triphenylphthalic acid)-4,4'-diphenyl ether dianhydride, bis(triphenylphthalic acid)-4,4'-diphenylmethane dianhydride, B Glycol-bis(anhydrous benzene trimellitate), propylene glycol-bis(anhydrous benzene trimellitate), 1,4-butanediol-bis(anhydrous benzene trimellitate), :1,6-hexane Alcohol-bis(anhydrous benzene trimellitate), 1,8 octanediol-bis(anhydrous benzene trimellitate), 2,2-bis(4-hydroxyphenyl)propane-bis(anhydrous benzotricarboxylic acid) Ester), an aromatic tetracarboxylic dianhydride of a compound such as the following formula (T-1) to (T-4): 0
COOCOO
-10- 200911884-10- 200911884
-11 - 200911884-11 - 200911884
該等四羧酸二酐可單獨使用一種或組合兩種以上使用 。該等芳香族四羧酸二酐之苯環亦可經一或兩個以上之碳 數1 ~4之烷基(較好爲甲基)取代。 上述聚醯胺酸之合成中所用之四殘酸二酐就可展現良 好液晶配向性之觀點而言’上述中較佳者爲包含選自丁垸 四羧酸二酐、1,2,3,4 -環丁烷四羧酸二酐、丨,3·二甲基_ 1,2,3,4 -環丁垸四錢酸二酐、丨,2,3,4-環戊院四竣酸二酐、 2,3,5-三竣基環戊基乙酸二酐、1,3,33,4,5,913-六氫_5-(四 氫-2,5-二氧代-3-呋喃基)_萘并[1,2-(:]-呋喃-1,3-二酮、 1,3,3&,4,5,91>-六氫-8-甲基-5-(四氫-2,5-二氧代-3-呋喃基 )-萘并[l,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b -六氫- 5,8 -二 甲基-5-(四氫-2,5-二氧代-3-呋喃基)-萘并[1,2^]-呋喃-1,3-二酮、雙環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酐、3-氧 雜雙環[3.2.1]辛烷_2,4 -二酮-6-螺- 3’-(四氫呋喃·2’,5’ -二 酮)、5- (2,5 -二氧代四氫-3 -呋喃基)-3 -甲基-3-環己烯-1,2-二羧酸二酐、3,5,6-三羧基-2-羧基甲基原冰片烷-2: -12- 200911884 3,5:6-二酐、4,9-二氧雜三環[5.3.1.02’6]十一烷-3,5,8,10- 四酮、均苯四酸二酐、3,3’,4,4’-二苯甲酮四羧酸二酐、 3,3’,4,4’-聯苯颯四羧酸二酐、2,2’,3,3’-二苯甲酮四羧酸 二酐、1,4,5,8-萘四羧酸二酐、以上式(T-1 )表示之化合 物中分別以下式(T-5 )〜(T-7 )表示之化合物: Ο 〇These tetracarboxylic dianhydrides may be used alone or in combination of two or more. The benzene ring of the aromatic tetracarboxylic dianhydride may also be substituted by one or more alkyl groups having 1 to 4 carbon atoms (preferably methyl groups). The above-mentioned four-residual acid dianhydride used in the synthesis of the polyamic acid exhibits good liquid crystal alignment. The above preferably comprises a compound selected from the group consisting of tetrabutyl phthalic acid dianhydride, 1, 2, 3, 4-cyclobutane tetracarboxylic dianhydride, hydrazine, 3· dimethyl _ 1,2,3,4-cyclobutane tetracarboxylic acid dianhydride, hydrazine, 2,3,4-cyclopentanyltetradecanoic acid Dihydride, 2,3,5-trimethylcyclopentyl acetic acid dianhydride, 1,3,33,4,5,913-hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl )_Naphtho[1,2-(:]-furan-1,3-dione, 1,3,3&,4,5,91>-hexahydro-8-methyl-5-(tetrahydro- 2,5-dioxo-3-furanyl)-naphtho[l,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5, 8-Dimethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphtho[1,2^]-furan-1,3-dione, bicyclo[2.2.2] -oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 3-oxabicyclo[3.2.1]octane-2,4-dione-6-spiro-3'-(tetrahydrofuran · 2',5'-dione), 5-(2,5-dioxotetrahydro-3-furanyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic dianhydride , 3,5,6-tricarboxy-2-carboxymethyl-formane-2: -12- 200911884 3,5:6-dianhydride, 4,9-dioxatricyclo[5.3 .1.02'6]undecane-3,5,8,10-tetraketone, pyromellitic dianhydride, 3,3',4,4'-benzophenone tetracarboxylic dianhydride, 3,3 ',4,4'-biphenylfluorene tetracarboxylic dianhydride, 2,2',3,3'-benzophenonetetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride The compound represented by the following formula (T-5) to (T-7) in the compound represented by the above formula (T-1): Ο 〇
(T-7) 以及以下式(T-II )表示之化合物中以下式(8 )表 示之化合物:(T-7) and a compound represented by the following formula (8) in the compound represented by the following formula (T-II):
之至少一種(以下稱爲「特定四羧酸二酐」)者。 最佳者之特定四羧酸二酐舉例爲選自由下列組成之群 組之至少一種:1,2,3,4-環丁烷四羧酸二酐、2,3,5-三羧基 -13 - 200911884 環戊基乙酸二酐、l,3,3a,4,5,9b-六氫-5-(四氫-2 代-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a 六氫-8-甲基- 5-(四氫-2,5-二氧代-3-呋喃基)-萘 c]-呋喃-1,3-二酮、3-氧雜雙環[3.2.1]辛烷-2,4-二f 3’-(四氫呋喃-2’,5’-二酮)、5-(2,5-二氧代四氫 基)-3-甲基-3-環己烯-1,2-二羧酸二酐、3,5,6-三 羧基甲基原冰片烷-2 : 3,5 : 6 -二酐、4,9 -二氧 [5.3.1.02’6]十一烷-3,5,8,10-四酮、均苯四酸二酐;g (T-5 )表示之化合物。 上述聚醯胺酸之合成中所用之四羧酸二酐, 部四羧酸二酐,較好爲含有20莫耳%以上之如上 定四羧酸二酐者,更好含有50莫耳%以上者,且 含有80莫耳%者。 上述聚醯胺酸之合成中所用之二胺可舉例爲下 對一苯二胺、間一苯二胺、4,4’-二胺基二苯基 4,4’ -二胺基二苯基乙烷、4,4’-二胺基二苯基硫醚 二胺基二苯基諷、3,3’-二甲基-4,4’-二胺基聯苯、 胺基苯甲醯苯胺、4,4’-二胺基二苯基醚、1,5-二胺 2,2 ’ -二甲基-4,4 ’ -二胺基聯苯、5 -胺基-1 - ( 4 ’ -胺 )-1,3,3 -三甲基茚滿、6 -胺基-1-( 4’-胺基苯基) 三甲基茚滿、3,4’-二胺基二苯基醚、3,3’-二胺基 酮、3,4’-二胺基二苯甲酮、4,4’-二胺基二苯甲酮 ,5 -二氧 ,4,5,9b-并[1,2-阔 6 -螺- -3 -呋喃 羧基-2- 雜三環 .以上式 :對於全 述之特 最好爲 列等: 甲烷、 、4,4,-4,4,_二 基萘、 基苯基 -1,3,3- 二苯甲 2,2-雙 -14- 200911884 [4- ( 4-胺基苯氧基)苯基]丙烷、2,2-雙[4- ( 4-胺基苯基 )苯基]六氟丙烷、2,2-雙(4-胺基苯基)六氟丙烷、雙 [4- (4-胺基苯氧基)苯基]砸、I,4-雙(4-胺基苯氧基) 苯、4,4’-雙(4-胺基苯氧基)聯苯、1,3-雙(4-胺基苯氧 基)苯、1,3-雙(3-胺基苯氧基)苯、9,9-雙(4_胺基苯 基)-10-氫蒽、2,7-二胺基芴、9,9-二甲基-2,7-二胺基芴 、9,9-雙(4-胺基苯基)芴、雙(4•胺基-2-氯苯基)甲烷 、2,2’,5,5’-四氯-4,4’-二胺基聯苯、2,2’-二氯-4,4’-二胺 基-5,5’-二甲氧基聯苯、3,3’-二甲氧基- 4,4’-二胺基聯苯、 4,4’-(對-伸苯基二異亞丙基)雙苯胺、4,4’-(間一伸苯 基二異亞丙基)雙苯胺、2,2’-雙[4- (4-胺基-2-三氟甲基 苯氧基)苯基]六氟丙烷、4,4’-二胺基- 3,3’-雙(三氟甲基 )聯苯、4,4’-二胺基-2,2’-雙(三氟甲基)聯苯、4,4’-雙[ (4-胺基-2-三氟甲基)苯氧基]-八氟聯苯、分別以下式( D-l ) ~ ( D-5 )表示之化合物等之芳香族二胺:At least one of them (hereinafter referred to as "specific tetracarboxylic dianhydride"). The preferred tetracarboxylic dianhydride is exemplified by at least one selected from the group consisting of 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 2,3,5-tricarboxy-13 - 200911884 Cyclopentyl acetic acid dianhydride, l,3,3a,4,5,9b-hexahydro-5-(tetrahydro-2-3-pyranyl)-naphtho[1,2-c]-furan -1,3-diketone, 1,3,3a hexahydro-8-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene c]-furan-1,3 -dione, 3-oxabicyclo[3.2.1]octane-2,4-dif 3'-(tetrahydrofuran-2',5'-dione), 5-(2,5-dioxotetra Hydroxy)-3-methyl-3-cyclohexene-1,2-dicarboxylic dianhydride, 3,5,6-tricarboxymethylnorbornane-2 : 3,5 : 6 -dianhydride, 4,9-dioxy[5.3.1.0''6]undecane-3,5,8,10-tetraone, pyromellitic dianhydride; a compound represented by g(T-5). The tetracarboxylic dianhydride used in the synthesis of the polyamic acid, the tetracarboxylic dianhydride preferably contains 20 mol% or more of the above tetracarboxylic dianhydride, and more preferably 50 mol% or more. And contain 80% of the person. The diamine used in the synthesis of the above polyamic acid can be exemplified by p-p-phenylenediamine, m-phenylenediamine, 4,4'-diaminodiphenyl 4,4'-diaminodiphenyl. Ethane, 4,4'-diaminodiphenyl sulfide diaminodiphenyl, 3,3'-dimethyl-4,4'-diaminobiphenyl, aminobenzamide , 4,4'-diaminodiphenyl ether, 1,5-diamine 2,2 '-dimethyl-4,4 '-diaminobiphenyl, 5-amino-1 - ( 4 ' -amine)-1,3,3-trimethylindan, 6-amino-1-(4'-aminophenyl)trimethylindan, 3,4'-diaminodiphenyl ether , 3,3'-diamino ketone, 3,4'-diaminobenzophenone, 4,4'-diaminobenzophenone, 5-dioxo, 4,5,9b-[ 1,2-wide 6-spiro--3-furancarboxyl-2-heterotricyclic. The above formula: for the whole description, it is preferably a column, etc.: methane, 4, 4, -4, 4, _ diyl Naphthalene, phenyl-1,3,3-diphenyl 2,2-bis-14- 200911884 [4-(4-Aminophenoxy)phenyl]propane, 2,2-bis[4-( 4-aminophenyl)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, bis[4-(4-aminophenoxy)phenyl]indole, I 4-bis(4-aminophenoxy)benzene, 4,4'-bis(4-aminophenoxy)biphenyl, 1,3-bis(4-aminophenoxy)benzene, 1, 3-bis(3-aminophenoxy)benzene, 9,9-bis(4-aminophenyl)-10-hydroquinone, 2,7-diaminopurine, 9,9-dimethyl- 2,7-Diaminopurine, 9,9-bis(4-aminophenyl)anthracene, bis(4•amino-2-chlorophenyl)methane, 2,2',5,5'-four Chloro-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4'-diamino-5,5'-dimethoxybiphenyl, 3,3'-dimethoxy -4,4'-diaminobiphenyl, 4,4'-(p-phenylene diisopropylidene)diphenylamine, 4,4'-(m-phenylene diisopropylidene) double Aniline, 2,2'-bis[4-(4-amino-2-trifluoromethylphenoxy)phenyl]hexafluoropropane, 4,4'-diamino-3,3'-bis ( Trifluoromethyl)biphenyl, 4,4'-diamino-2,2'-bis(trifluoromethyl)biphenyl, 4,4'-bis[(4-amino-2-trifluoromethyl) Aromatic diamines such as phenoxy]-octafluorobiphenyl, compounds represented by the following formula (Dl) ~ (D-5):
-15- 200911884 ch3 ,ch3-15- 200911884 ch3 ,ch3
nh2Nh2
(D-5) (式(D-4)中之y爲2~12之整數,式(D-5)中之 z爲1〜5之整數); 1 , 1 -對二甲苯基二胺、1 , 3 -丙烷二胺、四亞甲基二胺 、五亞甲基二胺、六亞甲基二胺、七亞甲基二胺、八亞甲 -16- 200911884 基二胺、九亞甲基二胺、1,4-二胺基環己烷、異彿爾酮二 胺、四氫二環戊烷二烯亞基二胺、六氫-4,7-甲橋伸茚滿二 亞甲基二胺、三環[6.2.1.02’7]-伸十一烷基二甲基二胺、 4,4’-亞甲基雙(環己基胺)、1,3-雙(胺基甲基)環己烷 、:l,4-雙(胺基甲基)環己烷等脂肪族及脂環式二胺; 2,3-二胺基吡啶、2,6-二胺基吡啶、3,4-二胺基吡啶 、2,4 -二胺基嘧啶、5,6 -二胺基-2,3 -二氰基哌啶、5,6 -二 胺基-2,4 -二羥基嘧啶、2,4 -二胺基-6 -二甲胺基-1 , 3,5 -三嗪 、1,4-雙(3-胺基丙基)哌啶、2,4-二胺基-6-異丙氧基-1,3,5-三嗪、2,4-二胺基-6-甲氧基-1,3,5-三嗪、2,4-二胺 基-6-苯基-1,3,5-三嗪、2,4-二胺基-6-甲基-s-三嗪、2,4-二 胺基-1,3,5-三嗪、4,6-二胺基-2-乙烯基-s-三嗪、2,4-二胺 基-5-苯基噻唑、2,6-二胺基嘌呤、5,6-二胺基-1,3-二甲基 脲、3,5-二胺基-1,2,4-三唑、3,8-二胺基-6-苯基菲啶、 1,4 -二胺基哌啶、3,6 -二胺基吖啶、N,N ’ -雙(4 -胺基苯基 )苯基胺、3,6-二胺基咔唑、N-甲基-3,6-二胺基咔唑、N-乙基- 3,6-二胺基味唑、N -苯基- 3,6 -二胺基咔唑、N,N’-雙 (4-胺基苯基)-聯苯胺、Ν,Ν’-雙(4-胺基苯基)-N,N’-二甲基-聯苯胺、以下式(D- 1 )表示之化合物:(D-5) (wherein y in the formula (D-4) is an integer of 2 to 12, and z in the formula (D-5) is an integer of 1 to 5); 1, 1 - p-xylylenediamine, 1, 3-propanediamine, tetramethylenediamine, pentamethylenediamine, hexamethylenediamine, heptamethylenediamine, octamethyl-16-200911884 bisamine, jiapaya Diamine, 1,4-diaminocyclohexane, isophoronediamine, tetrahydrodicyclopentanedienediamine, hexahydro-4,7-methyl bridge Diamine, tricyclo[6.2.1.02'7]-exedecyldimethyldiamine, 4,4'-methylenebis(cyclohexylamine), 1,3-bis(aminomethyl) An aliphatic or alicyclic diamine such as cyclohexane, l,4-bis(aminomethyl)cyclohexane; 2,3-diaminopyridine, 2,6-diaminopyridine, 3, 4-diaminopyridine, 2,4-diaminopyrimidine, 5,6-diamino-2,3-dicyanopiperidine, 5,6-diamino-2,4-dihydroxypyrimidine, 2,4-diamino-6-dimethylamino-1,3,5-triazine, 1,4-bis(3-aminopropyl)piperidine, 2,4-diamino-6- Isopropoxy-1,3,5-triazine, 2,4-diamino-6-methoxy-1,3,5-triazine, 2,4-diamino-6-phenyl- 1,3,5-three Pyrazine, 2,4-diamino-6-methyl-s-triazine, 2,4-diamino-1,3,5-triazine, 4,6-diamino-2-vinyl- S-triazine, 2,4-diamino-5-phenylthiazole, 2,6-diaminopurine, 5,6-diamino-1,3-dimethylurea, 3,5-di Amino-1,2,4-triazole, 3,8-diamino-6-phenylphenanthridine, 1,4-diaminopiperidine, 3,6-diaminoacridine, N,N '-Bis(4-aminophenyl)phenylamine, 3,6-diaminocarbazole, N-methyl-3,6-diaminocarbazole, N-ethyl-3,6-di Amino oxazole, N-phenyl-3,6-diaminocarbazole, N,N'-bis(4-aminophenyl)-benzidine, anthracene, Ν'-bis(4-aminobenzene a compound represented by the following formula (D-1): -N,N'-dimethyl-benzidine:
(式(D - 1 )中,R5爲選自妣卩定、喃症、三曝、哌D定 及哌嗪之具有含氮原子之環構造之1價有機基,X1表示2 -17- 200911884 價有機基,R6爲碳數1~4之烷基,al爲0〜3之整 以下式(D-II)表不之化合物等之分子內具有2個 基及除該一級胺基以外之氮原子之二胺: 數)、 〜級胺 (R8)a2(In the formula (D-1), R5 is a monovalent organic group selected from the group consisting of ruthenium, sulfonate, triple exposure, piperidine and piperazine having a nitrogen atom-containing ring structure, and X1 represents 2-17-200911884 The valence organic group, R6 is an alkyl group having 1 to 4 carbon atoms, and al is 0 to 3, and the compound represented by the following formula (D-II) has two groups and a nitrogen other than the primary amine group. Amine diamine: number), ~-amine (R8) a2
(R8)a2(R8)a2
(D-II) (式(D-II)中,R7爲選自吡啶、嘧啶、Ξ嗓 及哌嗪之具有含氮原子之環構造之2價有機基,χ 爲2價有機基,複數存在之X 1 1可分別相同或不同 別爲碳數1〜4之烷基,a2分別爲0〜3之整數); 以下式(D-III)表示之化合物等之單取代之 (R11)a3 OR9—R10 (D-III) L nh2 (式(D-III )中,r9 爲-〇-、-COO-、-OCO-、 、-CONH-或-CO-,R1Q爲具有選自類固醇骨架、三 苯基、三氟甲氧基苯基及氟苯基之骨架或基之1價 ,或碳數6〜30之烷基,R1 1爲碳數1〜4之烷基, 0〜3之整數); 以下式(D-l IV )表示之化合物等之二胺基有 、哌啶 丨1分別 ,R8分 #二胺 -NHCO- 氟甲基 有機基 a3爲 機矽氧 -18- 200911884 烷: R12 R12 H2N-fCH2^Si—(-〇-Si^-CH3^NH2 R12 R12 (D-IV) (式(D-IV)中’ R12各爲碳數i~12之烴基,複數 存在之R12可分別相同或不同,p分別爲1〜3之整數,q 爲1〜2 0之整數)。該等二胺可單獨使用或組合兩種以上 使用。 上述芳香族二胺之苯環亦可經一或兩個以上之碳數 1〜4之烷基(較好爲甲基)取代。上式(D-I) 、(D-II) 及(D-ΠΙ )中R6、R8及R1 1較好分別爲甲基,al、a2及 a3較好分別爲〇或1 ’且更好爲0。 上式(D-ΙΠ )中之r1()之類固醇骨架謂爲由環戊烷多 氫菲核組成之骨架或其碳-碳鍵之一個或兩個以上爲雙鍵 之骨架。具有如此類固醇骨架之R1()之一價有機基較好爲 碳數17〜51者,更好爲碳數17〜29者。具有類固醇骨架之 R1()之具體例可舉例爲例如膽甾烷_3·基、膽留-5-烯_3·基 、膽甾-2 4烯-3 -基、膽甾-5,2 4 -二烯-3 -基、羊毛甾院-3 -基 等。 用以合成上述聚醯胺酸使用之二胺’較好包含選自由 下列所構成之群組之至少一種(以下稱爲「特定二胺」) :於上述中之對一苯二胺、4,4’_二胺基二苯基甲院、 4,4,-二胺基二苯基硫醚、1,5_二胺基萘、2,2’-二甲基- -19- 200911884 4,4’-二胺基聯苯、4,4’-二胺基- 2,2’-雙(三氟甲基)聯苯 、2,7-二胺基芴、4,4’-二胺基二苯基醚、2,2-雙[4- (4-胺 基苯氧基)苯基]丙烷、9,9-雙(4_胺基苯基)芴、2,2-雙 [4- (4-胺基苯氧基)苯基]六氟丙烷、2,2-雙(4-胺基苯 基)六氟丙烷、4,4’-(對-伸苯基二異亞丙基)聯苯胺、 4,4’-(間一伸苯基二異亞丙基)聯苯胺、1,4-雙(4-胺基 苯氧基)苯、4,4’-雙(4-胺基苯氧基)聯苯、1,4-二胺基 環己烷、4,4’-亞甲基雙(環己基胺基)、1,3-雙(胺基甲 基)環己烷、分別以上式(D-1 )〜(D-5 )表示之化合物 、2,6 -二胺基吡啶、3,4 -二胺基吡啶、2,4 -二胺基嘧啶、 3,6 -二胺基咔唑、N -甲基-3,6 -二胺基咔唑、N·乙基-3,6 -二 胺基咔唑、N-苯基- 3,6 -二胺基咔唑、Ν,Ν’-雙(4-胺基苯 基)-聯苯胺、Ν,Ν’-雙(4-胺基苯基)-Ν,Ν’-二甲基聯苯 胺、以上式(D-1 )表示之化合物中以下式(D-6 )表示之 化合物:(D-II) (In the formula (D-II), R7 is a divalent organic group having a ring structure containing a nitrogen atom selected from the group consisting of pyridine, pyrimidine, anthracene and piperazine, and χ is a divalent organic group, and the plural is present X 1 1 may be the same or different alkyl groups having a carbon number of 1 to 4, and a2 is an integer of 0 to 3, respectively; and the compound of the following formula (D-III) is monosubstituted (R11) a3 OR9 —R10 (D-III) L nh2 (in the formula (D-III), r9 is -〇-, -COO-, -OCO-, -CONH- or -CO-, and R1Q has a structure selected from steroids, three a valence of a skeleton or a base of a phenyl group, a trifluoromethoxyphenyl group, and a fluorophenyl group, or an alkyl group having a carbon number of 6 to 30, and R1 1 is an alkyl group having 1 to 4 carbon atoms, an integer of 0 to 3) The diamine group of the compound represented by the following formula (Dl IV ), piperidinium 1 respectively, R8 minute #diamine-NHCO-fluoromethylorgano group a3 is a gas oxime-18- 200911884 alkane: R12 R12 H2N -fCH2^Si—(-〇-Si^-CH3^NH2 R12 R12 (D-IV) (In the formula (D-IV), R12 is a hydrocarbon group having a carbon number i~12, and the plural R12 may be the same or Different, p is an integer of 1 to 3, and q is an integer of 1 to 2 0. The diamines may be used alone or in combination. The above-mentioned aromatic diamine benzene ring may be substituted by one or two or more alkyl groups having 1 to 4 carbon atoms (preferably methyl groups). The above formulas (DI), (D-II) and In the case of D-ΠΙ), R6, R8 and R1 1 are each preferably a methyl group, and al, a2 and a3 are preferably 〇 or 1 ' and more preferably 0. The above formula (D-ΙΠ) is r1() The steroid skeleton is a skeleton composed of a cyclopentane polyhydrophenanthrene nucleus or one or two or more carbon-carbon bonds thereof, which is a double bond. The R1 () one-valent organic group having such a steroid skeleton is preferably carbon. The number is from 17 to 51, more preferably from 17 to 29 carbon atoms. Specific examples of R1() having a steroid skeleton can be exemplified by, for example, cholestane-3-yl, cholest-5-ene-3, and biliary甾-2 4 ene-3-yl, cholest-5,2 4 -dien-3-yl, wool broth-3, and the like. The diamine used to synthesize the above polyamic acid is preferably included Select at least one of the following groups (hereinafter referred to as "specific diamines"): in the above-mentioned p-phenylenediamine, 4,4'-diaminodiphenylcarbamate, 4, 4, -diaminodiphenyl sulfide, 1,5-diaminonaphthalene, 2,2'-dimethyl--19- 200911884 4,4'-Diaminobiphenyl, 4,4'-diamino-2,2'-bis(trifluoromethyl)biphenyl, 2,7-diaminopurine, 4,4'- Diaminodiphenyl ether, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 9,9-bis(4-aminophenyl)anthracene, 2,2-double [4-(4-Aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 4,4'-(p-phenylene diiso) Propyl)benzidine, 4,4'-(m-phenylenediisopropylidene)benzidine, 1,4-bis(4-aminophenoxy)benzene, 4,4'-bis (4- Aminophenoxy)biphenyl, 1,4-diaminocyclohexane, 4,4'-methylenebis(cyclohexylamino), 1,3-bis(aminomethyl)cyclohexane a compound represented by the above formula (D-1) to (D-5), 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6- Diaminocarbazole, N-methyl-3,6-diaminocarbazole, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6-diaminocarbazole ,Ν,Ν'-bis(4-aminophenyl)-benzidine, anthracene, Ν'-bis(4-aminophenyl)-indole, Ν'-dimethylbenzidine, above formula (D- 1 ) The compound represented by the following formula diagram (D-6) Compound:
以上式(D-II )表示之化合物中以下式(D-7 )表示 之化合物:A compound represented by the following formula (D-7) in the compound represented by the above formula (D-II):
(D-7) -20- 200911884 以上式(D-III )表示之化合物中之十二烷氧基-2,4-二胺基苯、十五烷氧基-2,4-二胺基苯、十六烷氧基-2,4-二胺基苯、十八烷氧基-2,4 -二胺基苯、十二烷氧基-2,5-—胺基苯、十五院氧基-2,5 - _•胺基本、十六院氧基-2,5-二胺基苯、十八烷氧基- 2,5-二胺基苯、分別以下式(D-8 )~ ( D -1 5 )表示之化合物:(D-7) -20- 200911884 Dodecyloxy-2,4-diaminobenzene, pentadecyloxy-2,4-diaminobenzene in the compound represented by the above formula (D-III) , cetyloxy-2,4-diaminobenzene, octadecyloxy-2,4-diaminobenzene, dodecyloxy-2,5-aminobenzene, fifteen courtyard oxygen Base-2,5--•amine basic, hexamethyleneoxy-2,5-diaminobenzene, octadecyloxy-2,5-diaminobenzene, respectively, of the following formula (D-8)~ Compound represented by (D -1 5 ):
h2n— nh2H2n— nh2
-21 - 200911884-21 - 200911884
及以上式(D-IV)表示之化合物中之1,3-雙(3-胺基 丙基)-四甲基二矽氧烷所成群中至少選出包含一種(以 下,稱之「特定二胺」)爲佳。 用以合成上述聚醯胺酸所用之二胺相對於全部二胺較 好爲含有20莫耳%以上之如上述特定二胺者,更好爲含 -22- 200911884 有5 0莫耳%以上者,最好爲含有80莫耳%以上者。 <聚醯胺酸之合成> 本發明之液晶配向劑中之聚醯胺酸可藉由使如上述之 四羧酸二酐與二胺反應而獲得。 供於聚醯胺酸合成反應中之四羧酸二酐與二胺之使用 比例,相對於1當量之二胺之胺基,四羧酸二酐之酸酐基 比例較好爲0.2〜2當量,更好爲0.8〜1 . 2當量之比例。 聚醯胺酸之合成反應較好在有機溶劑中’且較好在 -2 0 °C〜1 5 0 °C,更好在 0 ~ 1 〇 〇 °C之溫度條件下進行,較好 0 . 1〜2 4小時,更好0.5〜1 2小時。其中,有機溶劑並無特 別限制,只要可使合成之聚醯胺酸溶解即可’可舉例爲例 如N-甲基-2-吡咯啶酮、N,N-二甲基乙醯胺、N,N-二甲基 甲醯胺、二甲基亞颯、γ -丁內酯、四甲基尿素、六甲基磷 三醯胺等非質子系極性溶劑;間一甲酚、二甲酣、酣、鹵 化酚等酚系溶劑。有機溶劑之使用量(a ) ’較好爲使四 羧酸二酐與二胺化合物之總量(b ) ’相對於反應溶液之 總量(a + b)爲0.1〜30重量%之量。而且’當有機溶劑與 後述之弱溶劑倂用時,上述有機溶劑之使用量(a )可理 解意指有機溶劑與弱溶劑之總使用量。 上述有機溶劑可在不使產生之聚醯胺酸析出之範圍內 倂用對聚醯胺酸爲弱溶劑之醇類、酮類、醋類、醚類、鹵 化烴、烴等。該弱溶劑之具體例可舉例爲例如甲醇、乙醇 '異丙醇、環己醇、乙二醇、丙二醇、〗,4 -丁二醇、三乙 -23- 200911884 二醇、乙二醇單甲基醚、乳酸乙酯、乳酸丁酯、丙酮、甲 基乙基酮、甲基異丁基酮、環己酮、乙酸甲酯、乙酸乙酯 、乙酸丁酯、甲氧基丙酸甲酯、乙氧基丙酸乙酯、草酸二 乙酯、丙二酸二乙酯、二乙醚、乙二醇甲基醚、乙二醇乙 基醚、乙二醇正丙基醚、乙二醇異丙基醚' 乙二醇正丁基 醚、乙二醇二甲基醚、乙二醇乙基醚乙酸酯、二乙二醇二 甲基醚、二乙二醇二乙基醚、二乙二醇單甲基醚、二乙二 醇單乙基醚、二乙二醇單甲基醚乙酸酯、二乙二醇單乙基 醚乙酸酯、四氫呋喃、二氯甲烷、1,2-二氯乙烷、1,4-二 氯丁烷、三氯乙烷、氯苯、鄰-二氯苯、己烷、庚烷、辛 烷、苯、甲苯、二甲苯、異胺基丙酸酯、異胺基異丁酸酯 、二異戊基醚等。 有機溶劑與弱溶劑倂用時,弱溶劑之使用比例可適當 地設定在不使聚醯胺酸析出之範圍,但相對於溶劑之總量 較好爲5 0重量%以下,更好爲4 0重量%以下,且最好爲 30重量%以下。 如上述,可獲得溶解有聚醯胺酸之反應溶液。該反應 溶液可就此供於調製液晶配向劑,亦可使反應溶液中所含 之聚醯胺酸單離後供於液晶配向劑之調製’或者亦可將單 離之聚醯胺酸純化後供於液晶配向劑之調製。聚醯胺酸之 單離可藉由將上述反應溶液大量的注入弱溶劑中獲得析出 物,使該析出物減壓乾燥之方法,或者,以蒸發器減壓餾 除反應溶液之方法而進行。另外’可藉由使該聚醯胺酸再 溶解於有機溶劑中,接著以弱溶劑析出之方法,或者進行 -24- 200911884 一次或數次之以蒸發器減壓餾除之步驟之方法使聚醯胺酸 純化。 <聚醯亞胺> 本發明之液晶配向劑中之聚醯亞胺可藉由使如上述聚 醯胺酸進行脫水閉環並醯亞胺化而獲得。 本發明之液晶配向劑中所含之聚醯亞胺可爲使原料聚 醯酸所具有之醯胺酸構造之全部經脫水閉環而成之完全醯 亞胺化物,亦可爲僅使醯胺酸構造之一部分脫水閉環而成 爲醯胺酸構造與醯亞胺環構造並存之部分醯亞胺化物。 本發明之液晶配向劑中之聚醯亞胺其醯亞胺化率較好 爲30%以上,更好爲50%以上,且最好爲80%以上。上述 醯亞胺化率爲相對於聚醯亞胺之醯胺酸構造數與醯亞胺環 構造之總數,以百分比表示之醯亞胺環構造數所佔之比例 ,此時,醯亞胺環之一部分亦可爲異醯亞胺環。如此般之 醯亞胺化率可由聚醯亞胺之'h-nmr得知。 聚醯胺酸之脫水閉環較好(i )藉由將聚醯胺酸加熱 之方法,或(Π )藉由將聚醯胺酸溶解於有機溶劑中,於 該溶液中添加脫水劑及脫水閉環觸媒,並視情況加熱之方 法而進行。 上述(i)之使聚醯胺酸加熱之方法中之反應溫度較 好爲50〜200 °C,更好爲60〜170°C。反應溫度未達50°C則 難以充分進行脫水閉環反應,反應溫度超過2〇〇°C會使所 得醯亞胺化聚合物之分子量降低。反應時間較好爲1 · 0〜2 4 -25- 200911884 小時,更好爲1.0 ~ 1 2小時。 另一方面,上述(Η )之於聚醯胺酸溶液中添加脫水 劑及脫水閉環觸媒之方法中,脫水劑可使用例如乙酸酐、 丙酸酐、三氟乙酸酐等酸酐。脫水劑之用量,依期望之醯 亞胺化率,相對於聚醯胺酸之醯胺酸構造1莫耳,較好爲 0.01〜20莫耳。另外,脫水閉環觸媒可使用例如吡啶、三 甲基吡啶、二甲基吡啶、三乙胺等三級胺。但,並不限於 該等。脫水閉環觸媒之使用量,相對於1莫耳所用之脫水 劑,較好爲0.0 1〜1 〇莫耳。脫水化率可能隨著上述脫水劑 及脫水閉環劑之使用量愈多而愈高。脫水閉環反應中所用 之有機溶劑可舉例爲於聚醯胺酸合成中所用者例示之有機 溶劑。脫水閉環反應之反應溫度較好爲〇〜1 8 0 °c,更好爲 1 0〜1 5 0 °c。反應時間較好爲1 · 〇〜1 2 0小時,更好爲2.0〜3 0 小時。 上述方法(i )中獲得之聚醯亞胺,其可就此供於液 晶配向劑之調製,或者亦可將所得聚醯亞胺純化後供於液 晶配向劑之調製。另一方面,於上述方法(i i )可獲得含 有聚醯亞胺之反應溶液。該反應溶液可就使供於至液晶配 向劑之調製,亦可自反應溶液去除脫水劑及脫水閉環觸媒 後供於液晶配向劑之調製,亦可使聚醯亞胺單離後供於液 晶配向劑之調製’或者使單離之聚醯亞胺純化後供於液晶 配向劑之調製。自反應溶液去除脫水劑及脫水閉環觸媒可 適當地使用溶劑置換等方法。聚醯亞胺之單離、純化可藉 由進行與上述聚醯胺酸之單離、純化方法相同操作而進行 -26- 200911884 -末端修飾型之聚合物- 本發明之液晶配向劑中所含聚醯胺酸或聚醯亞胺亦可 分別爲分子量經調整之末端修飾型聚合物。藉由使用該末 端修飾型聚合物’可在不損及本發明效果下進一步改善液 晶配向劑之塗佈特性等。該等末端修飾型聚合物可在合成 聚醯胺酸時,藉由將分子量調節劑添加於聚合反應系統中 而進行。分子量調節劑可舉例爲例如酸酌1、單胺化合物、 單異氰酸酯化合物等。 上述酸酐可舉例爲例如馬來酸酐、苯二甲酸酐、衣康 酸酐、正癸基琥珀酸酐、正十二烷基琥珀酸酐、正十四烷 基琥珀酸酐、正十六烷基琥珀酸酐等。上述單胺化合物可 舉例爲例如苯胺、環己胺、正丁基胺、正戊基胺、正己基 胺、正庚基胺、正辛基胺、正壬基胺、正癸基胺、正十一 烷基胺、正十二烷基胺、正十三烷基胺、正十四烷基胺、 正十五烷基胺、正十六烷基胺、正十七烷基胺、正十八烷 基胺、正二十烷基胺等。上述單異氰酸酯化合物可舉例爲 例如異氰酸苯基酯、異氰酸萘基酯等。 分子量調節劑之使用比例相對於合成聚醯胺酸時使用 之四羧酸二酐及二胺之總量100重量份,較好爲20重量 份以下,更好爲1 0重量份以下。 -溶液黏度- -27- 200911884 如上述獲得之聚醯胺酸及聚醯亞胺,於該等分別作爲 濃度10重量%之溶液時,較好具有2〇~800mPa · s之溶液 黏度,更好具有30〜500mPa.s之溶液黏度。 上述聚合物之溶液黏度(mPa*s)係由使用該聚合物 之良好溶劑(例如γ-丁內酯、N-甲基-2-吡咯啶酮等)所 調製之濃度1 0重量%之聚合物溶液,使用Ε型旋轉黏度 計在2 5 t下測定之値。 < (B )化合物> 本發明之液晶配向劑中所含(B )化合物爲具有藉由 波長200~400nm之光可產生交聯反應或異構化反應之感 光基及環氧基之化合物。 上述(B )化合物只要具有上述性質’則無特別限制 ,例如化合物可爲具有下列基之化合物:碳數4〜2 0之烷 基、碳數1〜2 0之氟烷基、環己基、具有碳數1〜2 0之烷基 之烷基環己基或烷基苯基、具有碳數1〜20之氟烷基之氟 院基環己基或氣院基苯基、碳數4~20之院基氧基、碳數 1〜2 0之氟烷基氧基、環己基氧基、具有碳數1〜20之烷基 氧基之烷基氧基環己基或烷基氧基苯基' 具有碳數1〜20 之氟烷基之氟烷基環己基或氟烷基氧基苯基、或具有類固 醇骨架之碳數17〜51之基’與 環氧基,及 以下式(1 )表示之基° -28- 200911884And at least one selected from the group consisting of 1,3-bis(3-aminopropyl)-tetramethyldioxane in the compound represented by the above formula (D-IV) (hereinafter, referred to as "specific two Amine" is preferred. The diamine used for the synthesis of the above polyamic acid preferably contains 20 mol% or more of the specific diamine as described above, and more preferably 50% or more of the -22-200911884. It is best to contain more than 80% by mole. <Synthesis of Polylysine> The polyglycolic acid in the liquid crystal alignment agent of the present invention can be obtained by reacting a tetracarboxylic dianhydride as described above with a diamine. The ratio of the tetracarboxylic dianhydride to the diamine used in the polyamine acid synthesis reaction is preferably from 0.2 to 2 equivalents based on the amine group of one equivalent of the diamine. More preferably, it is a ratio of 0.8 to 1.2 equivalents. The synthesis reaction of poly-proline is preferably carried out in an organic solvent 'and preferably at -2 0 ° C to 150 ° C, more preferably at a temperature of 0 to 1 ° C, preferably 0. 1~2 4 hours, better 0.5~1 2 hours. The organic solvent is not particularly limited as long as the synthetic polyaminic acid can be dissolved. For example, N-methyl-2-pyrrolidone, N,N-dimethylacetamide, N, Aprotic polar solvent such as N-dimethylformamide, dimethyl hydrazine, γ-butyrolactone, tetramethyl urea, hexamethylphosphoric acid triamide; m-cresol, dimethylhydrazine, hydrazine A phenolic solvent such as a halogenated phenol. The amount (a) of the organic solvent used is preferably such that the total amount (b) of the tetracarboxylic dianhydride and the diamine compound is from 0.1 to 30% by weight based on the total amount (a + b) of the reaction solution. Further, when the organic solvent is used in combination with a weak solvent to be described later, the amount (a) of the above organic solvent can be understood to mean the total amount of the organic solvent and the weak solvent. The organic solvent may be an alcohol, a ketone, a vinegar, an ether, a halogenated hydrocarbon, a hydrocarbon or the like which has a polyacetic acid as a weak solvent in a range in which the produced polyaminic acid is not precipitated. Specific examples of the weak solvent include, for example, methanol, ethanol 'isopropyl alcohol, cyclohexanol, ethylene glycol, propylene glycol, 〗 〖, 4-butanediol, triethyl-23-200911884 diol, ethylene glycol monomethyl Ether, ethyl lactate, butyl lactate, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, methyl acetate, ethyl acetate, butyl acetate, methyl methoxypropionate, Ethyl ethoxypropionate, diethyl oxalate, diethyl malonate, diethyl ether, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl Ether 'ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol single Methyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, tetrahydrofuran, dichloromethane, 1,2-dichloroethane Alkane, 1,4-dichlorobutane, trichloroethane, chlorobenzene, o-dichlorobenzene, hexane, heptane, octane, benzene, toluene, xylene, isoamylpropionate, isoammine Isobutyrate, diisoamyl ether . When the organic solvent and the weak solvent are used, the ratio of the weak solvent to be used may be appropriately set within a range in which the polyamic acid is not precipitated, but it is preferably 50% by weight or less, more preferably 4 0, based on the total amount of the solvent. It is below weight%, and is preferably 30% by weight or less. As described above, a reaction solution in which polylysine is dissolved can be obtained. The reaction solution can be used for preparing a liquid crystal alignment agent, and can also be used for preparing a liquid crystal alignment agent after the polyamic acid contained in the reaction solution is separated, or the isolated polyamic acid can be purified. Modulation of liquid crystal alignment agent. The separation of the polyamic acid can be carried out by injecting a large amount of the above reaction solution into a weak solvent to obtain a precipitate, drying the precipitate under reduced pressure, or distilling off the reaction solution under reduced pressure in an evaporator. In addition, the poly-proline can be re-dissolved in an organic solvent, followed by precipitation in a weak solvent, or by the step of -24-200911884 one or several times of evaporation of the evaporator under reduced pressure. Purification of proline. <Polyimine> The polyimine in the liquid crystal alignment agent of the present invention can be obtained by subjecting the polylysine as described above to dehydration ring closure and hydrazine imidization. The polyimine contained in the liquid crystal alignment agent of the present invention may be a fully ruthenium imide formed by dehydration ring closure of the proline structure of the raw material polyphthalic acid, or may be only a proline One part of the structure is dehydrated and closed to form a partial yttrium imide of the proline structure and the quinone ring structure. The polyimine in the liquid crystal alignment agent of the present invention preferably has a ruthenium iodide ratio of 30% or more, more preferably 50% or more, and most preferably 80% or more. The sulfhydrylation ratio is the ratio of the number of decanoic acid structures to the total number of quinone imine ring structures, and the proportion of the quinone imine ring structure expressed as a percentage. A part of it may also be an isoindole ring. Such a ruthenium imidization rate can be known from the 'h-nmr of polyimine. The dehydration ring of polylysine is preferably (i) a method of heating polylysine or (Π) by dissolving polylysine in an organic solvent, adding a dehydrating agent and dehydrating ring in the solution. Catalyst, and depending on the method of heating. The reaction temperature in the above method (i) for heating the polyglycolic acid is preferably from 50 to 200 ° C, more preferably from 60 to 170 ° C. When the reaction temperature is less than 50 °C, it is difficult to sufficiently carry out the dehydration ring-closure reaction, and the reaction temperature exceeds 2 °C to lower the molecular weight of the obtained ruthenium iodide polymer. The reaction time is preferably from 1 to 0 to 2 4 to 25 to 200911884 hours, more preferably from 1.0 to 12 hours. On the other hand, in the above method of adding a dehydrating agent and a dehydration ring-closing catalyst to the polyaminic acid solution, an acid anhydride such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride can be used as the dehydrating agent. The amount of the dehydrating agent, depending on the desired imidization ratio, is 1 mol per mol of the glycine acid of the polyglycolic acid, preferably 0.01 to 20 mol. Further, as the dehydration ring-closing catalyst, a tertiary amine such as pyridine, trimethylpyridine, lutidine or triethylamine can be used. However, it is not limited to these. The amount of the dehydration ring-closing catalyst used is preferably 0.01 to 1 mol with respect to the dehydrating agent used for 1 mol. The dehydration rate may be higher as the amount of the above dehydrating agent and dehydration ring-clogging agent is used. The organic solvent used in the dehydration ring-closure reaction can be exemplified by an organic solvent exemplified for use in the synthesis of polylysine. The reaction temperature of the dehydration ring closure reaction is preferably from 〇1 to 18 ° C, more preferably from 10 to 150 ° C. The reaction time is preferably from 1 to 11 to 12 hours, more preferably from 2.0 to 30 hours. The polyimine obtained in the above method (i) may be prepared by the liquid crystal alignment agent, or may be obtained by subjecting the obtained polyimine to a liquid crystal alignment agent. On the other hand, a reaction solution containing polyimine can be obtained in the above method (i i ). The reaction solution can be prepared for the preparation of the liquid crystal alignment agent, or can be prepared by the liquid crystal alignment agent after removing the dehydrating agent and the dehydration ring-closing catalyst from the reaction solution, or can be used for liquid crystal after being separated from the polyimide. Modulation of the alignment agent' or the preparation of the liquid crystal alignment agent after purification of the isolated polyimine. The dehydrating agent and the dehydration ring-closing catalyst are removed from the reaction solution, and a method such as solvent replacement can be suitably used. The separation and purification of the polyimine can be carried out by performing the same operation as the separation and purification method of the above polyamic acid to carry out the -26-200911884-end modified type polymer - which is contained in the liquid crystal alignment agent of the present invention. The polyaminic acid or polyimine may also be a molecularly modified terminal modified polymer, respectively. By using the terminal modified polymer ', the coating characteristics and the like of the liquid crystal alignment agent can be further improved without impairing the effects of the present invention. These terminal modified polymers can be carried out by adding a molecular weight modifier to the polymerization reaction system in the synthesis of polyamic acid. The molecular weight modifier may, for example, be an acid 1, a monoamine compound, a monoisocyanate compound or the like. The above acid anhydride may, for example, be, for example, maleic anhydride, phthalic anhydride, itaconic anhydride, n-decyl succinic anhydride, n-dodecyl succinic anhydride, n-tetradecyl succinic anhydride, n-hexadecyl succinic anhydride or the like. The above monoamine compound can be exemplified by, for example, aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-decylamine, n-decylamine, and positive ten Monoalkylamine, n-dodecylamine, n-tridecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-heptadecylamine, n-eighteen Alkylamine, n-icosylamine, and the like. The above monoisocyanate compound may, for example, be phenyl isocyanate, naphthyl isocyanate or the like. The use ratio of the molecular weight modifier is preferably 20 parts by weight or less, more preferably 10 parts by weight or less, based on 100 parts by weight of the total of the tetracarboxylic dianhydride and the diamine used in the synthesis of the polyamic acid. -Solid viscosity - -27- 200911884 The poly-proline and polyimine obtained as described above preferably have a solution viscosity of 2 〇 to 800 mPa · s, respectively, as a solution having a concentration of 10% by weight, respectively. It has a solution viscosity of 30 to 500 mPa.s. The solution viscosity (mPa*s) of the above polymer is a polymerization of a concentration of 10% by weight prepared by using a good solvent of the polymer (for example, γ-butyrolactone, N-methyl-2-pyrrolidone, etc.). The solution was measured at 25 ° t using a Ε-type rotary viscometer. <(B) Compound> The compound (B) contained in the liquid crystal alignment agent of the present invention is a compound having a photosensitive group and an epoxy group which can generate a crosslinking reaction or an isomerization reaction by light having a wavelength of 200 to 400 nm. . The compound (B) is not particularly limited as long as it has the above properties. For example, the compound may be a compound having the following groups: an alkyl group having 4 to 20 carbon atoms, a fluoroalkyl group having 1 to 20 carbon atoms, and a cyclohexyl group having An alkylcyclohexyl or alkylphenyl group having an alkyl group having 1 to 20 carbon atoms, a fluorine-based cyclohexyl group having a carbon number of 1 to 20 or a phenyl group, or a hospital having a carbon number of 4 to 20 a oxy group, a fluoroalkyloxy group having 1 to 20 carbon atoms, a cyclohexyloxy group, an alkyloxycyclohexyl group having an alkyloxy group having 1 to 20 carbon atoms or an alkyloxyphenyl group having carbon a fluoroalkylcyclohexyl group or a fluoroalkyloxyphenyl group of a fluoroalkyl group having 1 to 20 or a group having a carbon number of 17 to 51 having a steroid skeleton and an epoxy group, and a group represented by the following formula (1) ° -28- 200911884
y—CH=CH—CO— (1) 該(B )化合物較好爲以下式(1 -1 )表示之化合物: (A-W)—X—(Ep)n (1-1) (式(1-1)中,A爲以下式(A-l)〜(A-8)之任一 種表示之基,W爲以下式(W-1)〜(W-4 )之任一種表示 之基,X爲以下式(X-1 )〜(X-5 )之任一種表示之4價 基,Ep爲以下式(Ep-1)或(Ep-2)表示之基,m爲1〜3 之整數,η爲4-m ):y—CH=CH—CO— (1) The compound (B) is preferably a compound represented by the following formula (1-1): (AW)—X—(Ep)n (1-1) (Formula (1-) In 1), A is a group represented by any one of the following formulas (Al) to (A-8), and W is a group represented by any one of the following formulas (W-1) to (W-4), and X is the following formula; A tetravalent group represented by any one of (X-1) to (X-5), Ep is a group represented by the following formula (Ep-1) or (Ep-2), m is an integer of 1 to 3, and η is 4 -m ):
(式(A-1)中,R1各獨立爲碳數4〜20之烷基、碳 數1〜20之氟烷烷基、環己基、具有碳數1〜20之烷基之烷 基ϊ哀己基或院基苯基、具有碳數1~20之氣院基之氣院基 環己基或氟烷基氧基苯基、或具有類固醇骨架之碳數 1 7〜5 1之基, X1爲單鍵、氧原子、硫原子、-COO-、-NHCO-、-C0NH- 或-CO-,X2爲單鍵或以下式(X2-l )〜(X2-3 )之任一式 表不之基:(In the formula (A-1), R1 is independently an alkyl group having 4 to 20 carbon atoms, a fluoroalkyl group having 1 to 20 carbon atoms, a cyclohexyl group, and an alkyl group having an alkyl group having 1 to 20 carbon atoms. a hexyl or a phenyl group, a gas-based cyclohexyl group or a fluoroalkyloxyphenyl group having a carbon number of 1 to 20, or a carbon number of 17 to 5 1 having a steroid skeleton, X1 being a single a bond, an oxygen atom, a sulfur atom, -COO-, -NHCO-, -C0NH- or -CO-, X2 is a single bond or a formula of any of the following formulae (X2-l)~(X2-3):
C00— (X2-1) -29 - 200911884C00— (X2-1) -29 - 200911884
OrΟ- (Χ2-2) (Χ2-3) (上述式中,「*」表示附有其之鍵結鍵位X1側)。 X3 爲單鍵、*-〇-(CH2)a-、*-0-(CH2)a-C0-、*-(CH2)a-OCO-(CH2)a-、或以下式表示之基: 本OrΟ- (Χ2-2) (Χ2-3) (In the above formula, "*" indicates the side of the bonding key X1 attached thereto). X3 is a single bond, *-〇-(CH2)a-, *-0-(CH2)a-C0-, *-(CH2)a-OCO-(CH2)a-, or a base represented by the following formula:
cyo (其中,a各獨立爲1〜6之整數,「*」表示附有其 之鍵結鍵位於-C H = C Η - C Ο -側),但,相鄰之2個鍵均爲 單鍵時,該等可一起成爲一單鍵),Cyo (where a is an integer of 1 to 6 independently, "*" means that the key with the key is located at -CH = C Η - C Ο - side), but the adjacent two keys are single bonds When these can be together as a single button),
R1—X4—X5—CO—CH=CH (A-2) (式(A-2)中,R1具有與上式(A-l)中之R1相同 意義’ X4爲單鍵、氧原子、硫原子、-C〇〇_、-OCO-、-NHCO-、-CONH-或-CO-, X5爲單鍵或伸苯基, X6爲單鍵或以下式(X6-;!)表示之基:R1—X4—X5—CO—CH=CH (A-2) (In the formula (A-2), R1 has the same meaning as R1 in the above formula (Al). X4 is a single bond, an oxygen atom, a sulfur atom, -C〇〇_, -OCO-, -NHCO-, -CONH- or -CO-, X5 is a single bond or a phenyl group, and X6 is a single bond or a formula represented by the following formula (X6-;!):
•OCO•OCO
(X6-1) -30- 200911884 (式(X6-l )中,「*」表示附有其之鍵結鍵位於X7 側), X7 爲單鍵、*-〇CO-(CH2)a-、*-OCO-(CH2)a-CO-或以 下式(X7-l )表示之基: (X7-1)(X6-1) -30- 200911884 (in the formula (X6-l), "*" indicates that the key with the key is located on the X7 side), X7 is a single bond, *-〇CO-(CH2)a-, *-OCO-(CH2)a-CO- or the base represented by the following formula (X7-l): (X7-1)
*-OCO (於以上,a爲1〜6之整數,「*」表示附有其之鍵 結鍵位於X6側)),但,相鄰之2個鍵均爲單鍵時,該 等可一起成爲一單鍵),*-OCO (in the above, a is an integer from 1 to 6, and "*" indicates that the key with the key is located on the X6 side)). However, when two adjacent keys are single keys, these may be together. Become a single button),
R1—OCO—CH=CHR1—OCO—CH=CH
—CH=CH—CO— (A-3) (式(A-3)中,R1具有與上式(A-1)中之R1相同 意義),—CH=CH—CO— (A-3) (In the formula (A-3), R1 has the same meaning as R1 in the above formula (A-1)),
-31 - 200911884-31 - 200911884
(式(A-4)至(A-6)中,R1分別與上式(A-l)中 之R1相同意義,X8分別爲單鍵、氧原子、硫原子、-COO-(In the formulae (A-4) to (A-6), R1 has the same meaning as R1 in the above formula (A-1), and X8 is a single bond, an oxygen atom, a sulfur atom, or -COO-, respectively.
(式(A-7)及(A-8)中,R1分別與上式(A-1)中 之R1相同意義,X9分別爲單鍵或*-(CH2)a-COO-(其中, a爲1〜6之整數,「*」表示附有其之鍵結鍵位於-CO-側 )),(In the formulae (A-7) and (A-8), R1 has the same meaning as R1 in the above formula (A-1), and X9 is a single bond or *-(CH2)a-COO- (where a An integer of 1 to 6, "*" indicates that the key with the key is located on the -CO- side),
OH —Ο——CH2-CH——CH2——* (W-1) —-Ο HO——CH2-CH—CH2——* (W2) -32- 200911884OH —Ο—CH2-CH——CH2——* (W-1) ———Ο HO——CH2-CH—CH2——* (W2) -32- 200911884
HOHO
(W-3)(W-3)
OO
HOHO
CH2— * (W-4) (上式中,「*」表示附有其之鍵結鍵位於X側),CH2— * (W-4) (In the above formula, “*” means that the key with the key is on the X side).
-33 - 200911884-33 - 200911884
(上式中,γ 馬單鍵、-Ο-、-S-、-CH2-、-C(CH3)2- 或以下式(y-1)表示之基:(In the above formula, γ horse single bond, -Ο-, -S-, -CH2-, -C(CH3)2- or the formula represented by the following formula (y-1):
R分別爲可經氟原子取代之碳數1 ~6之烷基或氟原 子’ b爲0〜4之整數),R is an alkyl group having 1 to 6 carbon atoms which may be substituted by a fluorine atom, or a fluorine atom 'b is an integer of 0 to 4),
其中’上式(A-ι)至(A-8)中,成爲如〇-〇鍵之 取代基組合爲不容許者。 上式(A-1)至(A-8)中R1之碳數4〜20之院基可分 別列舉爲例如正丁基、正戊基、正己基、正辛基、正癸基 、正十二烷基、正十六烷基、正十八烷基、正二十烷基等 碳數1〜2 0之氟烷基可分別列舉爲例如三氟甲基、全 氟乙基、3,3,3-三氟丙基、4,4,4-三氟丁基、4,4_5,5,5-五 氟戊基、4,4-5,5_6,6,6-六氟己基等; -34- 200911884 具有碳數1〜20烷基之烷基環己基可分別列舉爲例如 4-甲基環己基、4-正丁基環己基、4-正戊基環己基、4-正 己基環己基等; 具有碳數1〜20烷基之烷基苯基可分別列舉爲例如4-正丁基環己基、4-正戊基苯基等; 具有碳數1〜2-氟烷基之氟烷基環己基可分別列舉爲 例如4-三氟甲基環己基等; 具有碳數1〜2〇氟烷基之氟烷基苯基可分別列舉爲例 如4 -三氟甲基苯基等。 R1中之類固醇骨架謂爲由環戊烷多氫菲核組成之骨架 或其碳-碳鍵之一個或兩個以上爲雙鍵之骨架。具有如此 般之類固醇骨架之R1之一價有機基較好爲碳數17~29者 。具有類固醇骨架之R1之具體例可舉例爲例如膽甾烷-3 -基、膽甾-5 -烯-3 -基、膽甾- 24 -烯-3-基、膽甾- 5,24 -二烯-3-基、羊毛甾烷-3-基等。 上式(X-1 )中之兩個氮原子分別位在間位或對位上 ♦ 上式(X-2)中之兩個氮原子分別位在4,4’-位上; 上式(X-3)中之兩個氮原子分別位在L3 —位或1,4-位上; 上式(X-4)中之兩個N_取代之亞甲基分別位在I、 位或1,4 -位上; 上式(X-5 )中之兩個N-取代之亞甲基較好分別位在 間位或對位上。 ~ 35 - 200911884 如上述之(B )化合物可藉由使例如化合物Χ·(Ερ)4 (其中,X及Ερ分別與上式(1-1)中所述相同意義)與 化合物Α-ΟΗ (其中,Α係與上式(1-1)中所述相同意義 )之混合物,較好在適當有機溶劑中,於所需觸媒存在下 加熱而合成。 化合物X-(Ep)4之具體例,可分別舉例爲如下:作爲 基X若爲上式(X-1)者,可舉例爲例如以下式(X-1-1) 及(X-1-2 )分別表示之化合物等; 作爲基X若爲上式(X-2 )者,爲例如以下式(X-H )至(X-2-6 )分別表示之化合物等; 作爲基X若爲上式(X-3)者,爲例如以下式(χ_3_ι )及(Χ-3-2 )分別表示之化合物等; 作爲基X若爲上式(Χ-4)者,爲例如以下式(χ-n )及(Χ-4-2)分別表示之化合物等; 作爲基X若爲上式(X·5)者,爲例如以下式 )及(X-5-2 )分別表示之化合物等。In the above formulas (A-ι) to (A-8), the substituents such as the 〇-〇 bond are not allowed to be combined. The groups of carbons 4 to 20 of R1 in the above formulas (A-1) to (A-8) can be exemplified by, for example, n-butyl group, n-pentyl group, n-hexyl group, n-octyl group, n-decyl group, and positive ten. A fluoroalkyl group having 1 to 20 carbon atoms such as a dialkyl group, a n-hexadecyl group, an n-octadecyl group or a n-icosyl group can be exemplified by, for example, a trifluoromethyl group, a perfluoroethyl group, and 3,3. , 3-trifluoropropyl, 4,4,4-trifluorobutyl, 4,4-5,5,5-pentafluoropentyl, 4,4-5,5-6,6,6-hexafluorohexyl, etc.; 34- 200911884 An alkylcyclohexyl group having a carbon number of 1 to 20 alkyl groups may be exemplified by, for example, 4-methylcyclohexyl group, 4-n-butylcyclohexyl group, 4-n-pentylcyclohexyl group, 4-n-hexylcyclohexyl group. And the alkylphenyl group having a carbon number of 1 to 20 alkyl groups may be exemplified by, for example, 4-n-butylcyclohexyl group, 4-n-pentylphenyl group, etc.; fluorocarbon having a carbon number of 1 to 2-fluoroalkyl group; The cyclohexyl group can be exemplified by, for example, 4-trifluoromethylcyclohexyl group; and the fluoroalkylphenyl group having a carbon number of 1 to 2 fluorinated fluoroalkyl group can be exemplified by, for example, 4-trifluoromethylphenyl group or the like. The steroid skeleton in R1 is a skeleton composed of a cyclopentane polyhydrophenanthrene nucleus or a skeleton in which one or two or more carbon-carbon bonds are double bonds. The one-valent organic group of R1 having such a steroid skeleton is preferably a carbon number of 17 to 29. Specific examples of R1 having a steroid skeleton can be exemplified by, for example, cholestane-3-yl, cholest-5-en-3-yl, cholestyl-2-en-3-yl, cholestyl-5,24-di Alk-3-yl, lanostan-3-yl and the like. The two nitrogen atoms in the above formula (X-1) are respectively located in the meta or para position. ♦ The two nitrogen atoms in the above formula (X-2) are respectively located at the 4, 4'-position; The two nitrogen atoms in X-3) are located at the L3-position or the 1,4-position, respectively; the two N-substituted methylene groups in the above formula (X-4) are respectively at the I, the position or the 1 , wherein the two N-substituted methylene groups in the above formula (X-5) are preferably located in the meta or para position. ~ 35 - 200911884 The compound (B) as described above can be obtained by, for example, Χ·(Ερ)4 (wherein X and Ερ have the same meanings as described in the above formula (1-1)) and the compound Α-ΟΗ ( Among them, a mixture of a lanthanide series and the same meaning as described in the above formula (1-1) is preferably synthesized by heating in a suitable organic solvent in the presence of a desired catalyst. Specific examples of the compound X-(Ep) 4 can be exemplified as follows: If the group X is the above formula (X-1), for example, the following formula (X-1-1) and (X-1-) can be exemplified. 2) a compound or the like which is represented by the above formula; wherein, if the group X is the above formula (X-2), it is, for example, a compound represented by the following formulas (XH) to (X-2-6); (X-3) is, for example, a compound represented by the following formulas (χ_3_ι) and (Χ-3-2); and if the base X is the above formula (Χ-4), it is, for example, the following formula (χ-n) And a compound represented by the following formula (X-5), and a compound represented by the following formula (X-5-2).
(Χ-2-1) (Χ-2-2) -36- 200911884(Χ-2-1) (Χ-2-2) -36- 200911884
(Χ-4-2)(Χ-4-2)
至於化合物A- OH之例可分別舉例爲:基Α爲以上式 (A-1)表示者爲例如分別以下式(A-1-1)至(A-1-30) -37- 200911884 表示之化合物; 基A爲以上式(A-2 )表示者爲例如分別以下式(A- 2- 1)至(A-2-15)表示之化合物; 基A爲以上式(A- 3 )表示者爲例如分別以下式(A- 3- 1)至(A-3-42)表不之化合物, 基A爲以上式(A - 4 )表示者爲例如分別以下式(A - 4- 1 )至(A-4-3 )表示之化合物; 基A爲以上式(A-5 )表示者爲例如以下式(A-5-l ) 表示之化合物; 基A爲以上式(A-6 )表示者爲例如以下式(A-6-1 ) 表示之化合物; 基A爲以上式(A-7 )表示者爲例如以下式(A-7-1 ) 表示之化合物; 基A爲以上式(A- 8 )表示者爲例如分別以下式(A-8-1)及(A-8-2)表示之化合物。 -38- 200911884Examples of the compound A-OH can be exemplified as follows: those represented by the above formula (A-1) are, for example, represented by the following formulas (A-1-1) to (A-1-30) -37- 200911884, respectively. The compound represented by the above formula (A-2) is, for example, a compound represented by the following formulas (A-2-1) to (A-2-15); and the base A is represented by the above formula (A-3). For example, the compounds represented by the following formulas (A-3 - 1) to (A-3-42), respectively, wherein the base A is represented by the above formula (A - 4 ) are, for example, the following formula (A - 4- 1 ) to The compound represented by (A-4-3); the base A is a compound represented by the following formula (A-5-1), and the base A is represented by the above formula (A-6). For example, the compound represented by the following formula (A-6-1); the base A is a compound represented by the following formula (A-7), for example, represented by the following formula (A-7-1); the base A is the above formula (A- 8) The compounds represented by the following formulas (A-8-1) and (A-8-2), respectively. -38- 200911884
CH=CH—COOHCH=CH—COOH
coo CH=CH—COOH (A-1-3)Coo CH=CH—COOH (A-1-3)
coo <y CH=CH—COOH (A-1-4)Coo <y CH=CH—COOH (A-1-4)
R^OO—CQ〇-^~^—CH=CH-COOH (A-1-5)R^OO—CQ〇-^~^—CH=CH-COOH (A-1-5)
CH=CH-COOHCH=CH-COOH
Ri〇^G^°-^y CH=CH—COOH (A-1-7) (A-1-6)Ri〇^G^°-^y CH=CH—COOH (A-1-7) (A-1-6)
R^OO—CH=CH-COOH (A-1-8) R^OO—CH=CH—COOH (A-1-9)R^OO—CH=CH-COOH (A-1-8) R^OO—CH=CH—COOH (A-1-9)
R1—CH=CH—COO-(CH2)a-QH (A-1-10) -39- 200911884R1—CH=CH—COO-(CH2)a-QH (A-1-10) -39- 200911884
CH=CH—COO-(CH2)a-OH (A-1-11)CH=CH—COO-(CH2)a-OH (A-1-11)
R^OO-^^—CH=CH—COO—(CH2)a-〇HR^OO-^^—CH=CH—COO—(CH2)a-〇H
R1—^~y~CH=CH—COO-(CH2)a-COOH (A-1-13)R1—^~y~CH=CH—COO-(CH2)a-COOH (A-1-13)
RR
CH=CH—COO—(CH2)a—COOH (A-1-14)CH=CH—COO—(CH2)a—COOH (A-1-14)
RiCOORiCOO
COO-(CH2)a-COOH (A-1-15)COO-(CH2)a-COOH (A-1-15)
Rl-〇- COO-^~~^>—CH=CH—COO-(CH2)a-OH COQ-^~^—CH=CH—COQ-(CH2)a-QHRl-〇-COO-^~~^>—CH=CH—COO-(CH2)a-OH COQ-^~^—CH=CH—COQ-(CH2)a-QH
R!COO COO-^^—CH=CH-C00-(CH2)a-0HR!COO COO-^^—CH=CH-C00-(CH2)a-0H
*~Qr COO-^~^—CH=CH—COO-(CH2)a-COOH (A-1-19) COO-^~^—CH=CH—COO-(CH2)a-COOH (A-1-20) -40- 200911884*~Qr COO-^~^—CH=CH—COO-(CH2)a-COOH (A-1-19) COO-^~^—CH=CH—COO-(CH2)a-COOH (A-1 -20) -40- 200911884
R^OO—COO--^~~^—CH=CH—COQ-(CH2)a-COOH (A-1-22)R^OO—COO--^~~^—CH=CH—COQ-(CH2)a-COOH (A-1-22)
rIO^ COO-^~~^—CH=CH-C0-CH2-0C0(CH2)a~0HrIO^ COO-^~~^—CH=CH-C0-CH2-0C0(CH2)a~0H
rI〇hQ- COO-^~^—CH=CH-C0-CH2-0C0(CH2)a-0H (A-1-23)rI〇hQ- COO-^~^—CH=CH-C0-CH2-0C0(CH2)a-0H (A-1-23)
R^OO—COO-(^~^)—CH=CH-C0-CH2-0C0(CH2)a-0H (A-1-24) rI-0Ό*R^OO—COO-(^~^)—CH=CH-C0-CH2-0C0(CH2)a-0H (A-1-24) rI-0Ό*
CH=CH-C〇-(CH2)a-〇H (A-1-25)CH=CH-C〇-(CH2)a-〇H (A-1-25)
R^COO-^"^—CH=CH-CO-(CH2)a-OH (A-1-26)R^COO-^"^-CH=CH-CO-(CH2)a-OH (A-1-26)
coo J〇T CH=CH—COOH (A-1-27) )_〇- CH=CH一C0-<\ />-COOH (A-1-28)Coo J〇T CH=CH—COOH (A-1-27) )_〇- CH=CH—C0-<\ />-COOH (A-1-28)
CH=CH—CO COOH (A-1-29)CH=CH—CO COOH (A-1-29)
R^OQ—^~~^~CH=CH—CO—COOH (A-1-30) -41 - 200911884R^OQ—^~~^~CH=CH—CO—COOH (A-1-30) -41 - 200911884
R!0C0—CH=CH OH (A-2-1)R!0C0—CH=CH OH (A-2-1)
R1C〇-CH=CHR1C〇-CH=CH
卜OH (A-2-2)Bu OH (A-2-2)
R!0C0-CH=CH-"OCO 分〇H (A-2-3) F^CO—CH=CH -o- oco O~oh ‘ (A-2-4)R!0C0-CH=CH-"OCO classification H (A-2-3) F^CO—CH=CH -o- oco O~oh ‘ (A-2-4)
RI0C0-CH=CH OCO <y OCO - (CH2)a-OH (A-2-5)RI0C0-CH=CH OCO <y OCO - (CH2)a-OH (A-2-5)
R1OC〇-CH=CH—OCO—(CH2)a-COOH (A-2-6)R1OC〇-CH=CH—OCO—(CH2)a-COOH (A-2-6)
RIC〇-CH=CH—OCO O~ OCO-(CH2)a—OH (A-2-7)RIC〇-CH=CH—OCO O~ OCO-(CH2)a—OH (A-2-7)
RICO-CH=CH—OCO J〇T OCO - (CH2)a-COOH (A-2-8)RICO-CH=CH—OCO J〇T OCO - (CH2)a-COOH (A-2-8)
CO-CH=CH OH (A-2-9) rI〇^0~ CO-CH=CH -^\)r OH (A-2-10) CO_CH=CH <y (A-2-11) OC〇-(CH2)a-〇H (A-2-12) -42- 200911884CO-CH=CH OH (A-2-9) rI〇^0~ CO-CH=CH -^\)r OH (A-2-10) CO_CH=CH <y (A-2-11) OC 〇-(CH2)a-〇H (A-2-12) -42- 200911884
C〇-CH=CHC〇-CH=CH
COOH (A-2-13)COOH (A-2-13)
C〇-CH=CH~(\ /)—COOH (A-2-14)C〇-CH=CH~(\ /)—COOH (A-2-14)
COOH (A-2-15) -43 200911884COOH (A-2-15) -43 200911884
CgHn-O-C ΟCgHn-O-C Ο
C-OH u Ο (A-3-1) 〇6闩12一〇—?C-OH u Ο (A-3-1) 〇 6 latch 12 〇 -?
(A-3-2)(A-3-2)
CgH-j/-〇_C II οCgH-j/-〇_C II ο
C-OH II Ο (A-3-3) C1〇H2i—O-CoC-OH II Ο (A-3-3) C1〇H2i-O-Co
C-OH II O (A-3-4) 6C-OH II O (A-3-4) 6
C-OH u O (A-3-5)C-OH u O (A-3-5)
〇16Η33 一 〇_C〇16Η33 one 〇_C
(A-3-6)(A-3-6)
Ci8H37_〇—CCi8H37_〇—C
(A-3-7) cf3—o-c(A-3-7) cf3—o-c
(A-3-8) CF3(CH2)2_〇_Co(A-3-8) CF3(CH2)2_〇_Co
C-OH IIo (A-3-9) C2F5—o~c ^ 3 II oC-OH IIo (A-3-9) C2F5-o~c ^ 3 II o
C-OH II 0 (A-3-10) C2F5-O-C 〇C-OH II 0 (A-3-10) C2F5-O-C 〇
C-OH II 〇 (A-3-11) -44 - 200911884C-OH II 〇 (A-3-11) -44 - 200911884
O F 〇 (A-3-15) (A- 3-12) (A 各 13) (A.3-14) (A-3-16) C16H33 - 〇_c 6O F 〇 (A-3-15) (A- 3-12) (A each 13) (A.3-14) (A-3-16) C16H33 - 〇_c 6
(A-3-17)(A-3-17)
(A-3-18) C18H37_〇~C o(A-3-18) C18H37_〇~C o
(A-3-19) CF3(CH2)2-〇-C o(A-3-19) CF3(CH2)2-〇-C o
(A-3-20)(A-3-20)
(A-3-21)(A-3-21)
(A-3-22) 45- 200911884 CHF2CF2CH2 - 〇-ρ(A-3-22) 45- 200911884 CHF2CF2CH2 - 〇-ρ
Ο C-OH 11 Ο (Α-3-23)Ο C-OH 11 Ο (Α-3-23)
C-OH Η Ο (Α-3-24)C-OH Η Ο (Α-3-24)
CsFi7-〇-C ΟCsFi7-〇-C Ο
(Α-3-25) C5H”—y~ ceHi3— o-c II Ο O-C II ο(Α-3-25) C5H”—y~ ceHi3—o-c II Ο O-C II ο
C-OH n Ο (A-3-26) C-OH II Ο (A-3-27) CF3C-OH n Ο (A-3-26) C-OH II Ο (A-3-27) CF3
(A-3-28) C5H11(A-3-28) C5H11
(A-3-29) cf3(A-3-29) cf3
(A-3-30)(A-3-30)
(A-3-31)(A-3-31)
(A-3-32) -46- 200911884 CHF2CF2CH2-0-兄~"(A-3-32) -46- 200911884 CHF2CF2CH2-0-Brother~"
(Α-3-33)(Α-3-33)
CsFi7一0一 CCsFi7-011 C
(A-3-34)(A-3-34)
(A-3-35) C5H”(A-3-35) C5H”
(A-3-36)(A-3-36)
CeHi3—^-0-0CeHi3—^-0-0
(A-3-37) cf3 KD-°-(A-3-37) cf3 KD-°-
(A-3-38)(A-3-38)
CsH^-^jKO-CCsH^-^jKO-C
(A-3-39) CF3 备一(A-3-39) CF3
(A-3-40)(A-3-40)
47- 200911884 ο47- 200911884 ο
CH=CH—COOH (A-4-1) οCH=CH—COOH (A-4-1) ο
CH=CH—COOH (A-4-2)CH=CH—COOH (A-4-2)
R!-SR!-S
CH=CH—COOH O (A-4-3)CH=CH—COOH O (A-4-3)
Rl-OCORl-OCO
CH=CH-COOH (A-5-1)CH=CH-COOH (A-5-1)
Rl~0Rl~0
CH=CH—COOH O (A-6-1)CH=CH—COOH O (A-6-1)
O HOCOO HOCO
CH=CH—COOR O (A-7-1) -48- 200911884CH=CH—COOR O (A-7-1) -48- 200911884
(上式中,R1分別爲與上式(A-l )中之R1相同意義 ,a與分別在上式(A-1)中之X3、式(A-2)中之X7、 或式(A-8 )中之X9之定義中出現之a意義相同)。 上式(A-3-1 )〜(A-3-42 )中,苯環兩側之雙鍵分別 以反式體描述,但應可理解同樣揭示爲兩者均爲順式體以 及單個爲反式體而另一個爲順式體之化合物。 該等中,分別以(A-1-1 ) 、 ( A-l-2 ) 、 ( A-1-3 ) 、(A-1 -4 ) 、 (A-l-27) 、 ( A-3-1 )〜(A-3-7) 、 ( A- 3-12)〜(A-3-18) 、 ( A-3-26 ) ~ ( A-3-29) 、 ( A-3- 36 )〜(A-3-39 )及(A-4-1 )表示之化合物,就生產性以 及所形成之液晶配向膜之液晶配向性及UV吸收性之觀點 而言爲較佳。 如上述之化合物A-OH可藉由適當組合有機化學之定 律而合成。 例如以上式(A - 1 - 1 )表示之化合物可藉由使丙二酸 與具有相當於R1之烷基之苯甲醛,在哌嗪等適當鹼存在 下加熱反應而獲得。 以上式(A-1 -2 )表示之化合物可藉由使例如羥基桂 -49 - 200911884 皮酸與具有相當於R1之烷基之鹵化烷基在碳酸鉀等適當 鹼存在下加熱反應後,以氫氧化鈉等之含有適當鹼之鹼性 水溶液水解而獲得。 以上式(A- 1 -3 )表示之化合物可藉由使例如具有相 當於R1之烷基之苯甲酸衍生物在亞硫醯氯中成爲醯氯後 ,使之在碳酸鉀等適當鹼存在下,於o°c至室溫下與羥基 桂皮酸反應而獲得。 以上式(A-1 -4 )表示之化合物可藉由使例如羥基苯 甲酸甲酯與具有相當於Ri之烷基之鹵化烷基或對甲苯磺 酸化烷基在碳酸鉀等適當鹼存在下,於室溫至1 0 0 °C之溫 度下反應後,以含有氫氧化鈉等適當鹼之鹼性水溶液水解 ,接著以亞硫醯氯使之成爲醯氯後,在碳酸鉀等適當鹼存 在下,於〇°c至室溫之溫度下與羥基桂皮酸反應而獲得。 以上式(A-1 -2 7 )表示之化合物可藉由使例如具有相 當於R1之烷基之4-烷基環己基羧酸藉由亞硫醯氯形成醯 氯後,在碳酸鉀等適當鹼存在下,於〇°C至室溫之溫度下 與羥基桂皮酸反應而獲得。 以上式(A-2-1 )表示之化合物可藉由使例如酚碘與 具有相當於R1之烷基之丙烯酸烷酯,利用鈀觸媒之偶合 反應(該反應一般稱爲「Heck」反應)而獲得。 以上式(A-2-6)表示之化合物可藉由於上式(A-2-l )表示之化合物上加成以下式表示之化合物而獲得: -50- 200911884(In the above formula, R1 has the same meaning as R1 in the above formula (Al), and a and X3 in the above formula (A-1), X7 in the formula (A-2), or the formula (A-). 8) The meaning of a in the definition of X9 is the same). In the above formulas (A-3-1) to (A-3-42), the double bonds on both sides of the benzene ring are respectively described in trans form, but it should be understood that both are cis-form and single The trans form and the other is a compound of the cis form. Among these, (A-1-1), (Al-2), (A-1-3), (A-1 -4), (Al-27), (A-3-1)~ (A-3-7), (A- 3-12)~(A-3-18), (A-3-26) ~ (A-3-29), (A-3- 36)~(A The compounds represented by -3-39) and (A-4-1) are preferred from the viewpoints of productivity and liquid crystal alignment and UV absorbability of the formed liquid crystal alignment film. The compound A-OH as described above can be synthesized by appropriately combining the laws of organic chemistry. For example, the compound represented by the above formula (A-1 - 1 ) can be obtained by heating a reaction between malonic acid and benzaldehyde having an alkyl group corresponding to R1 in the presence of a suitable base such as piperazine. The compound represented by the above formula (A-1 - 2 ) can be obtained by heating, for example, a hydroxy laurel-49 - 200911884 citric acid and a halogenated alkyl group having an alkyl group corresponding to R1 in the presence of a suitable base such as potassium carbonate. It is obtained by hydrolysis of an alkaline aqueous solution containing a suitable base such as sodium hydroxide. The compound represented by the above formula (A-1 - 3 ) can be obtained by, for example, benzoic acid derivative having an alkyl group corresponding to R1 in the presence of ruthenium chloride in sulfinium chloride, in the presence of a suitable base such as potassium carbonate. It is obtained by reacting with hydroxycinnamic acid at o °c to room temperature. The compound represented by the above formula (A-1 - 4 ) can be obtained by, for example, using a methyl or hydroxybenzoate with a halogenated alkyl group having an alkyl group corresponding to Ri or an alkyl group of p-toluene in the presence of a suitable base such as potassium carbonate. After the reaction is carried out at a temperature of from room temperature to 100 ° C, it is hydrolyzed with an aqueous alkaline solution containing a suitable base such as sodium hydroxide, and then converted to ruthenium chloride with sulfinium chloride, in the presence of a suitable base such as potassium carbonate. It is obtained by reacting with hydroxycinnamic acid at a temperature of from °C to room temperature. The compound represented by the above formula (A-1 - 27) can be formed by, for example, forming potassium chloride with a 4-alkylcyclohexylcarboxylic acid having an alkyl group corresponding to R1 by using sulfinium chloride. It is obtained by reacting with hydroxycinnamic acid at a temperature of from 〇 ° C to room temperature in the presence of a base. The compound represented by the above formula (A-2-1) can be subjected to a coupling reaction using a palladium catalyst by, for example, phenol iodide and an alkyl acrylate having an alkyl group corresponding to R1 (this reaction is generally referred to as "Heck" reaction). And get. The compound represented by the above formula (A-2-6) can be obtained by adding a compound represented by the above formula (A-2-l) to a compound represented by the following formula: -50- 200911884
(上式中’ a與上式(A-2-6 )中所述相同意義)。 以上式(A-3-1)〜(A-3_42)表示之化合物可分別藉 由使例如4_溴桂皮酸或4 -溴桂皮醯氯與具有所需之基之 醇類、酚、鹵化烷基、鹵化芳基或烷基胺反應成爲4 -溴 桂皮酸酯後,藉由Heck反應於其上加成丙烯酸而合成。 以上式(A - 4 -1 )表示之化合物可藉由使例如具有所 需R1基之酸酐衍生物與4 -胺基桂皮酸在乙酸中回流,或 者在甲苯或二甲苯中,於硫酸、三乙胺等適當觸媒存在下 回流之方法而合成。 以上式(A-4-2)表示之化合物可藉由使例如具有所 需R1基之碘化烷基或溴化烷基與蘋果酸之甲酯或乙酯在 氧化銀等適當觸媒存在下反應成爲醚類後,以鹼使其水解 ’進而以酸酐脫水閉環成爲具有R1 - 〇 -之酸酐衍生物,以 其作爲原料藉由與上述以式(A_4_l)表示之化合物之合 成相同之方法而合成。 以上式(A-4-3 )表示之化合物可藉由例如在馬來醯 亞胺上邁克爾加成(Michael Addition)具有所需R1基之 院基硫醇後,使馬來醯亞胺水解,接著經脫水閉環,以此 作爲原料與以上述式(A — 4」)表示之化合物之合成相同 之方法合成。 以上式(A-5-1 )表示之化合物係藉由例如以亞硫醯 -51 - 200911884 氯使偏本二酸之氫加成物成爲醯氯,使其與具有所需rI 基之醇類’在例如三乙胺等適當之適當鹼存在下反應成爲 酯類’且以此作爲原料以與上述式(A-4-1)表示之化合 物之合成相同之方法合成。 以上式(A - 6 -1 )表示之化合物係藉由使例如羥基苯 二甲酸酐脫水閉環後,使之與4-胺基桂皮酸在乙酸中回 流’或者在甲苯或二甲苯中,於硫酸、三乙胺等適宜觸媒 存在下回流之方法合成醯亞胺化合物後,使其與具有相當 於R1之烷基之鹵化物在碳酸鉀等鹼存在下反應而獲得。 以上式(A - 7 - 1 )表示之化合物係以例如使4 _硝基桂 皮酸與具有所需R1基之烷基鹵化物在碳酸鉀等適宜鹼存 在下反應成爲酯類後’藉由氯化錫使之還原並使硝基轉化 成胺基獲得中間物後,使該中間物在乙酸中與環己烷三羧 酸酐一起回流,或者在甲苯或二甲苯中,於三乙胺等適當 觸媒存在下回流之方法而合成。 以上式(A-8-1 )表示之化合物可藉由在如上述式( A-7-1 )表示之化合物之合成中,使用偏苯三酸酐替代環 己烷三羧酸酐’以與如上述式(A-7-1)表示之化合物之 合成同樣地合成。 以上述式(A - 8 - 2 )表示之化合物係以例如使4 -硝基 桂皮酸與具有所需R1基之烷基鹵化物在碳酸鉀等適當鹼 存在下反應成爲酯類後’藉氯化錫使之還原並使硝基轉化 成胺基獲得中間物後,使該中間物在乙酸中與羥基苯二甲 酸酐一起回流,或者在甲苯或二甲苯中,於三乙胺等適宜 -52- 200911884 觸媒存在下回流,進而於該產物上加成號拍酸酐之方法合 成。 化合物X-(Ep)4與化合物A-OH反應之際’相對於1 莫耳之化合物X-(EP)4’化合物A_0H較好使用1〜3莫耳 ,更好爲1~2莫耳。 化合物Χ-(Ερ)4與化合物A-OH反應之際可使用之有 機溶劑可較好使用非質子性有機溶劑,就液晶配向劑調製 方便之觀點而言,其具體例可舉例較好爲例如Ν_甲基-2 -啦咯陡酮、γ_丁內酯、Ν,Ν_二甲基乙醯胺、Ν,Ν_二甲基甲 醯胺、二甲基亞砸、四甲基尿素、六甲基磷三醯胺等’但 亦可使用與作爲液晶配向劑之溶劑所用之有機溶劑相同之 有機溶劑。當使用混合溶劑作爲液晶配向劑之有機溶劑時 ,較好選擇構成混合溶劑之有機溶劑中之一種作爲有機溶 劑。 有機溶劑之使用比例較好爲使固體成分濃度(化合物 Χ-(Ερ)4與化合物Α-ΟΗ之合計重量於反應溶液中所佔比 例)成爲1重量%以上之比例,且該値更好爲5~5 0重量% 之比例。 化合物Χ-(Ερ)4與化合物Α-ΟΗ反應之際可使用之觸 媒可列舉爲例如鹼,具體而言可舉例爲咪唑、四丁基溴化 銨等。觸媒之使用比例相對於100重量份之Χ-(Ερ)4較好 爲20重量份以下,更好爲5重量份以下。 反應溫度較好爲20~250°C,更好爲50~180°C。反應 時間較好爲〇.1〜24小時,更好爲1〜6小時。 -53- 200911884 如此獲得之以上式(1 -1 )表示之化合物可僅使用一 種作爲單一化合物使用,亦可混合使用上式(1-1)中之 A、D、X及Ep之種類及m與η之値之一個以上不同之兩 種以上之化合物。 本發明之液晶配向劑中(Β )化合物之使用比例相對 於1〇〇重量份之(Α)聚合物較好爲1~200重量份’更好 爲5〜100重量份。 <其他成分> 本發明之液晶配向劑可爲含有如上述(A )聚合物及 (B )化合物作爲必要成分者,但亦可視需要含有其他成 分。該等其他成分可列舉爲例如感熱性交聯劑、官能性矽 烷化合物等。 上述感熱性交聯劑係爲了進一步提升所形成之液晶配 向膜之預傾角之安定性及膜強度而於本發明之液晶配向劑 中含有者,至於該感熱性交聯劑可舉例爲例如一分子中具 有兩個以上環氧基之化合物(但,相當於該(B )化合物 者除外’以下稱爲「環氧化合物」),其具體例可舉例之 較佳者爲例如分別以上式(X-1-1 ) 、(X-l-2) 、( X-2- 1) ~(X-2-6) 、(X-3-1) 、(X-3-2) 、(X-4-1)、( X-4-2) 、 (X-5-1)及(X-5-2)表示之化合物、乙二醇 二縮水甘油醚、聚乙二醇二縮水甘油醚、丙二醇二縮水甘 油醚、二丙二醇二縮水甘油醚 '聚丙二醇二縮水甘油醚、 新戊二醇二縮水甘油醚、1,6 -己二醇二縮水甘油醚、丙三 -54- 200911884 醇二縮水甘油醚、三羥甲基丙烷三縮水甘油醚 新戊二醇二縮水甘油醚、N,N-二縮水甘油基苄基 二縮水甘油基胺基甲基環己烷、Ν,Ν-二縮水甘油 胺等。本發明之液晶配向劑中之環氧化合物之使 對於100重量份之(Α)聚合物較好爲40重量 更好爲2 5重量份以下。 上述官能性矽烷化合物係爲了進一步提升所 配向膜與基板之接著性之目的而於本發明之液晶 含有者,該官能性矽烷化合物可舉例爲例如3 -三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2-胺 甲氧基矽烷、2-胺基丙基三乙氧基矽烷、Ν- ( 2-)_3_胺基丙基三甲氧基矽烷、Ν- ( 2-胺基乙基 丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基砂 基丙基三乙氧基矽烷、Ν-乙氧基羰基-3-胺基丙 基矽烷、Ν-乙氧基羰基-3-胺基丙基三乙氧基矽 乙氧基矽烷基丙基三伸乙基三胺、Ν-三甲氧基矽 三伸乙基三胺、10-三甲氧基矽烷基-1,4,7-三氮 10-三乙氧基矽烷基-1,4,7-三氮雜癸烷、9-三甲 基-3,6-二氮雜壬基乙酸酯、9-三甲氧基矽烷基-3 壬基乙酸酯、9-三乙氧基矽烷基-3,6-二氮雜壬酸 三甲氧基矽烷基-3,6-二氮雜壬酸甲酯、9-三乙 基-3,6-二氮雜壬酸甲酯、Ν-苄基-3-胺基丙基三 烷、Ν -苄基-3 -胺基丙基三乙氧基矽烷、Ν -苯基 基三甲氧基矽烷、Ν-苯基-3-胺基丙基三乙氧基 .2,2-二溴 胺、Ν,Ν-基環己基 用比例相 份以下, 形成液晶 配向劑中 胺基丙基 基丙基三 •胺基乙基 )-3-胺基 烷、3-脲 基三甲氧 烷、N-三 烷基丙基 雜癸烷、 氧基矽烷 ,6 -二氮雜 甲酯、9-氧基矽烷 甲氧基矽 -3 -胺基丙 矽烷、縮 -55- 200911884 水甘油氧基甲基三甲氧基矽烷、縮水甘油氧基甲基三乙氧 基矽烷、2-縮水甘油氧基乙基三甲氧基矽院、2·縮水甘油 氧基乙基三乙氧基矽烷、3-縮水甘油氧基丙基三甲氧基矽 烷、3 -縮水甘油氧基丙基三乙氧基矽烷等。本發明之液晶 配向劑中官能性矽烷之使用比例,相對於(A )聚合物 100重量份,較好爲2重量份以下’更好爲0.2重量份以 下。 <液晶配向劑> 本發明之液晶配向劑爲含有如上述之(A )聚合物及 (B )化合物作爲必要成分,進而可含有任意之上述其他 成分,且較好以使該等成分溶解於溶劑中之狀態調製。 本發明之液晶配向劑中可使用之溶劑較好爲可使上述 各成分溶解但不與其反應之有機溶劑’其例可舉例爲例如 作爲聚醯胺酸之合成中使用者之上述列舉之有機溶劑等。 聚醯胺酸合成中所用者亦可與例示之弱溶劑倂用。該等有 機溶劑可單獨使用或組合兩種以上使用。較佳之溶劑組成 爲組合上述之溶劑而得之組成,不使液晶配向劑中之各成 分析出,且使液晶配向劑之表面張力成爲25~40mN/m範 圍之組成。 本發明之液晶配向劑中之固體成分濃度(液晶配向劑 中除溶劑以外之成分總重量佔液晶配向劑總重量之比例) 可考量黏性、揮發性等加以適當選擇,但較好爲1〜1 0重 量%之範圍。亦即,本發明之液晶配向劑係塗佈於基板表 -56- 200911884 面而形成作爲液晶配向膜之塗膜,但於固體成分濃度未達 1重量%時,因塗膜膜厚過小而有難以獲得良好的液晶配 向膜之情況。另一方面,於固體成分濃度超過10重量% 時,因塗膜膜厚過大同樣有難以獲得良好液晶配向膜之情 況,另外,液晶配向劑之黏度過大,則有塗佈特性不足之 情況。 最佳之固體成分濃度範圍將隨著基板上塗佈液晶配向 劑時所用之塗佈方法而異。例如,於旋轉塗佈法之情況’ 特佳範圍爲1 . 5〜4.5重量%。以印刷法之情況’固體成分 濃度3〜9重量%之範圍,據此,溶液黏度以成爲12〜50 mPa · s之範圍最佳。噴墨法之情況,固體成分濃度成爲 1〜5重量%之範圍,據此,溶液黏度以3~15mPa.s之範圍 爲最佳。 調製本發明液晶配向劑之溫度較好爲0°C~100°C,更 好爲 10°c~4 0°c。 <液晶配向膜> 以下敘述本發明液晶配向膜之形成方法。 本發明之液晶配向膜之形成方法爲具有下列步驟:在 基板上塗佈上述液晶配向劑形成塗膜,且於該塗膜上照射 偏光或非偏光輻射線。 首先在基板上塗佈本發明之液晶配向劑,接著經由將 塗佈面加熱而在基板上形成塗膜。 製造TN型、STN型或VA型液晶顯示元件時,係使 -57- 200911884 設有圖案化透明導電膜之兩片基板作爲一對, 明性導電膜形成面上,以例如平版印刷法、旋 噴墨印刷法’塗佈本發明之液晶配向劑,接著 塗佈面形成塗膜。此處之基板可使用例如浮法 玻璃等之玻璃;聚對苯二甲酸乙二醇酯、聚苯 醇酯、聚醚颯、聚碳酸酯、聚(脂環式烴)等 成之透明基板。作爲設於基板一面上之透明導 例如由氧化錫(Sn02)所構成之NESA膜(赛 司之註冊商標)、由氧化銦-氧化錫(Ιη203 - 成之ITO膜等,獲得圖案化透明導電膜可使用 圖案化之透明導電膜後採用光.鈾刻形成圖案 形成透明導電膜時使用具有所需圖案之光罩之 配向劑塗佈時,爲了使基板表面及透明導電膜 著性更良好’亦可於基板表面上欲形成塗膜之 預先塗佈官能性矽烷化合物、官能性鈦化合物 〇 液晶配向塗佈劑塗佈後,爲了防止塗佈之 垂流,較好進行預加熱(預烘烤)。預烘烤之 30〜200°C ’更好爲40~150°C,最好爲40〜100°C 間較好爲0.25〜10分鐘,更好爲0.5〜5分鐘。 完全去除溶劑等目的而實施燒成(後烘烤)步 (後烘烤)溫度較好爲8 0〜3 0 0 °C,更好爲1 2 烘烤時間較好爲5〜200分鐘,更好爲1〇〜1〇〇 明之液晶配向劑中含有之(A )聚合物爲具有 且在其各透 轉塗佈法或 藉由加熱各 玻璃、鈉鈣 二甲酸丁二 之塑膠所構 電膜可使用 !國 PPG公 Sn02)所構 例如在形成 之方法,在 方法。液晶 與塗膜之接 面上,施以 等之前處理 配向劑液體 溫度較好爲 。預烘烤時 隨後,爲了 驟。該燒成 2 5 0。。。後 分鐘。本發 醯胺酸構造 -58- 200911884 者之情況下,亦可藉由上述加熱進行醯胺酸構造之脫 環成爲醯亞胺化塗膜。 所形成塗膜之膜厚較好爲〇.001〜1Pm,更好爲0 0.5 μπι 〇 另一方面,製造IPS型液晶顯示元件時’設有圖 成梳齒型之透明導電膜之基板之導電膜形成面與未設 電膜之對向基板之一面上’較好以平版印刷法、旋轉 法或噴墨印刷法分別塗佈本發明之液晶配向劑’接著 將各塗佈面加熱而形成塗膜。 此時使用之基板及透明導電膜之材質’透明導電 圖案化方法、基板之前處理,塗佈液晶配向劑後之加 法及形成塗膜之較佳膜厚係與製造上述TN型、STN VA型液晶顯示元件之情況相同。 接著對如上述形成之塗膜照射直線偏光或部分偏 輻射線或無偏光之輻射線,依據情況而定,進而較 150〜25 0 °C之溫度下進行加熱處理1〜120分鐘,成爲 膜賦予液晶配向能之液晶配向膜。其中,輻射線可使 如含15〇nm~800nm波長之光之紫外線及可見光,但 爲含3 00nm〜400nm波長之光之紫外線。所用輻射線 線偏光或部分偏光時,照射係自與基板面垂直之方向 ,爲了賦予預傾角亦可自傾斜之方向進行,另外,亦 合該等而進行。照射無偏光之輻射線時,照射方面有 成爲傾斜方向。自傾斜方向照射時之照射角度相對於 之法線較好爲20〜70°,更好爲30〜60、 水閉 .005- 案化 有導 塗佈 藉由 膜之 熱方 型或 光之 好在 對塗 用例 較好 爲直 進行 可組 必要 塗膜 -59- 200911884 使用之光源爲例如低壓水銀燈、 金屬鹵素燈、Μ氣共振燈、氣氣燈、 較佳波長範圍之紫外線可藉由將濾光 源倂用之手段獲得。 輻射線之照射量較好爲U/m2以 ,更好爲100~3,000J/m2。又,藉由 知之液晶配向劑所形成之塗膜賦予液 J/m2以上之輻射線照射量爲必要。但 配向劑,光配向法時之輻射線照射量 進而以在l,〇〇〇J/m2以下亦可賦予良 降低液晶顯示元件之製造成本。 如此形成之液晶配向膜在將該等 之液晶顯示元件時,相較於以往已知 液晶回應速度快速之優點。 <液晶顯示元件> 以下說明本發明之液晶顯示元件 本發明之液晶顯示元件爲具備由 成液晶配向膜者。 本發明之液晶顯示元件可藉由準 有上述液晶配向膜之基板,於使之相 配置液晶而成之液晶單元之兩側外面 液晶單元之製造方法舉例爲例如 第〜種方法爲以往已知之方法。 筒壓水銀燈、気燈、 準分子雷射等。上述 片、光柵等與上述光 上、未達 1 0,000J/m2 光配向法對自以往已 晶配向能時,1 〇, 〇 〇 〇 若使用本發明之液晶 爲 3,000J/m2 以下, 好的液晶配向性,而 用於例如垂直配向型 之液晶配向膜,具有 本發明液晶配向劑开多 備一對(兩片)形$ 對配置形成之間隙中 配置偏光板而製造。 以下兩種方法。 首先,各液晶配向膜 -60- 200911884 以對向介隔一間隙(晶胞間隙)而對向配置2片基板,使 用密封劑使2片基板周圍部分貼合,於基板表面與密封劑 所區分出之液晶單元間隙內部注入並充塡液晶後,將注入 孔封住藉此構成液晶單元,藉此製造液晶單元。 第二種方法係稱爲ODF (—滴塡充)方式之方法。在 形成液晶配向膜之兩片基板中之一片基板上於既定位置塗 佈例如紫外線硬化性密封材,進而在液晶配向膜上滴加液 晶後,使液晶配向膜相對向之方式貼合另一片基板,接著 以紫外線照射基板之全部使密封劑硬化,藉此製造液晶單 元。 即使以任一種方法進行,亦較好使如上述般製造之液 晶單元藉由進而加熱至使所用液晶成爲各向同相之溫度後 ,緩慢冷卻至室溫,可消除液晶注入時之流動配向性。 接著,藉由在液晶單元之外側表面上貼合偏光板,可 獲得本發明之液晶顯示元件。 其中,密封劑可使用例如硬化劑及含有作爲隔離物之 氧化鋁球之環氧樹脂等。 上述液晶可使用例如向列型液晶及層列型液晶等。該 等中以向列型液晶較佳。於VA型液晶單元時,較好爲具 有負的介電各向異性之向列型液晶,例如可使用二氰基苯 系液晶、嗒嗪系液晶、薛福(Schiff)鹼系液晶、偶氮氧 (azoxy )系液晶、聯苯系液晶、苯基環己烷系液晶等。 於TN型液晶單元或STN型液晶單元時,較好爲具有正的 介電各向異性之向列型液晶,例如聯苯系液晶、苯基環己 -61 - 200911884 烷系液晶、酯系液晶、三聯苯系液晶、聯苯環己燒系液晶 、嘧啶系液晶、二噁烷系液晶、雙環辛烷系液晶、立方院 (Cubane)系液晶等。該等液晶中,亦可進而添加例如膽 醯氯、膽醯基壬酸酯、膽醯基碳酸酯等膽固醇酸型液晶; 或以商品名C-15、CB-15 ( Merck公司製)販售之對掌性 劑而使用;對-去甲矽氧烷苄叉-對-胺基-2-甲基丁基月桂 酸酯等強介電性液晶。 貼合在液晶單元外表面上之偏光板,可舉例有使聚乙 烯醇進行延伸配向同時吸收碘之稱爲「Η膜」之偏光膜以 乙酸纖維素保護膜挾持之偏光板或以Η膜本身構成之偏 光板。 貫施例 以下經由實施例更具體說明本發明,但本發明並不受 該等實施例之限制。 合成例1 (化合物(A -1 - 2 -1 )之合成) 依據下列反應程序1合成化合物(A -1 - 2 -1 ): -62- 200911884(in the above formula, 'a has the same meaning as described in the above formula (A-2-6)). The compounds represented by the above formulas (A-3-1) to (A-3_42) can be respectively obtained by using, for example, 4-bromocinnamic acid or 4-bromo cinnabarin chloride with an alcohol, a phenol or an alkyl halide having a desired group. After the group, the halogenated aryl group or the alkylamine is reacted to form 4-bromocinnamate, it is synthesized by adding acrylic acid thereto by a Heck reaction. The compound represented by the above formula (A - 4 -1 ) can be refluxed in acetic acid by, for example, an acid anhydride derivative having a desired R1 group and 4-amino cinnamic acid, or in toluene or xylene, in sulfuric acid, three It is synthesized by refluxing in the presence of an appropriate catalyst such as ethylamine. The compound represented by the above formula (A-4-2) can be obtained by, for example, an alkyl iodide or a brominated alkyl group having a desired R1 group and a methyl or ethyl ester of malic acid in the presence of a suitable catalyst such as silver oxide. After the reaction is carried out, the ether is hydrolyzed by a base, and the acid anhydride is dehydrated and closed to form an acid anhydride derivative having R1 - 〇-, which is used as a raw material by the same method as the synthesis of the compound represented by the above formula (A_4-1). synthesis. The compound represented by the above formula (A-4-3) can hydrolyze the maleimide by, for example, a Michael Addition having a desired R1 group on the maleimide. Subsequently, it is synthesized by the same method as the synthesis of the compound represented by the above formula (A-4) by using a dehydration ring closure. The compound represented by the above formula (A-5-1) is obtained by, for example, using sulfite-51 - 200911884 chlorine to form a hydrogen addition product of a partial diacid to ruthenium chloride, and an alcohol having a desired rI group. 'Reacted into an ester in the presence of a suitable appropriate base such as triethylamine' and synthesized as a raw material in the same manner as the synthesis of the compound represented by the above formula (A-4-1). The compound represented by the above formula (A - 6 -1 ) is obtained by subjecting, for example, hydroxyphthalic anhydride to dehydration and ring closure, and refluxing it with 4-aminocinnamic acid in acetic acid' or in toluene or xylene, in sulfuric acid The quinone imine compound is synthesized by refluxing in the presence of a suitable catalyst such as triethylamine, and then reacted with a halide having an alkyl group corresponding to R1 in the presence of a base such as potassium carbonate. The compound represented by the above formula (A - 7 - 1 ) is, for example, obtained by reacting 4-nitrocin cinnamic acid with an alkyl halide having a desired R1 group in the presence of a suitable base such as potassium carbonate to form an ester. After the tin is reduced and the nitro group is converted into an amine group to obtain an intermediate, the intermediate is refluxed with acetic acid in cyclohexane tricarboxylic acid anhydride, or in toluene or xylene, in a suitable contact with triethylamine or the like. The medium is synthesized by refluxing. The compound represented by the above formula (A-8-1) can be substituted with cyclohexanetricarboxylic anhydride by using trimellitic anhydride in the synthesis of the compound represented by the above formula (A-7-1) to be as in the above formula (A). The synthesis of the compound represented by -7-1) was synthesized in the same manner. The compound represented by the above formula (A - 8 - 2 ) is obtained by, for example, reacting 4-nitrocin cinnamic acid with an alkyl halide having a desired R1 group in the presence of a suitable base such as potassium carbonate to form an ester. After the tin is reduced and the nitro group is converted into an amine group to obtain an intermediate, the intermediate is refluxed with hydroxy phthalic anhydride in acetic acid, or in toluene or xylene, in triethylamine or the like -52 - 200911884 The catalyst is refluxed in the presence of a catalyst, and then the product is added to the product to form an acid anhydride. When the compound X-(Ep)4 is reacted with the compound A-OH, it is preferably used in an amount of 1 to 3 moles, more preferably 1 to 2 moles, per mole of the compound X-(EP) 4' compound A_0H. The organic solvent which can be used when the compound Χ-(Ερ)4 is reacted with the compound A-OH can be preferably an aprotic organic solvent. For the convenience of preparation of the liquid crystal alignment agent, a specific example thereof is preferably exemplified, for example. Ν_Methyl-2-pyrrolidone, γ-butyrolactone, hydrazine, hydrazine dimethyl dimethyl acetamide, hydrazine, hydrazine dimethyl carbamide, dimethyl hydrazine, tetramethyl urea And hexamethylphosphoric acid triamide or the like 'but an organic solvent similar to the organic solvent used as a solvent for the liquid crystal alignment agent can also be used. When a mixed solvent is used as the organic solvent of the liquid crystal alignment agent, one of the organic solvents constituting the mixed solvent is preferably selected as the organic solvent. The ratio of use of the organic solvent is preferably such that the solid content concentration (the ratio of the total weight of the compound Χ-(Ερ) 4 to the compound Α-ΟΗ to the reaction solution) is 1% by weight or more, and the ruthenium is more preferably The ratio of 5 to 50% by weight. The catalyst which can be used for the reaction of the compound Χ-(Ερ)4 with the compound Α-ΟΗ is exemplified by a base, and specific examples thereof include imidazole and tetrabutylammonium bromide. The use ratio of the catalyst is preferably 20 parts by weight or less, more preferably 5 parts by weight or less, per 100 parts by weight of Χ-(Ερ)4. The reaction temperature is preferably from 20 to 250 ° C, more preferably from 50 to 180 ° C. The reaction time is preferably from 1 to 24 hours, more preferably from 1 to 6 hours. -53- 200911884 The compound represented by the above formula (1 -1 ) thus obtained may be used as a single compound alone or in combination of the types A, D, X and Ep in the above formula (1-1) and m. Two or more compounds different from one or more of η. The use ratio of the (Β) compound in the liquid crystal alignment agent of the present invention is preferably from 1 to 200 parts by weight, more preferably from 5 to 100 parts by weight, per 1 part by weight of the (?) polymer. <Other components> The liquid crystal alignment agent of the present invention may contain, as an essential component, the above-mentioned (A) polymer and (B) compound, but may contain other components as needed. These other components may, for example, be a thermosensitive crosslinking agent or a functional decane compound. The heat-sensitive crosslinking agent is contained in the liquid crystal alignment agent of the present invention in order to further improve the stability of the pretilt angle of the liquid crystal alignment film to be formed and the film strength. The heat-sensitive crosslinking agent may, for example, have one molecule. A compound of two or more epoxy groups (except for the compound (B), which is hereinafter referred to as "epoxy compound"), and specific examples thereof are preferably, for example, the above formula (X-1-). 1), (Xl-2), (X-2- 1) ~(X-2-6), (X-3-1), (X-3-2), (X-4-1), ( Compounds represented by X-4-2), (X-5-1) and (X-5-2), ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, Propylene glycol diglycidyl ether 'polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, propylene-54- 200911884 alcohol diglycidyl ether, trimethylol Propane triglycidyl ether neopentyl glycol diglycidyl ether, N,N-diglycidylbenzyl diglycidylaminomethylcyclohexane, hydrazine, hydrazine-diglycidylamine, and the like. The epoxy compound in the liquid crystal alignment agent of the present invention is preferably 40 parts by weight or more, more preferably 25 parts by weight or less per 100 parts by weight of the (?) polymer. The functional decane compound is contained in the liquid crystal of the present invention for the purpose of further improving the adhesion between the alignment film and the substrate, and the functional decane compound is exemplified by, for example, 3-trimethoxydecane or 3-aminopropyl. Triethoxy decane, 2-amine methoxy decane, 2-aminopropyl triethoxy decane, Ν-(2-)_3_aminopropyltrimethoxy decane, Ν-(2-amino group Ethyl propyl methyl dimethoxy decane, 3-ureidopropyl trimethoxy oxapropyl triethoxy decane, hydrazine-ethoxycarbonyl-3-aminopropyl decane, hydrazine-ethoxy Carbocarbonyl-3-aminopropyltriethoxyphosphonium ethoxylated alkylpropyltriethylethylamine, bismuth-trimethoxysulfonium triethylidene triamine, 10-trimethoxydecyl-1 ,4,7-triazo 10-triethoxydecyl-1,4,7-triazadecane, 9-trimethyl-3,6-diazaindolyl acetate, 9-trimethyl Oxyalkylalkyl-3-mercaptoacetate, methyl 9-triethoxydecyl-3,6-diazepine trimethoxydecyl-3,6-diazepine, 9- Methyl triethyl-3,6-diazepine, Ν-benzyl-3-aminopropyltrioxane, Ν-benzyl-3-aminopropyl Ratio of triethoxy decane, fluorenyl-phenyltrimethoxydecane, fluorenyl-phenyl-3-aminopropyltriethoxy.2,2-dibromoamine, hydrazine, fluorenylcyclohexyl In the liquid crystal alignment agent, the aminopropyl propyl tri-aminoethyl)-3-aminoalkyl, 3-ureidotrimethoxy, N-trialkylpropyl oxane, oxygen Pyrantane, 6-diazamethyl ester, 9-oxydecane methoxyindole-3-aminopropane, condensed -55- 200911884 hydroglycidoxymethyltrimethoxydecane, glycidoxymethyl Triethoxy decane, 2-glycidoxyethyl trimethoxy oxime, 2 · glycidoxyethyl triethoxy decane, 3-glycidoxypropyl trimethoxy decane, 3-shrink Glyceroxypropyltriethoxydecane, and the like. The proportion of the functional decane used in the liquid crystal alignment agent of the present invention is preferably 2 parts by weight or less or more preferably 0.2 parts by weight or less based on 100 parts by weight of the (A) polymer. <Liquid crystal alignment agent> The liquid crystal alignment agent of the present invention contains the above-mentioned (A) polymer and (B) compound as essential components, and may further contain any of the other components described above, and is preferably dissolved in the above components. Modulation in the state of the solvent. The solvent which can be used in the liquid crystal alignment agent of the present invention is preferably an organic solvent which can dissolve the above components but does not react with them. Examples thereof can be exemplified, for example, as the above-exemplified organic solvents for users in the synthesis of polyglycine. Wait. Those used in the synthesis of polyaminic acid can also be used with the exemplified weak solvents. These organic solvents may be used singly or in combination of two or more. The solvent composition is preferably a composition obtained by combining the above solvents, and the composition of the liquid crystal alignment agent is not analyzed, and the surface tension of the liquid crystal alignment agent is set to be in the range of 25 to 40 mN/m. The solid content concentration in the liquid crystal alignment agent of the present invention (the ratio of the total weight of the liquid crystal alignment agent other than the solvent to the total weight of the liquid crystal alignment agent) can be appropriately selected in consideration of viscosity, volatility, etc., but is preferably 1~ A range of 10% by weight. That is, the liquid crystal alignment agent of the present invention is applied to the surface of the substrate table -56 to 200911884 to form a coating film as a liquid crystal alignment film. However, when the solid content concentration is less than 1% by weight, the coating film thickness is too small. It is difficult to obtain a good liquid crystal alignment film. On the other hand, when the solid content concentration exceeds 10% by weight, it is difficult to obtain a good liquid crystal alignment film because the film thickness of the coating film is too large. Further, when the viscosity of the liquid crystal alignment agent is too large, coating properties may be insufficient. The optimum solid concentration range will vary depending on the coating method used to coat the liquid crystal alignment agent on the substrate. For example, in the case of the spin coating method, a particularly preferable range is 1.5 to 4.5% by weight. In the case of the printing method, the solid content concentration is in the range of 3 to 9 % by weight, and accordingly, the solution viscosity is preferably in the range of 12 to 50 mPa · s. In the case of the ink jet method, the solid content concentration is in the range of 1 to 5 % by weight, and accordingly, the solution viscosity is preferably in the range of 3 to 15 mPa·s. The temperature of the liquid crystal alignment agent of the present invention is preferably from 0 ° C to 100 ° C, more preferably from 10 ° C to 40 ° C. <Liquid Crystal Alignment Film> A method of forming the liquid crystal alignment film of the present invention will be described below. The method for forming a liquid crystal alignment film of the present invention comprises the steps of: coating a liquid crystal alignment agent on a substrate to form a coating film, and irradiating the coating film with a polarized or non-polarizing radiation. First, the liquid crystal alignment agent of the present invention is applied onto a substrate, and then a coating film is formed on the substrate by heating the coated surface. When a TN type, STN type or VA type liquid crystal display element is manufactured, two substrates having a patterned transparent conductive film are provided as a pair on the surface of the transparent conductive film, for example, by lithography or spinning. The inkjet printing method 'coats the liquid crystal alignment agent of the present invention, and then coats the surface to form a coating film. Here, as the substrate, a glass such as float glass or a transparent substrate made of polyethylene terephthalate, polyphenylene glycol ester, polyether oxime, polycarbonate, or poly(alicyclic hydrocarbon) can be used. A transparent conductive film provided on one surface of the substrate is, for example, a NESA film made of tin oxide (SnO 2 ) (registered trademark of the company), and a patterned transparent conductive film is obtained from indium oxide-tin oxide (ITO film formed of 203η 203 -). When a patterned transparent conductive film is used, a transparent conductive film is formed by patterning a uranium engraved pattern, and when an alignment agent having a desired pattern is used, the substrate surface and the transparent conductive film are more favorable. After coating the pre-coated functional decane compound or the functional titanium compound 〇 liquid crystal alignment coating agent on the surface of the substrate to form a coating film, pre-heating (pre-baking) is preferably performed in order to prevent the coating from flowing. The pre-baked 30~200°C 'better is 40~150°C, preferably 40~100°C, preferably 0.25~10 minutes, more preferably 0.5~5 minutes. Complete solvent removal, etc. The baking (post-baking) step (post-baking) temperature is preferably 80 to 300 ° C, more preferably 1 2 baking time is preferably 5 to 200 minutes, more preferably 1 〇 ~ (A) a polymer contained in a liquid crystal alignment agent of the present invention has and is transparent in each The transfer coating method or the structure of the plastic film by heating each of the glass and the sodium sulphate dicarboxylic acid can be used, for example, in the formation method, in the method. On the interface between the liquid crystal and the coating film, it is preferred to treat the liquid of the alignment agent before the application. When pre-baking, then, in order to delay. The firing is 250. . . After the minute. In the case of the proline acid structure of the present invention -58-200911884, the deuteration of the proline structure by the heating described above may be used to form a ruthenium imide coating film. The film thickness of the formed coating film is preferably 〇.001 to 1 Pm, more preferably 0 0.5 μπι 〇. On the other hand, when the IPS type liquid crystal display element is manufactured, the conductive layer of the substrate having the comb-shaped transparent conductive film is provided. The film forming surface and the surface of the counter substrate not provided with the electric film are preferably coated with the liquid crystal alignment agent of the present invention by a lithography method, a rotary method or an inkjet printing method, respectively, and then each coated surface is heated to form a coating layer. membrane. The substrate used in this case and the material of the transparent conductive film 'transparent conductive patterning method, substrate pretreatment, addition after application of the liquid crystal alignment agent, and preferred film thickness for forming a coating film, and manufacturing of the above TN type, STN VA type liquid crystal The same is true for display elements. Then, the coating film formed as described above is irradiated with a linearly polarized light or a partially polarized radiation or a non-polarized radiation, depending on the case, and further heat-treated at a temperature of 150 to 250 ° C for 1 to 120 minutes to form a film. Liquid crystal alignment film for liquid crystal alignment. Among them, the radiation can be ultraviolet light and visible light such as light having a wavelength of from 15 〇 nm to 800 nm, but is ultraviolet light having a wavelength of from 300 nm to 400 nm. When the radiation is polarized or partially polarized, the irradiation is performed in a direction perpendicular to the surface of the substrate, and the pretilt angle may be applied from the direction of the tilt, and the same may be performed. When the radiation of the unpolarized light is irradiated, the irradiation direction is inclined. The irradiation angle when irradiated from the oblique direction is preferably 20 to 70° with respect to the normal line, more preferably 30 to 60, and the water is closed. 005- The coated coating is coated by the hot square of the film or the light is good. In the case of the coating, it is preferable to carry out the necessary coating film-59-200911884. The light source used is, for example, a low-pressure mercury lamp, a metal halide lamp, a xenon resonance lamp, a gas lamp, and a UV of a preferred wavelength range. The light source is obtained by means of the means. The irradiation amount of the radiation is preferably U/m2, more preferably 100 to 3,000 J/m2. Further, it is necessary to irradiate the irradiation amount of the coating liquid J/m2 or more formed by the known liquid crystal alignment agent. However, the irradiation amount of the alignment agent and the photo-alignment method may further lower the manufacturing cost of the liquid crystal display element by 1 or less, 〇〇〇J/m2 or less. The liquid crystal alignment film thus formed has an advantage in that the response speed of the liquid crystal is fast as compared with the conventional liquid crystal display element. <Liquid crystal display element> The liquid crystal display element of the present invention will be described below. The liquid crystal display element of the present invention is provided with a liquid crystal alignment film. The liquid crystal display device of the present invention is exemplified by a method for producing a liquid crystal cell on both sides of a liquid crystal cell in which a liquid crystal cell is formed by arranging a liquid crystal alignment film as a substrate, for example, the first method is a conventionally known method. . Tube pressure mercury lamp, xenon lamp, excimer laser, etc. When the above-mentioned sheet, grating, etc., and the above-mentioned optical alignment method of less than 10,000 J/m2 are used for the conventional alignment, 1 〇, 〇〇〇, if the liquid crystal of the present invention is used, it is 3,000 J/m 2 or less. The liquid crystal alignment property is used for, for example, a liquid crystal alignment film of a vertical alignment type, and the liquid crystal alignment agent of the present invention is provided in a pair of two-piece (two-piece) shape. The following two methods. First, each of the liquid crystal alignment films -60-200911884 is disposed opposite to each other with a gap (cell gap) disposed therebetween, and a sealant is used to bond the portions around the two substrates to distinguish the surface of the substrate from the sealant. After the inside of the liquid crystal cell gap is injected and filled with the liquid crystal, the injection hole is sealed to constitute the liquid crystal cell, thereby manufacturing the liquid crystal cell. The second method is called the ODF (Drip Charge) method. Applying, for example, an ultraviolet curable sealing material to a predetermined position on one of the two substrates on which the liquid crystal alignment film is formed, and further adding a liquid crystal to the liquid crystal alignment film, and then bonding the liquid crystal alignment film to the other substrate in a relatively opposed manner Then, the sealing agent is cured by irradiating all of the substrate with ultraviolet rays, thereby manufacturing a liquid crystal cell. Even if it is carried out by any method, it is preferred to further heat the liquid crystal cell produced as described above to a temperature at which the liquid crystal used is in the same phase, and then slowly cool to room temperature, thereby eliminating the flow alignment property at the time of liquid crystal injection. Next, the liquid crystal display element of the present invention can be obtained by laminating a polarizing plate on the outer surface of the liquid crystal cell. Among them, as the sealant, for example, a hardener and an epoxy resin containing alumina balls as a separator can be used. For the liquid crystal, for example, a nematic liquid crystal or a smectic liquid crystal can be used. Among these, nematic liquid crystals are preferred. In the case of the VA type liquid crystal cell, a nematic liquid crystal having a negative dielectric anisotropy is preferable, and for example, a dicyanobenzene liquid crystal, a pyridazine liquid crystal, a Schiff base liquid crystal, or an azo can be used. An azoxy liquid crystal, a biphenyl liquid crystal, a phenylcyclohexane liquid crystal, or the like. In the case of a TN type liquid crystal cell or an STN type liquid crystal cell, a nematic liquid crystal having positive dielectric anisotropy is preferable, for example, a biphenyl liquid crystal, a phenyl cyclohexene-61 - 200911884 alkyl liquid crystal, or an ester liquid crystal. And a terphenyl liquid crystal, a biphenyl cyclohexane liquid crystal, a pyrimidine liquid crystal, a dioxane liquid crystal, a bicyclooctane liquid crystal, a Cubane liquid crystal, or the like. In the liquid crystals, cholesteric acid liquid crystals such as cholesteryl chloride, cholesteryl phthalate, and cholesteryl carbonate may be further added; or sold under the trade names C-15 and CB-15 (manufactured by Merck). It is used as a palmitic agent; a strong dielectric liquid crystal such as p-norbyoxyalkyl bromide-p-amino-2-methylbutyl laurate. The polarizing plate which is bonded to the outer surface of the liquid crystal cell may, for example, be a polarizing film called a "ruthenium film" which is obtained by stretching and aligning polyvinyl alcohol while absorbing iodine, and a polarizing plate held by a cellulose acetate protective film or a film itself. A polarizing plate is constructed. The present invention is more specifically illustrated by the following examples, but the present invention is not limited by the examples. Synthesis Example 1 (Synthesis of Compound (A -1 - 2 -1 )) The compound (A -1 - 2 -1 ) was synthesized according to the following Reaction Scheme 1: -62- 200911884
CH=CH - COOH K2CO3 〇5Η·|·)Βγ 'rCH=CH - COOH K2CO3 〇5Η·|·)Βγ 'r
NaOH/H2〇NaOH/H2〇
C5H11 - O--COOH (A-1—2-1) 反應程序1 於1升梨型反應瓶中饋入82克對-羥基桂皮酸、3〇4 克之碳酸鉀及400毫升之N-甲基-2-吡咯啶嗣,在室溫τ 擾泮1小時後’添加1 6 6克之1 -漠戊垸,且在1 〇 〇 〇c下擾 拌5小時。隨後’減壓餾除溶劑。於其中添加48克之氯 氧化鈉及400毫升水,且回流3小時進行水解反應。反應 結束後’以鹽酸中和反應系統,回收產生之沉殺物,且以 乙醇再結晶’藉此獲得80克以下式(A-1-2-1 )表示之化 合物之白色結晶。 合成例2(化合物(A-1-2-2)之合成) 上述合成例1中’除使用262克1-碘-4,4,4 -三氟丁烷 替代1 -溴戊烷以外’與合成例2同樣實施,獲得8 5克以 下式(A-1-2-2)表示之化合物(化合物(a-1-2-2))之 白色粉末: -63- 200911884 CF3-C3H6 - οC5H11 - O--COOH (A-1—2-1) Reaction Procedure 1 In a 1 liter pear-shaped reaction flask, 82 g of p-hydroxycinnamic acid, 3 4 g of potassium carbonate and 400 ml of N-methyl were fed. -2-pyrrolidine oxime, after 1 hour of turbulence at room temperature τ, '1 6 6 gram of 1 - indigo pentoxide was added and spoiled at 1 〇〇〇c for 5 hours. The solvent was then distilled off under reduced pressure. 48 g of sodium oxychloride and 400 ml of water were added thereto, and refluxed for 3 hours to carry out a hydrolysis reaction. After the completion of the reaction, the reaction system was neutralized with hydrochloric acid, and the resulting precipitate was recovered and recrystallized from ethanol, whereby 80 g of a white crystal of the compound represented by the following formula (A-1-2-1) was obtained. Synthesis Example 2 (Synthesis of Compound (A-1-2-2)) In the above Synthesis Example 1, 'except that 262 g of 1-iodo-4,4,4-trifluorobutane was used instead of 1-bromopentane' Synthesis Example 2 was carried out in the same manner to obtain 85 g of a white powder of the compound (Compound (a-1-2-2)) represented by the following formula (A-1-2-2): -63- 200911884 CF3-C3H6 - ο
CH=CH—COOH (A-1-2-2) 合成例3 (化合物A - 1 - 4 - 1 )之合成) 依據下列反應程序2合成化合物(A-1-4-1 ) HO~^ ^~COOCH3 K2C〇3 CgHuBrCH=CH-COOH (A-1-2-2) Synthesis Example 3 (Synthesis of Compound A-1 - 4 - 1 ) The compound (A-1-4-1) was synthesized according to the following reaction procedure 2 HO~^ ^ ~COOCH3 K2C〇3 CgHuBr
Na0H/H20Na0H/H20
C5H-, COOH (A-1-4-1A) SOCI2C5H-, COOH (A-1-4-1A) SOCI2
T K2C〇3T K2C〇3
HO-<Q>-CH=CH—COOH ▼HO-<Q>-CH=CH-COOH ▼
CsHn-0 hQ-coo-h^- CH=CH—COOH (A-1-4-1) 反應程序2 (化合物(A-1-4-1A)之合成) 於1升梨型反應瓶中饋入91.3克4-羥基苯甲酸甲酯 -64 - 200911884 、182.4克碳酸鉀及3 20毫升之N-甲基-2-吡咯啶 室溫下進行攪拌1小時後,添加99.7克1-溴戊烷 1 00 °C下攪拌5小時進行反應。反應結束後,以水 沉澱。接著,將48克氫氧化鈉及400毫升水添加 澱中且回流3小時進行水解反應。反應結束後,以 和,以乙醇使產生之沉澱物再結晶,藉此獲得1 02 合物(A-〗-4-1 A)之白色結晶。 (化合物(A-1-4-1)之合成) 將該化合物(A-l-4-lA)中之52克置於反應 ,於其中添加200毫升亞硫醯氯及0.2毫升Ν,Ν-二 醯胺,且在80°C下攪拌1小時。接著,減壓餾除亞 ,添加二氯甲烷且以碳酸氫鈉水溶液洗滌,有機層 鎂乾燥,進行濃縮後,添加四氫呋喃成爲溶液。 接著,於與上述另外之5 00毫升三頸瓶中饋入 4-羥基桂皮酸、69克之碳酸鉀、2.4克四丁基銨、 升四氫呋喃及5 0 0毫升水。使該水溶液以冰冷卻, 加含有化合物(A-1-4-1 A )與亞硫醯氯之反應產物 四氫呋喃溶液,接著進行攪拌2小時。反應結束後 鹽酸中和,以乙酸乙酯萃取後,以硫酸鎂乾燥,進 後,以乙醇再結晶,獲得45克化合物(A-1-4-1 ) 結晶。 合成例4 (化合物(A -1 · 4 - 2 )之合成) 酮,在 ,且在 進行再 於該沉 鹽酸中 克以化 容器中 甲基甲 硫醯氯 以硫酸 37克 250毫 緩慢滴 之上述 ,添加 行濃縮 之白色 -65- 200911884 依據下列反應程序3合成化合物(A - 1 - 4 - 2 ) COOCH3 K2C03 CF3C3H6I Na0H/H20 CF3C3He-〇—COOH (A-1-4-2A) SOCI2 K2C03CsHn-0 hQ-coo-h^- CH=CH—COOH (A-1-4-1) Reaction procedure 2 (Synthesis of compound (A-1-4-1A)) Feed in a 1 liter pear type reaction flask After adding 91.3 g of methyl 4-hydroxybenzoate-64 - 200911884, 182.4 g of potassium carbonate and 3 20 ml of N-methyl-2-pyrrolidine at room temperature for 1 hour, 99.7 g of 1-bromopentane was added. The reaction was carried out by stirring at 100 ° C for 5 hours. After the reaction was completed, it was precipitated with water. Next, 48 g of sodium hydroxide and 400 ml of water were added to the lake and refluxed for 3 hours to carry out a hydrolysis reaction. After the completion of the reaction, the resulting precipitate was recrystallized from ethanol to obtain white crystals of the compound (A-)-4-1A. (Synthesis of Compound (A-1-4-1)) 52 g of the compound (Al-4-lA) was placed in the reaction, and 200 ml of sulfinium chloride and 0.2 ml of hydrazine, hydrazine-difluorene were added thereto. The amine was stirred at 80 ° C for 1 hour. Subsequently, the mixture was evaporated under reduced pressure, dichloromethane was added and washed with aqueous sodium hydrogencarbonate, and the organic layer was dried over magnesium and concentrated, and then tetrahydrofuran was added to the solution. Next, 4-hydroxycinnamic acid, 69 g of potassium carbonate, 2.4 g of tetrabutylammonium, liter of tetrahydrofuran and 500 ml of water were fed into the above-mentioned other 500 ml three-necked flask. The aqueous solution was cooled with ice, and a reaction product of the compound (A-1-4-1 A) and sulfinium chloride in tetrahydrofuran was added, followed by stirring for 2 hours. After completion of the reaction, the mixture was neutralized with EtOAc. EtOAc (EtOAc)EtOAc. Synthesis Example 4 (Synthesis of Compound (A -1 · 4 - 2 )) The ketone was slowly and dropwisely precipitated in methyl sulfonium chloride at 37 g of sulfuric acid in a chlorination vessel. Addition of concentrated white-65-200911884 According to the following reaction procedure 3, compound (A - 1 - 4 - 2 ) COOCH3 K2C03 CF3C3H6I Na0H/H20 CF3C3He-〇-COOH (A-1-4-2A) SOCI2 K2C03
H0-(\ />-CH=CH—COOHH0-(\ />-CH=CH-COOH
CF3C3H6Q—^~^-COO-^~y-CH=CH-COOH (A-1-4-2) 反應程序3 (化合物(A-1-4-2A)之合成) 於1升梨型反應瓶中饋入82克4-羥基苯甲酸甲酯、 166克碳酸鉀及400毫升之N,N-二甲基乙醯胺’在室溫下 進行攪拌1小時後,添加95克1,1,1-三氟-4-碘丁烷’且 在室溫下攪拌5小時進行反應。反應結束後,以水進行再 沉澱。接著,將32克氫氧化鈉及400毫升水添加於該沉 澱中且回流4小時進行水解反應。反應結束後,以鹽酸中 和,以乙醇使產生之沉澱再結晶,獲得80克化合物(A_ 1-4-2A)之白色結晶。 -66- 200911884 (化合物(A-1-4-2)之合成) 將該化合物(A-1-4_2A)中之46·4克置於反應容器 中,於其中添加200毫升亞硫醯氯及〇·2毫升Ν,Ν-二甲基 甲醯胺,且在8 0 °C下攪拌1小時。接著’減壓餾除亞硫醯 氯,添加二氯甲烷且以碳酸氫鈉水溶液洗滌’有機層以硫 酸鎂乾燥,進行濃縮後,添加四氫呋喃成爲溶液。 接著,於與上述另外之2升三頸瓶中饋入36克4 -羥 基桂皮酸、55克碳酸鉀、2_4克四丁基銨、200毫升四氫 呋喃及4 0 0毫升水。使該水溶液以冰冷卻,緩慢滴加含有 化合物(A-1-4-2A)與亞硫醯氯之反應產物之上述四氫呋 喃溶液,接著進行攪拌2小時。反應結束後,添加鹽酸中 和,以乙酸乙酯萃取後,以硫酸鎂乾燥,進行濃縮後,以 乙醇再結晶,藉此獲得39克桂皮酸衍生物(A-!-4-2 )之 白色結晶。 合成例5 依據下列反應程序4合成化合物(A - 4 -1 -1 ): -67- 200911884CF3C3H6Q—^~^-COO-^~y-CH=CH-COOH (A-1-4-2) Reaction procedure 3 (synthesis of compound (A-1-4-2A)) in 1 liter pear type reaction flask The solution of 82 g of methyl 4-hydroxybenzoate, 166 g of potassium carbonate and 400 ml of N,N-dimethylacetamide was stirred at room temperature for 1 hour, and then 95 g of 1,1,1 was added. -Trifluoro-4-iodobutane' and the reaction was carried out by stirring at room temperature for 5 hours. After the reaction was completed, reprecipitation was carried out with water. Next, 32 g of sodium hydroxide and 400 ml of water were added to the precipitate and refluxed for 4 hours to carry out a hydrolysis reaction. After completion of the reaction, the resulting precipitate was recrystallized with hydrochloric acid to give 80 g of a white crystal of compound (A_ 1-4-2A). -66- 200911884 (Synthesis of Compound (A-1-4-2)) 46. 4 g of the compound (A-1-4_2A) was placed in a reaction vessel, and 200 ml of sulfinium chloride was added thereto. 2 ml of hydrazine, hydrazine-dimethylformamide, and stirred at 80 ° C for 1 hour. Then, sulfite chloride was distilled off under reduced pressure, and dichloromethane was added thereto, and the organic layer was washed with aqueous sodium hydrogencarbonate. The organic layer was dried over magnesium sulfate and concentrated, and then tetrahydrofuran was added to a solution. Next, 36 g of 4-hydroxycinnamic acid, 55 g of potassium carbonate, 2-4 g of tetrabutylammonium, 200 ml of tetrahydrofuran and 400 ml of water were fed into the above other 2 liter three-necked flask. The aqueous solution was ice-cooled, and the above tetrahydrofuran solution containing the reaction product of the compound (A-1-4-2A) and sulfinium chloride was slowly added dropwise, followed by stirring for 2 hours. After completion of the reaction, the mixture was neutralized with hydrochloric acid, extracted with ethyl acetate, dried over magnesium sulfate, concentrated, and then recrystallized from ethanol to obtain white powder of 39 g of cinnamic acid derivative (A-!-4-2). crystallization. Synthesis Example 5 A compound (A - 4 -1 -1 ) was synthesized according to the following reaction procedure 4: -67- 200911884
Ο C10H2i CH=CH—COOH 〇 (A-4-1-1) 反應程序4 於裝置回流管、氮氣導入管及丁-斯達克(Dean-Stark )管之1升梨型反應瓶中饋入72克無水琥珀酸癸酯、49 克〇胺基桂皮酸、70毫升三乙胺、500毫升甲苯及200 毫升四氫呋喃,且在回流下進行反應3 6小時。反應結束 後’以稀鹽酸及水依序洗滌反應混合物後,以硫酸鎂乾燥 ’進行濃縮後,以乙醇與四氫呋喃之混合溶劑進行再結晶 ’藉此獲得72克化合物(A-4-1-1 )之白色結晶。 合成例6 依據下列反應程序5合成化合物(A - 5 -1 -1 ) -68- 200911884Ο C10H2i CH=CH—COOH 〇(A-4-1-1) Reaction Procedure 4 Feed in a 1 liter pear-shaped reaction flask with a reflux tube, a nitrogen inlet tube, and a Dean-Stark tube. 72 g of anhydrous decyl succinate, 49 g of decyl cinnamic acid, 70 ml of triethylamine, 500 ml of toluene and 200 ml of tetrahydrofuran were reacted under reflux for 36 hours. After the completion of the reaction, the reaction mixture was washed successively with dilute hydrochloric acid and water, dried over magnesium sulfate, concentrated, and then recrystallized from a mixed solvent of ethanol and tetrahydrofuran, whereby 72 g of a compound (A-4-1-1) was obtained. ) white crystals. Synthesis Example 6 Synthesis of Compound (A - 5 -1 -1 ) according to the following Reaction Scheme 5 -68- 200911884
SOCI2SOCI2
C2F5C3H6-OHC2F5C3H6-OH
反應程序5 於裝置有回流管之2升梨型反應瓶中饋入198克 1,2,4-環己烷三羧酸酐、500毫升亞硫醯氯及2毫升n,n. 二甲基甲醯胺,且在8 0 °C下回流1小時進行反應。反應結 束後,減壓去除亞硫醯氯’將一氯甲院添加於殘留物中, 有機層以飽和碳酸氫鈉水溶液及水依序洗漉後,以硫酸胃 乾燥,經濃縮至乾後,添加5 00毫升四氫咲喃。 另一方面,於裝置有滴加漏斗、溫度計及氮氣導入管 200911884 升吡啶及1 · 5升四氫呋喃,以水浴冷卻。於其中緩慢滴加 含有上述1,2,4-環己烷三羧酸酐及亞硫醯氯之反應物之四 氫呋喃溶液後,在室溫下攪拌4小時進行反應。反應結束 後,以乙酸乙酯進行萃取。有機層以水洗滌,以硫酸鎂乾 燥後,以矽膠管柱純化,獲得26 8克化合物(A-5-l-la) (化合物(A-5-1-1)之合成) 於裝置有丁 -斯達克管之200毫升梨型反應瓶中饋入 241克上述獲得之化合物(A-5-l-la) 、109克4-胺基桂 皮酸、190毫升三乙胺、16克4-二甲胺基吡啶、1升甲苯 及2升四氫呋喃,且在回流下進行反應24小時。反應結 束後’以稀鹽酸及水洗猴反應混合物。有機層以硫酸鎂乾 燥後’以甲醇再結晶,獲得78克化合物(A-5-1-1 )。 合成例7 依據下列反應程序6合成化合物(A-6-1-1 ): -70- 200911884 H°xxReaction Procedure 5 198 g of 1,2,4-cyclohexanetricarboxylic anhydride, 500 ml of sulfinium chloride and 2 ml of n,n. dimethylform were fed into a 2 liter pear-shaped reaction flask equipped with a reflux tube. The guanamine was refluxed at 80 ° C for 1 hour to carry out the reaction. After the completion of the reaction, the thiocyanine chloride was removed under reduced pressure. The chloroform was added to the residue, and the organic layer was washed successively with saturated aqueous sodium hydrogen carbonate solution and water, then dried over sodium sulfate and concentrated to dryness. Add 500 ml of tetrahydrofuran. On the other hand, the apparatus was provided with a dropping funnel, a thermometer and a nitrogen introduction tube of 200911884 liters of pyridine and 1.5 liters of tetrahydrofuran, and was cooled in a water bath. The tetrahydrofuran solution containing the above-mentioned reactant of 1,2,4-cyclohexanetricarboxylic anhydride and sulfinium chloride was slowly added dropwise thereto, and the mixture was stirred at room temperature for 4 hours to carry out a reaction. After the reaction was completed, extraction was carried out with ethyl acetate. The organic layer was washed with water, dried over magnesium sulfate, and purified on a silica gel column to obtain 26 8 g of compound (A-5-l-la) (synthesis of compound (A-5-1-1)) - a 200 ml pear-shaped reaction flask of a Stark tube was fed with 241 g of the compound obtained above (A-5-l-la), 109 g of 4-aminocinnamic acid, 190 ml of triethylamine, 16 g of 4- Dimethylaminopyridine, 1 liter of toluene and 2 liters of tetrahydrofuran were reacted under reflux for 24 hours. After the reaction is completed, the monkey reaction mixture is washed with dilute hydrochloric acid and water. The organic layer was dried over magnesium sulfate and then recrystallized from methanol to afford 78 g of Compound (A-5-1-1). Synthesis Example 7 Compound (A-6-1-1) was synthesized according to the following Reaction Scheme 6: -70- 200911884 H°xx
COOH COOH h2nCOOH COOH h2n
CH=CH 一 COOH CH=CH—COOH (A-6-1-1a)CH=CH a COOH CH=CH—COOH (A-6-1-1a)
O K2C03O K2C03
cf3c3h6—Icf3c3h6—I
HCI o cf3c3h6- o CH=CH-COOH (A-6-1-1) 反應程序6 (化合物(A-6-l-la )之合成) 於裝置有回流管、丁 -斯達克管及氮氣導入管之2升 三頸反應瓶中饋入90克5 -羥基苯二甲酸及500毫升二乙 基苯,且進行回流1小時。接著,於其中添加80克4_胺 基桂皮酸及5 0 0毫升四氫呋喃且在回流下進行反應1 2小 時。反應結束後,以稀鹽酸及水依序洗滌反應混合物,進 而以硫酸鎂乾燥,經濃縮後以乙酸乙酯及四氫呋喃之混合 -71 - 200911884 溶劑再結晶,藉此獲得9 5克化合物(A - 6 -1 -1 a )。 (化合物(A - 6 -1 -1 )之合成) 於5 00毫升梨型反應瓶中饋入75克上述獲得之化合 物(A-6-l-la) 、70克碳酸鉀及150毫升N-甲基-2-吡咯 啶酮,在室溫下攪拌1小時後,添加5 9克4,4,4 -三氟-1 _ 碑丁院 '且在室溫下擾梓2 4小時。反應結束後,添加1 升水且回收沉澱物。該沉澱物使用乙酸乙酯及己烷作爲溶 離液,以矽膠管柱純化後,去除溶劑藉此獲得5 0克彳匕合· 物(A-6-1 - 1 )。 合成例8 依據下列反應程序7合成化合物(A-7-1-1 ): -72- 200911884 o2nHCI o cf3c3h6- o CH=CH-COOH (A-6-1-1) Reaction procedure 6 (synthesis of compound (A-6-l-la)) with reflux tube, D-Stark tube and nitrogen A 2-liter three-neck reaction flask of the introduction tube was fed with 90 g of 5-hydroxyphthalic acid and 500 ml of diethylbenzene, and refluxed for 1 hour. Next, 80 g of 4-amino cinnamic acid and 500 ml of tetrahydrofuran were added thereto, and the reaction was carried out under reflux for 12 hours. After completion of the reaction, the reaction mixture was washed successively with dilute hydrochloric acid and water, and then dried over magnesium sulfate, and then concentrated, and then recrystallized from ethyl acetate and tetrahydrofuran-71-200911884 solvent, thereby obtaining 95 g of the compound (A - 6 -1 -1 a ). (Synthesis of Compound (A - 6 -1 -1 )) In a 500 ml pear-shaped reaction flask, 75 g of the compound (A-6-l-la) obtained above, 70 g of potassium carbonate and 150 ml of N- were fed. Methyl-2-pyrrolidone was stirred at room temperature for 1 hour, then 5 9 g of 4,4,4-trifluoro-1 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ After the reaction was completed, 1 liter of water was added and the precipitate was recovered. The precipitate was treated with ethyl acetate and hexane as a solvent, and after purifying on a silica gel column, the solvent was removed to obtain 50 g of a mixture (A-6-1-1). Synthesis Example 8 A compound (A-7-1-1) was synthesized according to the following Reaction Scheme 7: -72- 200911884 o2n
CH=CH 一 COOH K2C03 cf3c3h6-i 〇2N—^^-CH=:CH—COO-C3H6CF3 (A-7-1 -1 a)CH=CH a COOH K2C03 cf3c3h6-i 〇2N—^^-CH=:CH—COO-C3H6CF3 (A-7-1 -1 a)
SnCI2 H2N—^ CH=CH 一COO—C3H6CF3 (A-7-1-1b)SnCI2 H2N—^ CH=CH—COO—C3H6CF3 (A-7-1-1b)
HOOCHOOC
CH=CH—COO-C3H6CF3 (A-7-1-1) 反應程序7 (化合物(A-7-l-la)之合成) 於裝置有溫度計及氮氣導入管之300毫升三 中饋入9_7克4-硝基桂皮酸、12克4,4,4 -三氟-、14克碳酸鉀及〗50毫升丨·甲基-2_吡咯啶酮, 下攪拌1小時進行反應。反應結束後,添加乙酸 應混合物中並萃取。有機層經水洗瀨,以硫酸鎂 頸反應瓶 1-碘丁烷 且在5 0 t 乙酯於反 乾燥後, -73- 200911884 經濃縮進而去除溶劑,藉此獲得14克化合物([7-^1 a (化合物(A-7-l-lb)之合成) 於裝置溫度計及氮氣導入管之300毫升三頸反應瓶中 饋入14克上述獲得之化合物(A-7-l-la) 、53克之氯化 錫2水合物及150毫升乙醇,在70°C下攪拌1小時進行反 應。反應結束後,將反應混合物倒入冰水中,以2M氫氧 化鈉水溶液中和,添加乙酸乙酯後去除沉澱物。於濾液中 添加乙酸乙酯並萃取,獲得有機層。該有機層經水洗滌, 以硫酸鎂乾燥後,經濃縮進而去除溶劑,獲得12克化合 物(A - 7 - ;l - 1 b )。 (化合物(A-7-1-1 )之合成) 於裝置有回流管及氮氣導入管之2 00毫升梨型反應瓶 中饋入12克上述獲得之化合物(A-7-l-lb) 、8.7克 1,2,4 -環己烷三羧酸酐及1〇〇毫升乙酸,且在回流下進行 反應1小時。反應結束後,以乙酸乙酯萃取反應混合物獲 得有機層。該有機層經水洗淌,以硫酸鎂乾燥後,經濃縮 且去除溶劑,以由乙酸乙酯及己烷構成之混合溶劑中進行 再結晶,獲得1 1克化合物(A-7-1 -1 )之白色結晶。 合成例9 依據下列反應程序8合成化合物(A - 3 - 2 6 ): -74- 200911884CH=CH—COO-C3H6CF3 (A-7-1-1) Reaction procedure 7 (Synthesis of compound (A-7-l-la)) Feeding 9_7 g in 300 ml of three tubes equipped with thermometer and nitrogen inlet tube 4-Nitrocinnamic acid, 12 g of 4,4,4-trifluoro-, 14 g of potassium carbonate and 50 ml of hydrazine-methyl-2-pyrrolidone were stirred for 1 hour to carry out a reaction. After the end of the reaction, the acetic acid mixture was added and extracted. The organic layer was washed with water, and the mixture was stirred in a magnesium sulfate neck, 1-iodobutane, and after de-drying at 50 t of ethyl ester, and concentrated at -73 to 200911884 to remove the solvent, thereby obtaining 14 g of a compound ([7-^ 1 a (Synthesis of Compound (A-7-l-lb)) In a 300 ml three-neck reaction flask of a device thermometer and a nitrogen introduction tube, 14 g of the compound (A-7-l-la) obtained above, 53 The reaction mixture was stirred at 70 ° C for 1 hour, and the reaction mixture was poured into ice water, neutralized with 2M aqueous sodium hydroxide solution, and then added with ethyl acetate. Precipitate. Ethyl acetate was added to the filtrate and extracted to give an organic layer. The organic layer was washed with water, dried over magnesium sulfate, and concentrated to remove solvent to give 12 g of compound (A - 7 - ; l - 1 b (Synthesis of Compound (A-7-1-1)) Into a 200 ml pear-shaped reaction flask equipped with a reflux tube and a nitrogen introduction tube, 12 g of the compound obtained above (A-7-l-lb) was fed. ), 8.7 g of 1,2,4-cyclohexanetricarboxylic anhydride and 1 ml of acetic acid, and the reaction was carried out under reflux for 1 hour. After completion, the reaction mixture was extracted with ethyl acetate to obtain an organic layer. The organic layer was washed with water, dried over magnesium sulfate, concentrated, and solvent was removed, and recrystallized from a solvent mixture of ethyl acetate and hexane. 11 g of a white crystal of the compound (A-7-1 -1 ) was obtained. Synthesis Example 9 The compound (A - 3 - 2 6 ) was synthesized according to the following reaction procedure 8: -74- 200911884
HOOC—CH=CH SOCI2HOOC—CH=CH SOCI2
CICO—CH=CH (i ) C5H” -〇-〇h C5H1CICO—CH=CH (i ) C5H” -〇-〇h C5H1
i~^ ^-~〇〇C~~CH—CHi~^ ^-~〇〇C~~CH—CH
Br (ii)Br (ii)
Pd(OAc)2Pd(OAc)2
CH2=CH—COOH CH=CH—COOH (A-3-26)CH2=CH—COOH CH=CH—COOH (A-3-26)
CsH”—OOC-CH=CH- 反應程序8 (化合物(i ) ( 4-溴桂皮醯氯)之合成) 使107克(0.47莫耳)4-溴桂皮酸在83克亞硫醯氯 中回流4小時,獲得紅色透明溶液。接著,餾除未反應之 亞硫醯氯後,使殘留物自甲苯再結晶,以正己烷洗滌,藉 此獲得85克(產率74% )之化合物(i )之白色結晶。 (化合物(Π) (4-溴桂皮酸(4-胺基環己酯))之合成) 使25.0克(0.147莫耳)之4_胺基環己醇溶解於25 -75- 200911884 毫升吡啶中。使該溶液溫度維持在約3 °C,且於其中滴加 含43.3克(0.176莫耳)上述獲得之化合物(i)之350 毫升吡啶懸浮液’接著進行反應3小時。將所得反應混合 物(懸浮液)注入1 · 3公斤之鹽酸酸性冰水中,過濾所產 生之沉澱物,以水洗滌並經乾燥,藉此獲得5 0克(產率 8 5 % )化合物(i i )之粗製產物(乳白色粉末)。 (化合物(A-3-26)之合成) 在氮氣中,將125毫升(0.9莫耳)之無水三乙胺添 加於含50克上述獲得之化合物(ii)之粗製產物、0.28 克(1.25毫莫耳)乙酸鈀及1_52克(5毫莫耳)三(鄰 -甲苯)膦之混合物中且進行反應。化合物(ii )之粗製 產物完全溶解後,以針筒注入1 〇 · 8克(0 · 1 5莫耳)丙烯 酸,接著在95 °C下繼續反應2小時。將所得暗綠色反應混 合物投入1 .3公斤之鹽酸酸性冰水中,藉過濾回收所產生 之沉澱物。使該沉澱物溶解於500毫升乙酸乙酯中,依序 以1N鹽酸及5重量%之碳酸氫鈉溶液洗滌後,回收有機 層且以硫酸鎂乾燥,餾除溶劑獲得56克之化合物(A-3-26)之粗製產物(黃色固體)。使該粗製產物自乙醇再結 晶,藉此獲得3 0克(產率5 5 % )之化合物(A - 3 - 2 6 )之 黃色粉末。 合成例1 〇〜1 6 於上述合成例9中,分別使用表1中所列之化合物各 -76- 200911884 0.1 47莫耳替代4_胺基環己醇以外,其餘與實施例5同樣 般實施’合成分別以上式(A-3-1)〜(A-3-7)表示之化 合物(其中’苯環兩側之雙鍵均爲反式體。以下該等化合 物分別稱化合物(A - 3 -1 ) ~ ( A - 3 - 7 ))。 表1 化合物種類 產物 合成例10 正戊醇 化合物(A-3-1) 合成例11 正己醇 化合物(A-3-2) 合成例12 正辛醇 化合物(A-3-3) 合成例13 正癸醇 化合物(A-3-4) 合成例14 正一月桂基醇 化合物(A-3-5) 合成例15 正-鯨蠟基醇 化合物(A-3-6) 合成例16 正硬脂基醇 化合物(A-3-7 ) 合成例17〜24 於上述合成例9〜16中,分別使用各0.47莫耳2 -氟-4 -溴桂皮酸替代4 -溴桂皮酸以外,其餘與上述實施例 5〜12同樣實施,合成分別以上式(A-3-36)及(A-3-12 )〜(A - 3 -1 8 )表示之化合物(其中,任一苯環兩側之雙 鍵均爲反式體,以下’該等化合物分別稱爲化合物(A-3 -36)或化合物(A-3-12)〜(A-3-18))。 合成例2 5 依據下列反應程序9合成化合物(a - 2 - 1 4 - 1 ): -77- 200911884 ch3-c ° II oCsH"-OOC-CH=CH- Reaction procedure 8 (Synthesis of compound (i) (4-bromo cinnabarin chloride)) 107 g (0.47 mol) of 4-bromocinnamic acid was refluxed in 83 g of sulfite chloride After 4 hours, a red transparent solution was obtained. Then, after the unreacted sulfinium chloride was distilled off, the residue was recrystallized from toluene and washed with n-hexane, whereby 85 g (yield 74%) of compound (i) was obtained. White crystals. (Synthesis of compound (Π) (4-bromocinnamic acid (4-aminocyclohexyl))) 25.0 g (0.147 mol) of 4-aminocyclohexanol was dissolved in 25 -75- 200911884 ml of pyridine. The temperature of the solution was maintained at about 3 ° C, and 43.3 g (0.176 mol) of the above-obtained compound (i) in 350 ml of pyridine suspension was added dropwise, followed by a reaction for 3 hours. The obtained reaction mixture (suspension) was poured into 1 kg of hydrochloric acid acidic ice water, and the resulting precipitate was filtered, washed with water and dried, whereby 50 g (yield 85 %) of compound (ii) was obtained. Crude product (milky powder). (Synthesis of compound (A-3-26)) In nitrogen, 125 ml (0.9 mol) Anhydrous triethylamine was added to a crude product containing 50 g of the compound (ii) obtained above, 0.28 g (1.25 mmol) of palladium acetate and 1 to 52 g (5 mmol) of tris(o-toluene)phosphine. The reaction was carried out in the mixture. After the crude product of the compound (ii) was completely dissolved, 1 〇·8 g (0.55 mol) of acrylic acid was injected through a syringe, followed by continuing the reaction at 95 ° C for 2 hours. The green reaction mixture was poured into 1.3 kg of hydrochloric acid acidic ice water, and the resulting precipitate was recovered by filtration. The precipitate was dissolved in 500 ml of ethyl acetate, followed by 1N hydrochloric acid and 5 wt% sodium hydrogen carbonate solution. After washing, the organic layer was recovered and dried over magnesium sulfate, and evaporated to give the crude product (yellow solid) of 56 g of compound (A-3-26). The crude product was recrystallized from ethanol to obtain 30 g ( Yield 5 5 %) of a yellow powder of the compound (A - 3 - 2 6 ). Synthesis Example 1 〇~1 6 In the above Synthesis Example 9, the compounds listed in Table 1 were each used -76-200911884 0.1 47 Moore replaced 4_aminocyclohexanol, and the rest with Example 5 The compound represented by the above formula (A-3-1) to (A-3-7) is synthesized (wherein the double bonds on both sides of the benzene ring are trans-forms. Hereinafter, the compounds are respectively referred to as compounds ( A - 3 -1 ) ~ ( A - 3 - 7 )). Table 1 Compound type Product synthesis Example 10 n-pentanol compound (A-3-1) Synthesis Example 11 Synthesis of n-hexanol compound (A-3-2) 12-n-octanol compound (A-3-3) Synthesis Example 13 N-nonanol compound (A-3-4) Synthesis Example 14 Normal monolauryl alcohol compound (A-3-5) Synthesis Example 15 Normal-cetyl group Alcohol compound (A-3-6) Synthesis Example 16 n-Stearyl alcohol compound (A-3-7) Synthesis Examples 17 to 24 In the above Synthesis Examples 9 to 16, each of 0.47 mol 2 -fluoro-4 was used. - bromocinnamic acid was used in the same manner as in the above Examples 5 to 12 except that 4-bromocinnamic acid was replaced, and the above formula (A-3-36) and (A-3-12) to (A - 3 -1 8 were synthesized. a compound represented by the formula (wherein the double bond on either side of the benzene ring is a trans form, the following 'these compounds are respectively referred to as the compound (A-3 - 36) or the compound (A-3-12) ~ (A -3-18)). Synthesis Example 2 5 The compound (a - 2 - 1 4 - 1 ) was synthesized according to the following reaction procedure 9: -77- 200911884 ch3-c ° II o
OHOH
Br—CsH-n ch3-ch^V-oc5h o N^/ 11 (A-2-14-1A)Br—CsH-n ch3-ch^V-oc5h o N^/ 11 (A-2-14-1A)
COOHCOOH
C5H-11OC5H-11O
反應程序9 於1升三頸反應瓶中饋入27_2克4 -羥基苯乙酮、 27.6克碳酸鉀、1.0克碘化鉀及500毫升丙酮,在室溫下 進行攪拌30分鐘後,添加30.2克1-溴戊烷’且在氮氣下 回流進行反應5小時。反應結束後,將反應溶液倒入水中 ,使產物沉澱。回收所產生之沉澱物,以丙酮再結晶,藉 此獲得35克之4-戊基氧基苯乙酮(化合物(A-2-14-1A) )之白色結晶。 於500毫升三頸反應瓶中饋入上述獲得之4-戊基氧 基苯乙酮中之20.6克,15.0克之4-甲醯基苯甲酸、8.0克 氫氧化鈉及1 5 0毫升乙醇,且在回流下進行反應6小時。 反應結束後,使之靜置冷卻至室溫,且添加2 〇 〇毫升之水 -78- 200911884 ’攪拌至均勻獲得溶液。將所得溶液置於1升燒杯中,使 之攪拌且滴加濃鹽酸至ρ Η 7以下。回收所產生之沉澱物 ,以乙醇再結晶,藉此獲得25克4-羧基-4,-戊基氧基苯 丙烯醯苯(化合物(Α-2-1 4-1 ))之白色結晶。 合成例2 6 於上述合成例25中,除使用47.6克之1-碘-4,4,4-三 氟丁院替代1 -溴戊烷以外,與合成例1同樣進行,獲得 28克以下式(Α-2-14-2)表示之化合物(化合物(Α-2-14_2))之白色粉末:Reaction Procedure 9 In a 1-liter three-necked reaction flask, 27_2 g of 4-hydroxyacetophenone, 27.6 g of potassium carbonate, 1.0 g of potassium iodide and 500 ml of acetone were fed, and the mixture was stirred at room temperature for 30 minutes, and then added 30.2 g of 1- Bromopentane' and refluxing under nitrogen for 5 hours. After the reaction was completed, the reaction solution was poured into water to precipitate a product. The resulting precipitate was recovered and recrystallized from acetone to obtain 35 g of white crystals of 4-pentyloxyacetophenone (compound (A-2-14-1A)). 20.6 g of the above-obtained 4-pentyloxyacetophenone, 15.0 g of 4-methylmercaptobenzoic acid, 8.0 g of sodium hydroxide and 150 ml of ethanol were fed into a 500 ml three-necked reaction flask, and The reaction was carried out under reflux for 6 hours. After completion of the reaction, it was allowed to stand to cool to room temperature, and 2 〇 ml of water was added -78-200911884' to stir until the solution was uniformly obtained. The resulting solution was placed in a 1 liter beaker, stirred and concentrated hydrochloric acid was added dropwise to ρ Η 7 or less. The resulting precipitate was recovered and recrystallized from ethanol, whereby 25 g of white crystals of 4-carboxy-4,-pentyloxybenzenepropenebenzene (compound (Α-2-1 4-1 )) were obtained. Synthesis Example 2 6 In the same manner as in Synthesis Example 1, except that 47.6 g of 1-iodo-4,4,4-trifluorobutanol was used instead of 1-bromopentane, 28 g of the following formula was obtained (白色-2-14-2) A white powder of the compound (compound (Α-2-14_2)):
(Α-2-14-2) 合成例2 7 依璩下列反應程序10合成化合物(Α-1·29·1): -79- 200911884(Α-2-14-2) Synthesis Example 2 7 A compound was synthesized according to the following reaction procedure 10 (Α-1·29·1): -79- 200911884
Br—CsH” 0 (Α-1-29-1Α)Br—CsH” 0 (Α-1-29-1Α)
(Α-1-29-1) 27.6 進行 於回 水中 ,藉 )) 基苯 氧化 反應程序10 玲1升三頸反應瓶中饋入24.4克4-羥基苯甲醛、 克碳酸鉀、1.0克碘化鉀及500毫升丙酮,在室溫下 覺拌30分鐘後,添加30.2克1-溴戊烷,且在氮氣中 荒下進行反應5小時。反應結束後,將反應溶液倒入 ,使產物沉澱。回收所產生之沉澱物’以丙酮再結晶 比獲得33克4-戊基氧基苯甲醛(化合物(Α-1-29-1 A 之白色結晶。 冷500毫升三頸反應瓶中注入上述獲得之4 -戊基氧 P醛中之19.2克、16.4克4 -乙醯基苯甲酸、8.0克氫 ft及1 5 0毫升乙醇,且在回流下進行反應6小時。反 -80- 200911884 應結束後,靜置冷卻至室溫後,添加200毫升之水,且使 之攪拌至均勻獲得溶液。將所得溶液置於i升燒杯中,使 之攪拌且滴加濃鹽酸至PH7以下。回收所產生之沉源物 ,以乙醇再結晶,藉此獲得29克4_戊基氧基_4,_羧基苯 丙嫌釀苯(化合物(A-1-29-1 ))之白色結晶。 合成例2 8 於上述合成例27中,除使用47.6克丨_碘_4,4,4_三氟 丁烷替代1 -溴戊烷外’與合成例27同樣實施,(Α-1-29-1) 27.6 In the backwater, by)) benzene oxidation reaction procedure 10 Ling 1 liter three-neck reaction flask was fed with 24.4 g of 4-hydroxybenzaldehyde, gram of potassium carbonate, 1.0 g of potassium iodide and After 500 ml of acetone was stirred at room temperature for 30 minutes, 30.2 g of 1-bromopentane was added, and the reaction was carried out under nitrogen for 5 hours. After the reaction was completed, the reaction solution was poured to precipitate a product. The recovered precipitate was recovered from acetone to obtain 33 g of 4-pentyloxybenzaldehyde (the compound (white crystal of Α-1-29-1 A). The cold 500 ml three-necked reaction flask was injected into the above. 19.2 g of 4-pentyloxy P aldehyde, 16.4 g of 4-acetic benzoic acid, 8.0 g of hydrogen ft and 150 ml of ethanol, and reacting under reflux for 6 hours. Anti-80-200911884 should be finished After standing to cool to room temperature, 200 ml of water was added, and the mixture was stirred until homogeneously obtained. The obtained solution was placed in an i liter beaker, stirred and concentrated hydrochloric acid was added dropwise to pH 7 or less. The precipitate was recrystallized from ethanol to obtain white crystals of 29 g of 4-pentyloxy-4,-carboxyphenylpropene benzene (compound (A-1-29-1)). In the above Synthesis Example 27, except that 47.6 g of hydrazine-iodo-4,4,4-trifluorobutane was used instead of 1-bromopentane, the same procedure as in Synthesis Example 27 was carried out.
CF3(CH2)3-0_^_/-§O-c〇〇H (A-1-29-2) 獲得30克以下式(A-l-29-2))表示之化合物(化 合物(A-1-29-2))之白色粉末。 <以上式(B )表示之化合物之合成> 實施例1 於裝置有溫度計、攪拌器及氮氣導入管之500毫升三 頸反應瓶中饋入23.4克(0.10莫耳)作爲化合物a-OH 之上述合成例1獲得之化合物(A-l-2-l ) 、47.1克( 0.10莫耳)作爲化合物χ_(Ερ)4之以上式(x-2-4)表示 之化合物及188.4克Ν-甲基-2-吡咯啶酮(固體成分濃度 2 7重量%),且在氮氣流下,於1 4 〇它下進行反應5小時 ’獲得含有化合物(B -1 )之溶液。 -81 - 200911884 接著,以液體層析(ODS管柱,乙腈:水=8 0 : 20 ) 測定上述溶液,確認使用之化合物(A -1 - 2 -1 )全部消耗 完畢。 實施例2〜40 除分別使用表2中所列之種類及量作爲化合物A-OH 及化合物X-(Ep)4,且調製N-甲基-2-吡咯啶酮之使用量以 外’其餘與上述實施例1同樣,以固成分濃度各爲27重 量%進行反應,獲得分別含有化合物(B-2 )〜(B-40 )之 溶液。 以液體層析(ODS管柱,乙腈:水=80 : 20 )測定各 溶液,確認實施例2〜40全部中所用之化合物A-OH均消 耗掉。 表2 A-0] X-(Ep, U 化合物 名稱 種類 (A) 種類 (ά) 實施例1 A-1-2-1 0.1 X-2-4 0.1 Β-1 實施例2 A-1-2-1 0.1 X-4-2 0.1 Β-2 實施例3 A-1-2-1 0.1 X-5-2 0.1 Β-3 實施例4 A-1-2-2 0.1 X-2-4 0.1 Β-4 實施例5 A-1-2-2 0.1 X-4-2 0.1 Β-5 實施例6 A-1-2-2 0.1 X-5-2 0.1 Β-6 實施例7 A-1-4-1 0.1 X-2-4 0.1 Β-7 實施例8 A-1-4-1 0.1 X-4-2 0.1 Β-8 實施例9 A-1-4-1 0.1 X-5-2 0.1 Β-9 實施例10 A-1-4-2 0.1 X-1-1 0.1 Β-10 實施例11 A-1-4-2 0.2 X-1-1 0.1 Β-11 實施例12 A-1-4-2 0.1 X-2-1 0.1 Β-12 實施例13 A-1-4-2 0.1 X-2-2 0.1 Β-13 -82- 200911884 表2 (續) A-0 Η χ-(Ερ)4 化合物 名稱 種類 (莫耳) 種類 (莫耳) 實施例14 A-1-4-2 0.1 Χ-2-4 0.1 Β-14 實施例15 A-1-4-2 0.1 Χ-4-2 0.1 Β-15 實施例16 A-1-4-2 0.1 Χ-5-2 0.1 Β-16 實施例17 A-4-1-1 0.1 Χ-2-4 0.1 Β-17 實施例18 A-5-1-1 0.1 Χ-2-4 0.1 Β-18 實施例19 A-6-1-1 0.1 Χ-2-4 0.1 Β-19 實施例20 A-7-1-1 0.1 Χ-2-4 0.1 Β-20 實施例21 A-3-26 0.1 Χ-2-4 0.1 Β-21 實施例22 A-3-1 0.1 Χ-2-4 0.1 Β-22 實施例23 A-3-2 0.1 Χ-2-4 0.1 Β-23 實施例24 A-3-3 0.1 Χ-2-4 0.1 Β-24 實施例25 A-3-4 0.1 Χ-2-4 0.1 Β-25 實施例26 A-3-5 0.1 Χ-2-4 0.1 Β-26 實施例27 A-3-6 0.1 Χ-2-4 0.1 Β-27 實施例28 A-3-7 0.1 Χ-2-4 0.1 Β-28 實施例29 A-3-36 0.1 Χ-2-4 0.1 Β-29 實施例30 A-3-12 0.1 Χ-2-4 0.1 Β-30 實施例31 A-3-13 0.1 Χ-2-4 0.1 Β-31 實施例32 A-3-14 0.1 Χ-2-4 0.1 Β-32 實施例33 A-3-15 0.1 Χ-2-4 0.1 Β-33 實施例34 A-3-16 0.1 Χ-2-4 0.1 Β-34 實施例35 A-3-17 0.1 Χ-2-4 0.1 Β-35 實施例36 A-3-18 0.1 Χ-2-4 0.1 Β-36 實施例37 A-2-14-1 0.1 Χ-2-4 0.1 Β-37 實施例38 A-2-14-2 0.1 Χ-2-4 0.1 Β-38 實施例39 A-1-29-1 0.1 Χ-2-4 0.1 Β-39 實施例40 A-1-29-2 0.1 Χ-2-4 0.1 Β-40 上述表2中,化合物A-OH及化合物X-(Ep)4之簡稱 分別具有以下之意義。 (化合物A-OH ) -83- 200911884 A-1-2-1:上述合成例1中獲得之化合物(A-l-2-1) A-1-2-2:上述合成例2中獲得之化合物(A-1-2-2) A-1-4-1 :上述合成例3中獲得之化合物(A-1-4-1) A - 1 - 4 - 2 :上述合成例4中獲得之化合物(A -1 - 4 - 2 ) A-7-1-1 :上述合成例5中獲得之化合物(A-7-1-1) A - 5 -1 -1 :上述合成例6中獲得之化合物(A - 5 -1 -1 ) A-6-1-1 :上述合成例7中獲得之化合物(A-6-1-1) A-7-1-1:上述合成例8中獲得之化合物(A-7-1-1) A - 3 - 2 6 :上述合成例9中獲得之化合物(A - 3 - 2 6 ) A-3-1:上述合成例10中獲得之化合物(A_3_l) A - 3 - 2 :上述合成例11中獲得之化合物(A - 3 - 2 ) A-3-3:上述合成例12中獲得之化合物(A_3_3) A-3-4 :上述合成例13中獲得之化合物(A-3-4) A-3-5 :上述合成例14中獲得之化合物(A-3-5 ) A - 3 - 6 :上述合成例1 5中獲得之化合物(A - 3 - 6 ) A-3-7 :上述合成例16中獲得之化合物(A-3-7) A-3-36:上述合成例17中獲得之化合物(A-3-36) A-3-12:上述合成例18中獲得之化合物(A-3-12) A-3-13:上述合成例19中獲得之化合物(A-3-13) A-3-14:上述合成例20中獲得之化合物(A-3-14) A-3-15 :上述合成例21中獲得之化合物(A-3-15) A-3-16 :上述合成例22中獲得之化合物(A-3-16 ) A-3-17 :上述合成例23中獲得之化合物(A-3-17 ) A-3-18 :上述合成例24中獲得之化合物(A-3-18) -84- 200911884 A-2-14-1 .上述合成例25中獲得之化合物(A-2-14-1 ) A-2-14-2:上述合成例26中獲得之化合物(A-2-14-2 ) A-1-29-1 :上述合成例27中獲得之化合物(A-1-29-1 ) A-l-29_2:上述合成例28中獲得之化合物(A-1-29-2 ) (化合物X-(Ep)4 ) X-2-4:以上式(X-2-4)表示之化合物 X-4-2:以上式(X-4-2)表示之化合物 X-5·2:以上式(X-5-2)表示之化合物 X -1 -1 :以上式(X - 1 -1 )表示之化合物 X-2-1:以上式(X-2-1)表示之化合物 X-2-2:以上式(X-2-2)表示之化合物 <聚醯胺酸之合成> 合成例29 使作爲四羧酸二酐之19.6克(0.1莫耳)1,2,3,4-環 丁烷四羧酸二酐及作爲二胺之21.2克(0.1莫耳)2,2’-二 甲基-4,4 ’ -二胺基聯苯溶於3 6 7克N -甲基-2 -吡咯啶酮中, 且在4 (TC下進行反應3小時,獲得4 0 7克含有1 0重量% 聚醯胺酸(P A -1 )之溶液。該聚醯胺酸溶液之溶液黏度爲 -85- 200911884 1 70mPa · s o 合成例30 使作爲四羧酸二酐之22.4克(0.1莫耳)2,3,5-三羧 基環戊基乙酸二酐及作爲二胺之14.23克(0.1莫耳)環 己烷雙-1,3-(甲基胺)溶於3 29.3克N-甲基-2-吡咯啶酮 中,且在60°C下進行反應6小時,藉此獲得3 6 5克含有 10重量%聚醯胺酸(PA-2 )之溶液。該聚醯胺酸溶液之溶 液黏度爲11 0mPa . s。 <聚醯亞胺之合成> 合成例3 1 使作爲四羧酸二酐之22.4克(0.1莫耳)2,3,5-三羧 基環戊基乙酸二酐及作爲二胺之9.73克(0.09莫耳)對 苯二胺以及5.23克(〇_〇ι莫耳)以上式(D-10)表示之 化合物表示之二胺溶於336.2克N -甲基-2-吡咯啶酮中, 且在6〇°C下進行反應4小時,藉此獲得含有1〇重量%聚 醯胺酸之溶液。該聚醯胺酸溶液之溶液黏度爲1 2 6mP a · s ο 接著,追加3 4 8克Ν_甲基-2_吡咯啶酮於所得聚醯胺 酸溶液中’添加7.9克吡啶及1 〇 . 2克乙酸酐,且在丨丨〇 〇c 下進行脫水閉環4小時。經脫水閉環反應後,藉由以新的 N -甲基-2 -批略Π定酮置換系統內之溶劑(本操作中脫水閉 環反應中使用之吡啶及乙酸酐排除於系統外,以下相同) -86- 200911884 ,藉此獲得約23 0克含有16·1重量%醯亞胺化率約54%之 聚醯亞胺(Ρ I -1 )溶液。少量分取該聚醯亞胺溶液,以添 加Ν-甲基-2-吡咯啶酮使聚合物濃度成爲1〇重量%之溶液 所測定之溶液黏度爲75mPa · s。 合成例3 2 以將含有上述合成例30中獲得之聚醯胺酸(pa-2 ) 之溶液取換算成聚醯胺酸(PA-2 )相當於17.5克之量之 程度,於其中添加23 2.5克N-甲基-2-吡咯啶酮、克吡 啶及4.9克乙酸酐’且在1 1 〇 °C下進行脫水閉環4小時。 經脫水閉環反應後’藉由以新的N-甲基-2-吡咯啶酮溶劑 置換系統內之溶劑,獲得約81克含有14.8重量%醯亞胺 化率約50%之聚醯亞胺(PI-2 )溶液。少量分取該聚醯亞 胺溶液,以添加N -甲基-2 -吡咯啶酮使聚合物濃度成爲1 0 重量%溶液測定之溶液黏度爲6 9 m P a · s。 實施例4 1 <液晶配向劑之調製> 作爲(A )聚合物之含有上述合成例2 5中獲得之聚 醯胺酸(PA-1 )之溶液取換算成聚醯胺酸(PA_i )相當 於1 0 0重量份之量之程度,於其中添加作爲(B )化合物 之含有以上述實施例1獲得之化合物(B -1 )之溶液換算 成化合物(B-1)相當於50重量份之量,進而添加甲 基-2-吡咯啶酮及丁基溶纖素,溶劑組成爲N-甲基-2-[]比略 -87- 200911884 啶酮:丁基溶纖素=50 : 50 (重量比),成爲固體成分濃 度爲2.5重量%之溶液。使該溶液經孔徑1 μιη之過濾器過 濾,藉此調製液晶配向劑(S -1 )。 實施例42〜89 分別使用表3中所列種類及同表中所列之量作爲(A )聚合物及(B )化合物以外,與上述實施例4 1同樣地分 別調製液晶配向劑(S - 2 ) ~ ( S - 4 9 )。 而且(A)聚合物及(B)化合物係分別以上述a成 例或上述實施例中獲得之溶液供於液晶配向劑, 〜 < 調製,表 3中之量爲換算成各溶液中所含(Α)聚合物戍 4Β )化a 物之量之値。 ΏCF3(CH2)3-0_^_/-§Oc〇〇H (A-1-29-2) Obtained 30 g of the compound represented by the following formula (Al-29-2)) (compound (A-1-29-) 2)) White powder. <Synthesis of the compound represented by the above formula (B)> Example 1 23.4 g (0.10 mol) was fed as a compound a-OH in a 500 ml three-necked reaction flask equipped with a thermometer, a stirrer and a nitrogen introduction tube. The compound (Al-2-l) obtained in the above Synthesis Example 1 and 47.1 g (0.10 mol) of the compound represented by the above formula (x-2-4) of the compound χ_(Ερ)4 and 188.4 g of fluorene-methyl group 2-pyrrolidone (solid content concentration: 27% by weight), and the reaction was carried out under a nitrogen stream at 14 ° C for 5 hours to obtain a solution containing the compound (B-1). -81 - 200911884 Next, the above solution was measured by liquid chromatography (ODS column, acetonitrile: water = 80:20), and it was confirmed that all the compound (A-1 - 2 -1 ) used was consumed. Examples 2 to 40, except that the kinds and amounts listed in Table 2 were used as the compound A-OH and the compound X-(Ep) 4, respectively, and the amount of N-methyl-2-pyrrolidone used was adjusted. In the same manner as in the above Example 1, the reaction was carried out at a solid concentration of 27% by weight to obtain a solution containing the compounds (B-2) to (B-40), respectively. Each solution was measured by liquid chromatography (ODS column, acetonitrile: water = 80: 20), and it was confirmed that the compound A-OH used in all of Examples 2 to 40 was consumed. Table 2 A-0] X-(Ep, U Compound name type (A) Type (ά) Example 1 A-1-2-1 0.1 X-2-4 0.1 Β-1 Example 2 A-1-2 -1 0.1 X-4-2 0.1 Β-2 Example 3 A-1-2-1 0.1 X-5-2 0.1 Β-3 Example 4 A-1-2-2 0.1 X-2-4 0.1 Β -4 Example 5 A-1-2-2 0.1 X-4-2 0.1 Β-5 Example 6 A-1-2-2 0.1 X-5-2 0.1 Β-6 Example 7 A-1-4 -1 0.1 X-2-4 0.1 Β-7 Example 8 A-1-4-1 0.1 X-4-2 0.1 Β-8 Example 9 A-1-4-1 0.1 X-5-2 0.1 Β -9 Example 10 A-1-4-2 0.1 X-1-1 0.1 Β-10 Example 11 A-1-4-2 0.2 X-1-1 0.1 Β-11 Example 12 A-1-4 -2 0.1 X-2-1 0.1 Β-12 Example 13 A-1-4-2 0.1 X-2-2 0.1 Β-13 -82- 200911884 Table 2 (continued) A-0 Η χ-(Ερ) 4 Compound name type (mole) Species (mole) Example 14 A-1-4-2 0.1 Χ-2-4 0.1 Β-14 Example 15 A-1-4-2 0.1 Χ-4-2 0.1 Β-15 Example 16 A-1-4-2 0.1 Χ-5-2 0.1 Β-16 Example 17 A-4-1-1 0.1 Χ-2-4 0.1 Β-17 Example 18 A-5- 1-1 0.1 Χ-2-4 0.1 Β-18 Example 19 A-6-1-1 0.1 Χ-2-4 0.1 Β-19 Example 20 A-7-1-1 0.1 Χ-2-4 0.1 Β-20 Example 21 A-3-26 0.1 Χ-2 -4 0.1 Β-21 Example 22 A-3-1 0.1 Χ-2-4 0.1 Β-22 Example 23 A-3-2 0.1 Χ-2-4 0.1 Β-23 Example 24 A-3-3 0.1 Χ-2-4 0.1 Β-24 Example 25 A-3-4 0.1 Χ-2-4 0.1 Β-25 Example 26 A-3-5 0.1 Χ-2-4 0.1 Β-26 Example 27 A -3-6 0.1 Χ-2-4 0.1 Β-27 Example 28 A-3-7 0.1 Χ-2-4 0.1 Β-28 Example 29 A-3-36 0.1 Χ-2-4 0.1 Β-29 Example 30 A-3-12 0.1 Χ-2-4 0.1 Β-30 Example 31 A-3-13 0.1 Χ-2-4 0.1 Β-31 Example 32 A-3-14 0.1 Χ-2-4 0.1 Β-32 Example 33 A-3-15 0.1 Χ-2-4 0.1 Β-33 Example 34 A-3-16 0.1 Χ-2-4 0.1 Β-34 Example 35 A-3-17 0.1 Χ -2-4 0.1 Β-35 Example 36 A-3-18 0.1 Χ-2-4 0.1 Β-36 Example 37 A-2-14-1 0.1 Χ-2-4 0.1 Β-37 Example 38 A -2-14-2 0.1 Χ-2-4 0.1 Β-38 Example 39 A-1-29-1 0.1 Χ-2-4 0.1 Β-39 Example 40 A-1-29-2 0.1 Χ-2 -4 0.1 Β-40 In the above Table 2, the abbreviations of the compound A-OH and the compound X-(Ep)4 have the following meanings, respectively. (Compound A-OH) -83-200911884 A-1-2-1: Compound (Al-2-1) obtained in the above Synthesis Example 1 A-1-2-2: Compound obtained in the above Synthesis Example 2 ( A-1-2-2) A-1-4-1 : Compound (A-1-4-1) A - 1 - 4 - 2 obtained in the above Synthesis Example 3: the compound obtained in the above Synthesis Example 4 ( A -1 - 4 - 2 ) A-7-1-1 : Compound (A-7-1-1) A - 5 -1 -1 obtained in the above Synthesis Example 5: the compound obtained in the above Synthesis Example 6 ( A - 5 -1 -1 ) A-6-1-1 : Compound (A-6-1-1) obtained in the above Synthesis Example 7 A-7-1-1: Compound obtained in the above Synthesis Example 8 ( A-7-1-1) A - 3 - 2 6 : Compound (A - 3 - 2 6 ) A-3-1 obtained in the above Synthesis Example 9: Compound (A_3_l) A obtained in the above Synthesis Example 10. 3 - 2 : Compound (A - 3 - 2 ) A-3-3 obtained in the above Synthesis Example 11: Compound (A_3_3) obtained in the above Synthesis Example 12 A-3-4 : Compound obtained in Synthesis Example 13 above (A-3-4) A-3-5 : Compound (A-3-5) A - 3 - 6 obtained in the above Synthesis Example 14 : Compound (A - 3 - 6 ) obtained in the above Synthesis Example 15. A-3-7: Compound (A-3-7) obtained in the above Synthesis Example 16 A-3-36: the above combination Compound (A-3-36) A-3-12: Compound (A-3-12) obtained in the above Synthesis Example 18 A-3-13: Compound obtained in the above Synthesis Example 19 ( A-3-13) A-3-14: Compound (A-3-14) A-3-15 obtained in the above Synthesis Example 20: Compound (A-3-15) A- obtained in the above Synthesis Example 21. 3-16: Compound (A-3-16) A-3-17 obtained in the above Synthesis Example 22: Compound (A-3-17) A-3-18 obtained in the above Synthesis Example 23: Synthesis Example 24 above Compound (A-3-18) -84- 200911884 A-2-14-1. Compound (A-2-14-1) obtained in the above Synthesis Example 25 A-2-14-2: Synthesis as described above Compound (A-2-14-2) A-1-29-1 obtained in Example 26: Compound (A-1-29-1) obtained in Synthesis Example 27, Al-29_2: obtained in Synthesis Example 28 above Compound (A-1-29-2) (Compound X-(Ep)4) X-2-4: Compound X-4-2 represented by the above formula (X-2-4): Formula (X-4) -2) Compound X-5·2: Compound X-1:1 represented by the above formula (X-5-2): Compound X-2-1 represented by the above formula (X-1 -1): Compound X-2-2 represented by (X-2-1): compound represented by the above formula (X-2-2) <polyamine Synthesis of Synthesis Example 29 19.6 g (0.1 mol) of 1,2,3,4-cyclobutanetetracarboxylic dianhydride as a tetracarboxylic dianhydride and 21.2 g (0.1 mol) as a diamine were used. 2,2'-Dimethyl-4,4 '-diaminobiphenyl was dissolved in 3 6 7 g of N-methyl-2-pyrrolidone, and reacted at 4 (TC for 3 hours to obtain 4 0 7 g of a solution containing 10% by weight of polyaminic acid (PA-1). The solution viscosity of the polyaminic acid solution was -85-200911884 1 70 mPa · so Synthesis Example 30 22.4 g (0.1 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as tetracarboxylic dianhydride And 14.23 g (0.1 mol) of cyclohexane bis-1,3-(methylamine) as diamine dissolved in 3 29.3 g of N-methyl-2-pyrrolidone and carried out at 60 ° C The reaction was carried out for 6 hours, whereby 3 6 5 g of a solution containing 10% by weight of poly-proline (PA-2) was obtained. The solution viscosity of the polyaminic acid solution was 110 mPa·s. <Synthesis of Polyimine> Synthesis Example 3 1 22.4 g (0.1 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as a tetracarboxylic dianhydride and 9.73 g as a diamine (0.09 mol) p-phenylenediamine and 5.23 g (〇_〇ι Moule) The diamine represented by the compound represented by the above formula (D-10) is dissolved in 336.2 g of N-methyl-2-pyrrolidone. The reaction was carried out at 6 ° C for 4 hours, whereby a solution containing 1% by weight of poly-proline was obtained. The solution viscosity of the polyaminic acid solution was 1 2 6 mP a · s ο Next, 3 4 8 g of Ν-methyl-2-pyrrolidone was added to add 7.9 g of pyridine and 1 于 in the obtained poly-proline solution. 2 g of acetic anhydride, and dehydration ring closure was carried out for 4 hours under 丨丨〇〇c. After the dehydration ring-closure reaction, the solvent in the system is replaced by a new N-methyl-2-bendrolone (the pyridine and acetic anhydride used in the dehydration ring-closing reaction in this operation are excluded from the system, the same applies hereinafter) From -86 to 200911884, about 230 grams of a solution of a polyamidiamine (Ρ I -1 ) containing 6.1% by weight of a ruthenium iodide of about 54% was obtained. A small amount of the polyimine solution was added to add a solution of ruthenium-methyl-2-pyrrolidone to a polymer concentration of 1% by weight. The solution viscosity was determined to be 75 mPa·s. Synthesis Example 3 2 The solution containing the polyamic acid (pa-2) obtained in the above Synthesis Example 30 was converted to a polyacetic acid (PA-2) equivalent to an amount of 17.5 g, and 23 2.5 was added thereto. N-methyl-2-pyrrolidone, gram pyridine and 4.9 g of acetic anhydride' were dehydrated and closed at 1 1 ° C for 4 hours. After dehydration ring closure reaction, by replacing the solvent in the system with a new N-methyl-2-pyrrolidone solvent, about 81 g of polyimine containing about 14.8% by weight of hydrazine imidization (about 50%) was obtained ( PI-2) solution. A small amount of the polyimine solution was added to add N-methyl-2-pyrrolidone to a polymer concentration of 10% by weight. The solution had a solution viscosity of 6 9 m P a · s. Example 4 1 <Preparation of Liquid Crystal Aligning Agent> As a (A) polymer, a solution containing the polylysine (PA-1) obtained in the above Synthesis Example 25 was converted into polylysine (PA_i). The amount of the compound (B-1) obtained as the compound (B-1) obtained in the above-mentioned Example 1 is added to the compound (B-1) in an amount equivalent to 50 parts by weight, and is equivalent to 50 parts by weight. The amount, further added methyl-2-pyrrolidone and butyl cellosolve, the solvent composition of N-methyl-2-[] ratio slightly -87- 200911884 ketone: butyl cellosolve = 50: 50 (weight ratio) It became a solution having a solid concentration of 2.5% by weight. This solution was filtered through a filter having a pore size of 1 μm to thereby modulate the liquid crystal alignment agent (S -1 ). Examples 42 to 89 The liquid crystal alignment agents (S - were prepared in the same manner as in the above Example 4 except that the types listed in Table 3 and the amounts listed in the same table were used as the (A) polymer and the (B) compound, respectively. 2) ~ (S - 4 9 ). Further, the (A) polymer and the (B) compound are each supplied to the liquid crystal alignment agent by the above-mentioned a or the solution obtained in the above examples, and the amount in Table 3 is converted into the respective solutions. (Α) Polymer 戍 4Β ) The amount of a substance. Ώ
200911884 表3 (續) (A)聚合物 (B)化合物 液晶配向劑 名稱 種類 量 (重量份) 種類 量 (重量份) 實施例55 PA-2 100 B-15 50 S-15 實施例56 PI-2 100 B-16 50 S-16 實施例57 PI-1 100 B-10 50 S-17 實施例58 PI-1 100 B-11 50 S-18 實施例59 PI-1 100 B-12 50 S-19 實施例60 PI-1 100 B-13 50 S-20 實施例61 PI-1 100 B-14 50 S-21 實施例62 PI-1 100 B-14 25 S-22 實施例63 PI-2 100 B-15 50 S-23 實施例64 PI-2 100 B-16 50 S-24 實施例65 PA-1 100 B-17 50 S-25 實施例66 PA-1 100 B-18 50 S-26 實施例67 PA-1 100 B-19 50 S-27 實施例68 PA-1 100 B-20 50 S-28 實施例69 PA-1 100 B-21 50 S-29 實施例70 PA-1 100 B-22 50 S-30 實施例71 PA-1 100 B-23 50 S-31 實施例72 PA-1 100 B-24 50 S-32 實施例73 PA-1 100 B-25 50 S-33 實施例74 PA-1 100 B-26 50 S-34 實施例75 PA-1 100 B-27 50 S-35 實施例76 PA-1 100 B-28 50 S-36 實施例77 PA-1 100 B-29 50 S-37 實施例78 PA-1 100 B-30 50 S-38 實施例79 PA-1 100 B-31 50 S-39 實施例80 PA-1 100 B-32 50 S-40 實施例81 PA-1 100 B-33 50 S-41 實施例82 PA-1 100 B-34 50 S-42 實施例83 PA-1 100 B-35 50 S-43 實施例84 PA-1 100 B-36 50 S-44 實施例85 PI-1 100 B-14 100 S-45 實施例86 PA-1 100 B-37 50 S-46 實施例87 PA-1 100 B-38 50 S-47 實施例88 PA-1 100 B-39 50 S-48 實施例89 PA-1 100 B-40 50 S-49 -89- 200911884 實施例90 使用上述實施例4 1中調製之液晶配向劑 列般製造VA型液晶顯示元件,且進行液晶配 保持性之評價。 <VA型液晶顯示元件之製造> 使用旋轉塗佈機將上述調配之液晶配向劑 設有由ITO膜組成之透明電極之玻璃基板之透 ,且在8 0 °C之加熱板上乾燥1分鐘進行預供烤 置換成氮氣且在20(TC下進行後烘烤1小時 Ο.ίμιη之塗膜,在該塗膜表面上使用Hg-Xe燈 勒(Gian-Taylor )稜鏡,自與塗膜法線成40° 照射1,000J/m2之含3 1 3nm輝線之偏光紫外線 向膜。 重複該操作,獲得一對(兩片)在透明電 液晶配向膜之基板。 在該等一對基板之形成各液晶配向膜之面 版印刷塗佈加入有直徑5 . 5 μιη氧化鋁球之環氧 後,以與紫外線光軸之朝基板面射影之方向反 式將基板重疊並壓合,在150t下加熱1小時 化。接著,自液晶注入口於一對基板間充塡 Merck公司製造,MLC-66 08 )後,以環氧系 晶注入口封住。接著,爲了消除液晶注入時之 因此使之在1 50°C下加熱後緩慢冷卻至室溫。 S - 1,如下 向性及電壓 S -1塗佈於 明電極面上 後,烘箱中 ,形成膜厚 及葛蘭-泰 傾斜之方向 而成液晶配 極面上具有 之外緣以網 樹脂接著劑 向平行之方 使接著劑硬 負型液晶( 接著劑將液 流動配向, 接著,在基 -90 - 200911884 板之外側兩面上貼合偏光板,使其偏光方向相互正交且與 液晶配向膜之紫外線光軸之朝基板面射影方向成45。角度 ,藉此製造VA型液晶顯示元件。 <液晶配向性之評價> 針對上述製造之VA型液晶顯示元件,以光學顯微鏡 觀察使直流5V之電壓開·關(施加.解除)時是否有產 生異常區塊,於未觀察到上述液晶顯示元件有異常區塊時 ,則液晶配向性記爲「良好」。 <電壓維持率之評價> 在6 0 °C下對上述製造之V A型液晶顯示元件施加5 V 電壓歷時6 0微秒之時間、且在施加1 6 7毫秒間隔後,測 定自解除施加後1 6 7毫秒之電壓維持率。測定裝置使用( 股)東陽Technic製造之VHR-1。 該電壓維持率在90%以上時,電壓維持率評價爲「良 好」’除此之外’則評價爲「不良」,上述液晶顯示元件 之電壓維持率爲「良好」。 實施例 91~114、116、118〜135、138 及 139 除了分別使用表4中所列者作爲液晶配向劑,且液晶 顯示元件製造時之偏光紫外線照射量分別以表4中所列者 以外,與上述實施例9 0同樣地製造v a型液晶顯示元件 ,且進行液晶配向性及電壓維持率之評價,結果列於表4 -91 - 200911884 實施例1 1 5 使用上述實施例66調製之液晶配向劑S-26,如下列 般製造TN型液晶顯示元件,且進行液晶配向性及電壓維 持率之評價。 <TN型液晶顯示元件之製造> 使用旋轉塗佈機將上述調製之液晶配向劑S-26塗# 於設有由ITO膜組成之透明電極之玻璃基板之透明電極@ 上,且在8 (TC之加熱板上乾燥1分鐘進行預烘烤後,烘箱 中置換成氮氣且在2〇〇t下進行後烘烤1小時,形成膜厚 Ο.ίμιη之塗膜。在該塗膜之表面上使用Hg-Xe燈及葛蘭— 泰勒稜鏡,自與基板之法線成 40°傾斜之方向照射 l,000I/m2之含313nm輝線之偏光紫外線,藉此形成賦予 液晶配向能之液晶配向膜。 重複與上述相同之操作,製作一對(兩片)在透明導 電膜面上具有液晶配向膜之玻璃基板。 在此一對基板之形成各液晶配向膜之面之周圍部分以 網版印刷塗佈加入有直徑5 . 5 μηι氧化鋁球之環氧樹脂接著 劑後,以與偏光紫外線照射方向成正交之方式將基板重疊 並壓合’在1 5 0 °C下加熱1小時使接著劑硬化。接著,自 液晶注入口於基板之間隙內充塡正型向列型液晶(Merck 公司製造’ MLC-622 1 ’加入對掌性劑)後,以環氧系接 -92- 200911884 著劑將液晶注入口封住。接著,爲了消除液晶注入時之流 動配向,因此使之在1 5 0 °C下加熱1 〇分鐘且緩慢冷卻至室 溫。接著,在基板之外側兩面上貼合偏光板以使其偏光方 向相互正交且與液晶配向膜之偏光方向成爲平行,藉此製 造TN型液晶顯示元件。 <液晶配向性之評價> 針對上述製造之TN型液晶顯示元件,以光學顯微鏡 觀察使直流5V之電壓開·關(施加·解除)時是否有產 生異常區塊,若未觀察到上述液晶顯示元件有異常區塊, 則判斷液晶配向性爲「良好」。 <電壓維持率之評價> 在60°C下對上述製造之TN型液晶顯示元件施加5V 電壓歷時6 0微秒之時間,且在施加丨6 7毫秒間隔後,測 定自解除施加後1 67毫秒之電壓維持率。測定裝置使用( 股)東陽Technic製造之VHR-1。 該電壓維持率在90%以上時,電壓維持率評價爲「良 好」’除此之外’則評價爲「不良」,上述液晶顯示元件 之電壓維持率爲「良好」。 實施例117、136及137 除了分別使用表4中所列者作爲液晶配向劑,且液晶 顯示元件製造時之偏光紫外線照射量分別以表4中所列者 -93- 200911884 外,與上述實施例9 0同樣地製造TN型液晶顯示元件, 且進行液晶配向性及電壓維持率之評價,結果列於表4。 表4 液晶配向劑 名稱 偏光輸射線 照射量 (J/m2) 顯示模式 液晶 配向性 電壓 維持率 實施例90 S-1 1,000 VA 良好 良好 實施例91 S-2 1,000 VA 良好 良好 實施例92 S-3 1,000 VA 良好 良好 實施例93 S-4 1,000 VA 良好 良好 實施例94 S-5 1,000 VA 良好 良好 實施例95 S-6 1,000 VA 良好 良好 實施例96 S-7 1,000 VA 良好 良好 實施例97 S-8 1,000 VA 良好 良好 實施例98 S-9 1,000 VA 良好 良好 實施例99 S-10 1,000 VA 良好 良好 實施例100 S-11 1,000 VA 良好 良好 實施例101 S-12 1,000 VA 良好 良好 實施例102 S-13 1,000 VA 良好 良好 實施例103 S-14 1,000 VA 良好 良好 實施例104 S-15 1,000 VA 良好 良好 實施例105 S-16 1,000 VA 良好 良好 實施例106 S-17 1,000 VA 良好 良好 實施例107 S-18 1,000 VA 良好 良好 實施例108 S-19 1,000 VA 良好 良好 實施例109 S-20 1,000 VA 良好 良好 實施例110 S-21 1,000 VA 良好 良好 實施例111 S-22 1,000 YA 良好 良好 實施例112 S-23 1,000 VA 良好 良好 實施例113 S-24 1,000 VA 良好 良好 實施例114 S-25 1,000 VA 良好 良好 實施例115 S-26 1,000 TN 良好 良好 實施例116 S-27 1,000 VA 良好 良好 實施例1Π S-28 1,000 TN 良好 良好 實施例118 S-39 1,000 VA 良好 良好 -94- 200911884 表4 (續) 液晶配向劑 名稱 偏光輻射線 照射量 (J/m2) 顯示模式 液晶 配向性 電壓 維持率 實施例119 S-30 1,000 VA 良好 良好 實施例120 S-31 1,000 VA 良好 良好 實施例121 S-32 1,000 VA 良好 良好 實施例122 S-33 1,000 VA 良好 良好 實施例123 S-34 1,000 VA 良好 良好 實施例124 S-35 1,000 VA 良好 良好 實施例125 S-36 1,000 VA 良好 良好 實施例126 S-37 1,000 VA 良好 良好 實施例127 S-38 1,000 VA 良好 良好 實施例128 S-39 1,000 VA 良好 良好 實施例129 S-40 1,000 VA 良好 良好 實施例130 S-41 1,000 VA 良好 良好 實施例131 S-42 1,000 VA 良好 良好 實施例132 S-43 1,000 VA 良好 良好 實施例133 S-44 1,000 VA 良好 良好 實施例134 S-21 200 VA 良好 良好 實施例135 S-45 1,000 VA 良好 良好 實施例136 S-46 3,000 TN 良好 良好 實施例137 S-47 3,000 TN 良好 良好 實施例138 S-48 3,000 VA 良好 良好 實施例139 S-49 3,000 VA 良好 良好 [發明效果] 本發明之液晶配向劑,如由上述實施例中可具體暸解 ,可作爲適用於光配向法之液晶配向劑,而可形成藉比以 往更少之輻射線照射量即可顯示良好液晶配向性及高的電 壓維持率之液晶配向膜。所以,於液晶顯示元件中使用此 液晶配向膜時,可以比以往更價廉地製造顯示品質優異之 液晶顯示元件。 -95- 200911884 具備有由如此的本發明液晶配向劑所形成之液晶配向 膜之本發明之液晶顯示元件具有良好的顯示品質。因此, 本發明之液晶顯示元件可有效使用於各種裝置,例如可較 好地使用於桌上型電腦、手錶、座鐘、係數顯示板、數字 處理機、個人電腦或液晶電視等裝置。 -96 -200911884 Table 3 (continued) (A) Polymer (B) Compound Liquid crystal alignment agent Name Type (parts by weight) Species (parts by weight) Example 55 PA-2 100 B-15 50 S-15 Example 56 PI- 2 100 B-16 50 S-16 Example 57 PI-1 100 B-10 50 S-17 Example 58 PI-1 100 B-11 50 S-18 Example 59 PI-1 100 B-12 50 S- 19 Example 60 PI-1 100 B-13 50 S-20 Example 61 PI-1 100 B-14 50 S-21 Example 62 PI-1 100 B-14 25 S-22 Example 63 PI-2 100 B-15 50 S-23 Example 64 PI-2 100 B-16 50 S-24 Example 65 PA-1 100 B-17 50 S-25 Example 66 PA-1 100 B-18 50 S-26 Implementation Example 67 PA-1 100 B-19 50 S-27 Example 68 PA-1 100 B-20 50 S-28 Example 69 PA-1 100 B-21 50 S-29 Example 70 PA-1 100 B- 22 50 S-30 Example 71 PA-1 100 B-23 50 S-31 Example 72 PA-1 100 B-24 50 S-32 Example 73 PA-1 100 B-25 50 S-33 Example 74 PA-1 100 B-26 50 S-34 Example 75 PA-1 100 B-27 50 S-35 Example 76 PA-1 100 B-28 50 S-36 Example 77 PA-1 100 B-29 50 S-37 Example 78 PA-1 100 B-30 50 S-38 Example 79 PA-1 100 B-31 50 S-39 Example 80 PA-1 100 B-32 50 S-40 Example 81 PA-1 100 B-33 50 S-41 Example 82 PA-1 100 B-34 50 S-42 Example 83 PA-1 100 B -35 50 S-43 Example 84 PA-1 100 B-36 50 S-44 Example 85 PI-1 100 B-14 100 S-45 Example 86 PA-1 100 B-37 50 S-46 Example 87 PA-1 100 B-38 50 S-47 Example 88 PA-1 100 B-39 50 S-48 Example 89 PA-1 100 B-40 50 S-49 -89- 200911884 Example 90 Using the above implementation The VA type liquid crystal display element was produced in the same manner as the liquid crystal alignment agent prepared in Example 4, and the evaluation of the liquid crystal alignment property was performed. <Production of VA type liquid crystal display element> The above-mentioned liquid crystal alignment agent was provided with a transparent glass substrate composed of an ITO film by a spin coater, and dried on a hot plate at 80 ° C. Minutes were pre-supplied and replaced with nitrogen and post-baked at 20 (TC) for 1 hour ί. ίμιη coating on the surface of the coating using Hg-Xe lamp (Gian-Taylor) 稜鏡, self-coating The normal line of the film is irradiated with a polarized ultraviolet ray having a thickness of 130 J/m 2 and a 133 nm light line at 40°. This operation is repeated to obtain a pair of (two pieces) substrates on the transparent electro-optical liquid crystal alignment film. After forming a surface of each of the liquid crystal alignment films, an epoxy having a diameter of 5.5 μm is added, and then the substrate is superposed and pressed in a direction opposite to the ultraviolet light axis toward the substrate surface, at 150 t. The mixture was heated for 1 hour, and then filled with a liquid crystal injection port between a pair of substrates, manufactured by Merck Co., Ltd., MLC-66 08), and sealed with an epoxy-based crystal injection port. Next, in order to eliminate the liquid crystal injection, it was heated at 150 ° C and then slowly cooled to room temperature. S - 1, after the directionality and voltage S -1 are applied to the surface of the bright electrode, in the oven, the film thickness and the direction of the gradient of the Glan-Thai are formed, and the outer surface of the liquid crystal matching surface has a mesh resin. The agent is applied to the parallel side to make the adhesive hard-type liquid crystal (the agent then aligns the liquid flow, and then the polarizing plate is bonded on both sides of the base of the base-90 - 200911884, so that the polarization directions thereof are orthogonal to each other and the liquid crystal alignment film The VA type liquid crystal display element was manufactured by the ultraviolet light axis toward the substrate surface projection direction at an angle of 45. <Evaluation of liquid crystal alignment property> For the VA type liquid crystal display element manufactured as described above, DC 5V was observed by an optical microscope. When the voltage is turned on and off (applied or released), an abnormal block is generated. When the liquid crystal display element is not observed to have an abnormal block, the liquid crystal alignment property is described as "good". <Evaluation of voltage maintenance rate> Applying a voltage of 5 V to the VA type liquid crystal display device manufactured above at 60 ° C for a period of 60 μsec, and after the interval of 167 ms is applied, the voltage maintenance of 167 ms after the release of the application is measured. rate In the measurement device, the VHR-1 manufactured by Toyo Technic is used. When the voltage maintenance rate is 90% or more, the voltage maintenance rate is evaluated as "good", and the other is evaluated as "poor", and the liquid crystal display element is used. The voltage maintenance ratio was "good." Examples 91 to 114, 116, 118 to 135, 138, and 139 In addition to the use of the liquid crystal alignment agents listed in Table 4, respectively, and the polarized ultraviolet irradiation amounts of the liquid crystal display elements were respectively The va liquid crystal display element was produced in the same manner as in the above Example 90 except that the liquid crystal alignment property and the voltage maintenance ratio were evaluated. The results are shown in Tables 4 - 91 - 200911884. Example 1 1 5 The liquid crystal alignment agent S-26 prepared in the above Example 66 was used to produce a TN liquid crystal display element, and the liquid crystal alignment property and the voltage maintenance ratio were evaluated. <Production of TN liquid crystal display element> Using spin coating The above-prepared liquid crystal alignment agent S-26 was coated on a transparent electrode @ of a glass substrate provided with a transparent electrode composed of an ITO film, and dried on a hot plate of 8 (TC) for 1 minute for prebaking. The oven was replaced with nitrogen and post-baked at 2 Torr for 1 hour to form a film having a film thickness of ί. ίμιη. Hg-Xe lamp and Gülen-Taylor were used on the surface of the film. A polarized ultraviolet ray having a 313 nm illuminating line of 1,000 I/m 2 is irradiated in a direction inclined at 40° to the normal line of the substrate, thereby forming a liquid crystal alignment film imparting liquid crystal alignment energy. The same operation as above is repeated to produce a pair (two a glass substrate having a liquid crystal alignment film on a surface of the transparent conductive film. A portion of the surface of each of the pair of substrates on which the liquid crystal alignment film is formed is screen-printed and coated with a ring of alumina having a diameter of 5.5 μm After the oxy-resin adhesive, the substrate was superposed and pressed in a direction orthogonal to the direction in which the polarized ultraviolet rays were irradiated, and the adhesive was cured by heating at 150 ° C for 1 hour. Next, a positive nematic liquid crystal (manufactured by Merck Corporation 'MLC-622 1 ' is added to the palm powder) from the liquid crystal injection port in the gap between the substrates, and the liquid crystal is bonded to the liquid crystal-92-200911884. The entrance is sealed. Next, in order to eliminate the flow alignment at the time of liquid crystal injection, it was heated at 150 ° C for 1 〇 minute and slowly cooled to room temperature. Then, a polarizing plate is bonded to both surfaces of the outer surface of the substrate so that the polarization directions thereof are orthogonal to each other and parallel to the direction of polarization of the liquid crystal alignment film, whereby a TN liquid crystal display element is manufactured. <Evaluation of Liquid Crystal Alignment> Regarding the TN liquid crystal display device manufactured as described above, whether or not an abnormal block was generated when an ON voltage of 5 V was turned on and off (applied/released) by an optical microscope was observed. If the display element has an abnormal block, it is judged that the liquid crystal alignment property is "good". <Evaluation of Voltage Maintaining Rate> A voltage of 5 V was applied to the TN liquid crystal display device manufactured above at 60 ° C for 60 μs, and after the interval of 丨 6 7 ms was applied, the measurement was performed after the application was released. 67 milliseconds voltage maintenance rate. The measuring device used VHR-1 manufactured by Dongyang Technic. When the voltage holding ratio is 90% or more, the voltage holding ratio is evaluated as "good" and "other than" is evaluated as "poor", and the voltage holding ratio of the liquid crystal display element is "good". Examples 117, 136 and 137 Except that those listed in Table 4 were used as the liquid crystal alignment agent, respectively, and the amount of polarized ultraviolet rays at the time of manufacture of the liquid crystal display element was respectively -93-200911884 listed in Table 4, and the above examples In the same manner, a TN liquid crystal display device was produced in the same manner, and liquid crystal alignment properties and voltage maintenance ratios were evaluated. The results are shown in Table 4. Table 4 Liquid crystal alignment agent name polarized light irradiation amount (J/m2) Display mode liquid crystal alignment voltage maintenance rate Example 90 S-1 1,000 VA Good good example 91 S-2 1,000 VA Good good example 92 S-3 1,000 VA Good good example 93 S-4 1,000 VA Good good example 94 S-5 1,000 VA Good good example 95 S-6 1,000 VA Good good example 96 S-7 1,000 VA Good good example 97 S-8 1,000 VA Good Good Example 98 S-9 1,000 VA Good Good Example 99 S-10 1,000 VA Good Good Practice 100 S-11 1,000 VA Good Good Practice 101 S-12 1,000 VA Good Good Practice 102 S-13 1,000 VA Good good example 103 S-14 1,000 VA Good good example 104 S-15 1,000 VA Good good example 105 S-16 1,000 VA Good good example 106 S-17 1,000 VA Good good example 107 S-18 1,000 VA Good Good Example 108 S-19 1,000 VA Good Good Practice 109 S-20 1,000 VA Good Good Practice 110 S-21 1,000 VA Good Good Practice 111 S-22 1,000 YA Good Good Example 112 S-23 1,000 VA Good Good Practice 113 S-24 1,000 VA Good Good Practice 114 S-25 1,000 VA Good Good Practice 115 S-26 1,000 TN Good Good Practice 116 S-27 1,000 VA Good good example 1Π S-28 1,000 TN Good good example 118 S-39 1,000 VA Good good-94- 200911884 Table 4 (continued) Liquid crystal alignment agent name polarized radiation exposure (J/m2) Display mode liquid crystal alignment Voltage Maintainance Example 119 S-30 1,000 VA Good Good Example 120 S-31 1,000 VA Good Good Practice 121 S-32 1,000 VA Good Good Practice 122 S-33 1,000 VA Good Good Practice 123 S-34 1,000 VA Good Good Example 124 S-35 1,000 VA Good Good Example 125 S-36 1,000 VA Good Good Practice 126 S-37 1,000 VA Good Good Practice 127 S-38 1,000 VA Good Good Practice 128 S-39 1,000 VA Good Good Example 129 S-40 1,000 VA Good Good Example 130 S-41 1,000 VA Good Good Practice 131 S-42 1,000 VA Good Good Practice 132 S-43 1,000 VA Good Good Practice 133 S-44 1,000 VA Good Good Practice 134 S-21 200 VA Good Good Practice 135 S-45 1,000 VA Good Good Practice 136 S-46 3,000 TN Good Good Practice 137 S-47 3,000 TN Good Good Example 138 S-48 3,000 VA Good Good Practice 139 S-49 3,000 VA Good and Good [Effect of the Invention] The liquid crystal alignment agent of the present invention, as can be specifically understood from the above examples, can be used as It is suitable for the liquid crystal alignment agent of the photo-alignment method, and can form a liquid crystal alignment film which exhibits good liquid crystal alignment and high voltage retention by a radiation irradiation amount smaller than before. Therefore, when such a liquid crystal alignment film is used for a liquid crystal display device, a liquid crystal display element excellent in display quality can be manufactured more expensively than ever. -95- 200911884 The liquid crystal display element of the present invention having the liquid crystal alignment film formed of the liquid crystal alignment agent of the present invention has good display quality. Therefore, the liquid crystal display element of the present invention can be effectively used in various devices, for example, it can be preferably used in a desktop computer, a watch, a clock, a coefficient display panel, a digital processor, a personal computer, or a liquid crystal television. -96 -
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007201881 | 2007-08-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200911884A true TW200911884A (en) | 2009-03-16 |
| TWI482799B TWI482799B (en) | 2015-05-01 |
Family
ID=40304472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW097129403A TWI482799B (en) | 2007-08-02 | 2008-08-01 | A liquid crystal alignment agent, a liquid crystal alignment film, a method for forming the same, and a liquid crystal display device |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP5170468B2 (en) |
| KR (1) | KR101143129B1 (en) |
| CN (1) | CN101730862B (en) |
| TW (1) | TWI482799B (en) |
| WO (1) | WO2009017252A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI480317B (en) * | 2009-03-31 | 2015-04-11 | Jsr Corp | Liquid crystal alignment agent and liquid crystal display element |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5370646B2 (en) * | 2009-02-12 | 2013-12-18 | Jsr株式会社 | Method for producing radiation-sensitive polyorganosiloxane |
| JP5776152B2 (en) * | 2009-10-14 | 2015-09-09 | Jsr株式会社 | Liquid crystal aligning agent, liquid crystal display element, and polyorganosiloxane compound |
| KR20130001144A (en) * | 2011-06-23 | 2013-01-03 | (주)켐넥스 | Photoactive crosslinking compound, method for preparing the same, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device |
| JP6048117B2 (en) * | 2012-03-22 | 2016-12-21 | Jsr株式会社 | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, and method for manufacturing liquid crystal display element |
| CN102786488A (en) * | 2012-08-06 | 2012-11-21 | 天津信汇制药股份有限公司 | Preparation method of intermediate for synthesis of micafungin and derivative thereof |
| TWI487742B (en) | 2012-09-10 | 2015-06-11 | Lg Chemical Ltd | Composition for photo-alignment layer and photo-alignment layer |
| KR102069288B1 (en) | 2013-08-28 | 2020-01-23 | 삼성디스플레이 주식회사 | Liquid crystal aligning agent and liquid crystal display |
| CN104020609A (en) * | 2014-05-16 | 2014-09-03 | 京东方科技集团股份有限公司 | Liquid crystal coating method and display panel manufacturing method |
| TWI560242B (en) | 2014-11-05 | 2016-12-01 | Chi Mei Corp | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| TWI560241B (en) * | 2014-11-05 | 2016-12-01 | Chi Mei Corp | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| JP6701661B2 (en) * | 2014-12-25 | 2020-05-27 | Jsr株式会社 | Liquid crystal aligning agent, method for producing liquid crystal element, liquid crystal aligning film and liquid crystal element |
| CN105647548B (en) * | 2016-02-23 | 2018-10-16 | 京东方科技集团股份有限公司 | Orientation agent, the production method of alignment film, display panel and display device |
| JP7039166B2 (en) * | 2016-09-30 | 2022-03-22 | 東京応化工業株式会社 | Resin composition, method for producing cured product, and cured product |
| CN113167957B (en) * | 2018-11-29 | 2023-09-26 | 日产化学株式会社 | Liquid crystal aligning agent, liquid crystal aligning film and phase difference material |
| CN110526923A (en) * | 2019-08-09 | 2019-12-03 | 南京邮电大学 | A kind of Porphyrin Molecule of side chain modification and its application |
| CN113861416A (en) * | 2021-09-30 | 2021-12-31 | Tcl华星光电技术有限公司 | Liquid crystal alignment agent, liquid crystal display panel and preparation method thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61275325A (en) * | 1985-05-31 | 1986-12-05 | Toshiba Corp | Resin composition for sealing electronic element |
| JP2001290155A (en) * | 2000-04-10 | 2001-10-19 | Agency Of Ind Science & Technol | Method of forming liquid crystal alignment film |
| US7074344B2 (en) * | 2001-10-03 | 2006-07-11 | Jsr Corporation | Liquid crystal aligning agent and liquid crystal display element |
| WO2003100510A1 (en) | 2002-05-23 | 2003-12-04 | Nissan Chemical Industries, Ltd. | Liquid crystal aligning agent, liquid crystal aligning films and liquid crystal display devices |
| JP4653421B2 (en) * | 2004-06-08 | 2011-03-16 | 株式会社 日立ディスプレイズ | Liquid crystal display device |
| JP4968422B2 (en) * | 2004-12-15 | 2012-07-04 | Jsr株式会社 | Method for producing liquid crystal alignment film |
-
2008
- 2008-07-31 CN CN2008800238690A patent/CN101730862B/en active Active
- 2008-07-31 KR KR1020107002300A patent/KR101143129B1/en active Active
- 2008-07-31 JP JP2009525469A patent/JP5170468B2/en active Active
- 2008-07-31 WO PCT/JP2008/064166 patent/WO2009017252A1/en not_active Ceased
- 2008-08-01 TW TW097129403A patent/TWI482799B/en active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI480317B (en) * | 2009-03-31 | 2015-04-11 | Jsr Corp | Liquid crystal alignment agent and liquid crystal display element |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2009017252A1 (en) | 2010-10-28 |
| KR20100029144A (en) | 2010-03-15 |
| CN101730862B (en) | 2011-12-07 |
| TWI482799B (en) | 2015-05-01 |
| CN101730862A (en) | 2010-06-09 |
| KR101143129B1 (en) | 2012-05-08 |
| JP5170468B2 (en) | 2013-03-27 |
| WO2009017252A1 (en) | 2009-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200911884A (en) | Liquid crystal aligning agent, liquid crystal alignment film, method for producing the same, and liquid crystal display device | |
| TWI434111B (en) | Liquid crystal aligning agent and liquid crystal display element | |
| CN102031122B (en) | Liquid crystal orientation agent, liquid crystal display element, polyamide acids, polyimides, and compound | |
| TWI477861B (en) | Liquid crystal aligning agent and liquid crystal alignment film | |
| TWI448486B (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, polylysine, ruthenium iodide polymer and compound | |
| TWI427104B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element containing the liquid crystal alignment film | |
| TWI495685B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TWI471654B (en) | A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device | |
| TWI485183B (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display device, polyamic acid and polyimide | |
| TW201006869A (en) | Liquid crystal alignment agent and liquid crystal display element | |
| TWI461802B (en) | Liquid crystal aligning agent and liquid crystal display element | |
| TWI468813B (en) | Liquid crystal aligning agent and liquid crystal display element | |
| TWI433870B (en) | Liquid crystal aligning agent and liquid crystal display element | |
| TWI445735B (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
| TW201001029A (en) | Liquid crystal aligning agent and liquid crystal aligning element | |
| CN102193250B (en) | Manufacturing method of liquid crystal display element, polymer composition and liquid crystal display element | |
| TWI427103B (en) | Liquid crystal aligning agent and liquid crystal display element | |
| TWI501011B (en) | Liquid crystal aligning agent and liquid crystal display element | |
| TW201704293A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TWI488950B (en) | Liquid crystal alignment film forming composition, liquid crystal alignment film, and liquid crystal display element | |
| CN101359130B (en) | Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element | |
| TWI444726B (en) | Vertical alignment type liquid crystal alignment agent and vertical alignment type liquid crystal display element | |
| CN103702976B (en) | Amine compound, preparation method thereof, liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TWI537308B (en) | Liquid-crystal alignment material, liquid-crystal alignment film and liquid-crystal display device | |
| TWI602878B (en) | Liquid crystal aligning agent |